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 Abstract 
Musculoskeletal conditions are the most common cause of severe long-term pain 
and physical disability, accounting for the highest disability costs of about $17 billion 
yearly. To provide better rehabilitation tactics, the knowledge gap between injuries 
and their healing mechanisms needs to be addressed. The use of electromyography 
(EMG) is very popular in detecting neuromuscular diseases or nerve lesions; 
however, there is limited knowledge available for quantifying healing patterns of 
EMG in orthopedic patients who have injured their joints, muscles, or bones. In order 
to quantify the progress of orthopedic patients and assess their neuromuscular 
health and muscle synergy patterns, EMG signals were collected from 16 healthy 
individuals and 15 injured patients as they underwent rehabilitation. Subjects 
performed a series of standard motions such as flexion–extension of elbow and 
pronation–supination of the arm. Different metrics were used to process and analyze 
the EMG data collected using MATLAB. The metrics were as follows: root mean 
square, average rectified signal, mean spike amplitude, zero crossings, median 
power frequency, and mean power frequency. A normal range across the muscle 
groups has been identified and to which the patient population was compared. This 
comparison showed statistically significant differences in the magnitudes of muscle 
recruitment and activation between the two groups. Furthermore, a comparison 
within the patient population at the beginning of their therapy versus at the end of the 
therapy was conducted. Statistical differences arose in this second analysis, further 
proving that patients’ signals tend to change and showing trends closer to those of 
the healthy population. The time domain metrics showed the greatest significant 
differences between the groups, specifically the root mean square and average 
rectified signal. This analysis was successful in showing a general trend of increased 
mean in the patient population compared to healthy individuals. The frequency 
domain metrics did not show statistical significance. The work presented 
successfully used several EMG metrics in order to distinguish an injured person from 
a healthy person and to determine if an injured patient is healing. Additionally, a 
database of EMG signals to be fed into the control system of the mechatronics 
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rehabilitative brace was created. This work has advanced the use of EMG beyond 
the scope of nerve damage. The experiments conducted showed that EMG could be 
used as method to assess musculoskeletal health. 
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Chapter 1  
1 Introduction 
Musculoskeletal (MSK) disorders and injuries are one of the leading causes of pain 
and disability in Canada. In 2013, upper limb injuries accounted for 12.1% of claims of 
lost time in Canada [1]. In addition to the long-term chronic nature of these conditions, 
they also exert a significant psychological toll on the patient and their families. People 
suffering from these conditions can live for decades with these painful debilitating 
conditions, which are in need of revolutionary rehabilitation strategies [2]. Moreover, the 
pain caused by the conditions may lead to physical inactivity, which is a precursor for 
numerous long-term health concerns that cause a cascade of further conditions and 
diseases that the individual has to endure.  
 MSK injuries that are related to sports, falls, or accidents cost the Canadian 
economy $15 billion each year [2]. The direct costs of these MSK conditions, such as 
hospital visits, physician visits, and drug prescriptions, are only one quarter of the overall 
costs. The remaining three quarters are attributed to indirect costs, which include 
underperformance in work, absence from work, etc. In the year 2000, the economic 
burden of MSK diseases was the 5th highest at $7.2 billion in Canada.  A 2010 Canadian 
study showed that 11 million Canadians over the age of 12 are affected by MSK 
conditions yearly [3]. Additionally, it is predicted that the number of people with MSK 
conditions will increase from 11 million in 2007 to 15 million in 2031. 
 As a result of the huge burden of these conditions, the Canadian Institute of 
Musculoskeletal Health and Arthritis (IMHA) developed a strategic 5-year plan from 2014 
to 2018, which includes the establishment of innovative approaches for tackling big 
research questions to effectively address the significant socio-economic burden caused 
by them. The IMHA strategic plan has a focus on the prevention of chronic 
musculoskeletal conditions through identifying and managing common risk factors, 
improving health, reducing injury, managing disability in the workplace, and reducing 
musculoskeletal disparities in vulnerable populations based on ethnicity, gender, age 
and geography. In an effort to contribute to decreasing the economic burden, better 
rehabilitation strategies are required. 
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1.1 Motivation  
There is a growing interest in the interaction and interfacing of humans with robots 
as a new rehabilitation technique. The scientific and medical communities have been 
extensively doing research in the field of Rehabilitation Robotics as it is envisioned to 
restore mobility and functionally assist individuals who suffer from physical disabilities 
and disorders [4]. Therapies that rely on robotics have the potential to provide longer 
and more frequent treatment sessions as they can be done at home without the 
therapist. Additionally, they can deliver a higher degree of objectivity and repeatability 
than manual therapy. Moreover, they can overcome barriers of travel for frequent visits 
to the therapist, thereby increasing compliance. 
As the field of Rehabilitation Robotics is growing, extensive research to advance in 
the field is required, especially on exoskeletons. Exoskeletons are wearable mechatronic 
systems in which the physical interface allows for an immediate transfer of mechanical 
power and exchange of information. In rehabilitation applications, exoskeletons can be 
designed to replicate movements performed with a therapist during treatment. Moreover, 
sensors attached to the exoskeleton can assess the forces and movements of the 
wearer thus providing the therapist with quantitative feedback on the progress of the 
patient throughout their rehabilitation process [5]. In addition to improving rehabilitation 
techniques, the developmental advances of exoskeletons can make them capable of 
assisting the wearer when performing certain motions. Signals collected from the 
sensors are fed into the device, and in return, the exoskeleton will be able to provide the 
mechanical power to carry out the task [4]. In other words, exoskeletons would be able 
to amplify the performance of the wearer and provide functional compensation.  
The greater part of the information available on rehabilitation robots focuses on 
neurorehabilitation [6]. Some of these devices are driven by electromyography (EMG) 
sensor where the person is assisted with the motion according to the signals emitted. In 
contrast, very little research has been found on robotic therapy for orthopedic 
rehabilitation. This is where the CNS is intact and the limb has physical damage. 
Research shows that trauma or surgery may lead to disorders in the motor framework 
and mechanisms of compensation for adaptive functions [6]. Through the use of the 
emerging EMG technology, objective findings and information can be collected to aid in 
the assessment of functional movement tasks so that muscle imbalances can be 
  
 
3 
3 
examined and ultimately lead to the improvement of therapy methods. In order to 
quantify the progress of the patient and assess neuromuscular health and muscle 
activation patterns, further research on EMG signals must be conducted on orthopedic 
patients. Since this is a fairly new and growing field, there is limited knowledge available 
that quantifies EMG in patients with no direct nerve lesions. The information collected 
can then be placed into a database that is used by the control system of a rehabilitation 
robotic device. The control system can draw additional information from the signal 
patterns that quantify health and optimal function, tailoring the therapy to each individual 
according to their current MSK health.   
Further research on how to develop these control systems to perform smart 
decisions based on each patient’s status of injury is needed, in order to provide 
individualized therapy.  
1.2 General Problem Statement 
Ideally, upper limb exoskeletons would be able understand and interpret the 
intended motion of the wearer, regardless of their injury level. Additionally, they would be 
able to assess the musculoskeletal level of health and provide the proper rehabilitation 
exercises accordingly. However, there is currently not enough information on EMG as a 
way to quantify muscle health. Health care providers pay a lot more attention to aspects 
that they can see using imaging techniques, such as broken bones and joint 
degeneration, whereas muscle function is generally never investigated. 
In order to shift towards evidence-based practice in therapeutic modalities and 
provide proper individualized care, EMG research outside of the nerve conduction 
studies field is required. Emerging evidence proves that musculoskeletal injuries, 
trauma, and surgery can compromise muscle functions causing proprioceptive deficits 
that affect neuromuscular control [7]. The assessment of muscle as a diagnostic tool and 
an outcome measure of rehabilitation along with the creation of a database of signals to 
be fed into the control system is required for an exoskeleton to function properly. This 
will allow for a shift to the innovative paradigm for evaluating muscle energy which 
unlocks an entire new domain of data and information [8]. 
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1.3 Research Objectives and Scope 
The main goal of this thesis is to identify and classify patterns of muscle activation 
through the characterization of EMG signals in order to distinguish an injured person 
from a healthy person and to determine if an injured patient is healing. This will be done 
in a healthy control group and in patients solely with orthopedic trauma where their CNS 
is intact but the limb is damaged. This can be either a broken bone, a tear in the muscle, 
or damage to the joint itself. There is limited literature regarding an exact exercise 
prescription in this area therefore further research is needed. 
 
To achieve this objective, the work has focused on the following objectives: 
 To collect EMG data from healthy subjects and patients with musculoskeletal 
injuries 
 To generate and analyze muscle recruitment EMG metrics of healthy subjects 
 To generate, analyze, and compare EMG metrics of patients with 
musculoskeletal injuries to the healthy control group.  
 To examine the recovering EMG patterns as the patients go through a full 
rehabilitation process 
 To establish levels or phases of healing in attribution to the EMG signals  
 To establish a database encompassing various EMG metrics necessary for the 
control system of a smart wearable device to assess the current level of healing 
of the wearer. 
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1.4 Overview of the Thesis 
 
The structure of the rest of the thesis is as follows: 
 
Chapter 2 Literature Review: Summarizes anatomy, physiology, MSK 
injuries, biomechanics of elbow, EMG signals structure, 
factors affecting EMG, principles of rehabilitation and 
modalities of therapy, and current state of the art 
exoskeletons 
 
Chapter 3  Methods of Data Collection: Outlines the methods for 
collection of EMG signals. This includes the pilot study, 
instruments used, the protocol, and the iterations made. 
 
Methods of Signal Pre-Processing and Processing: 
Describes the process of extracting the important information 
from the signals such as application of filters for noise 
removal and calculating the linear envelope. Additionally, all 
the EMG based metrics used in both the time and frequency 
domain are discussed 
 
Chapter 4 Results and Discussion: An in-depth analysis and 
comparison between the healthy group and the patient group 
is discussed as well as the patients at the first month of their 
therapy versus those at 4 or more months of their therapy. 
 
 
Chapter 5 Conclusions and Future Work: Highlights the contributions of 
this thesis and proposed suggestions. 
 
Appendix A  Ethics Permission and Approvals, Consent Form, and Trial 
Form 
 
Appendix B MATLAB Code 
 
 
Appendix C Statistical Analyses Tables 
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Chapter 2  
2 Literature Review and Background 
In order to analyze muscle activity using EMG from the upper limb, the anatomy, 
physiology, injuries, and current postoperative motion rehabilitation techniques were 
reviewed. Additionally, the EMG signal structure and factors that affect it were 
investigated. This section presents a summary of the relevant literature, including the 
human body and how it functions, EMG signals and their relationships with the body, 
and principles of rehabilitation. An extensive literature search was carried out between 
the periods of October 2014 and June 2016 using Google Scholar, PubMed, and the 
library at Western University with a combination of the following keywords: elbow, injury, 
rehabilitation, electromyography, EMG, orthopedic, and analysis. The resulting list of 
papers and books from this search references was reviewed giving priority to papers and 
books published within the last 15 years. A total of 71 papers and books were included 
in the complied database.  
 
Based on the relevant information found in these papers, the remainder of this chapter is 
organized as follows: Section 2.2 outlines anatomical terminology related to position and 
orientation for a good understanding of references to the body. Section 2.3 describes the 
anatomy of bones, the articulations of the elbow joint, the receptors and what happens to 
them when the joint is injured. Section 2.4 outlines and explains the muscles in the arm, 
the breakdown of the muscle, how the muscle contracts on a micro level, and how a 
normal muscle contracts versus an injured muscle. Section 2.5 discusses EMG signals 
and their relationship with force, velocity, and fatigue. Section 2.6 mentions the different 
limiting factors of EMG. Section 2.7 overviews the principles of rehabilitation and current 
modalities of therapy.  Finally, Section 2.8 provides a brief review of the current 
rehabilitation robots available on the market and in the research field.  
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2.1 Anatomical Position and Orientation 
Anatomical position is the description of the body in a particular stance in which the 
body is upright, facing forward. The lower limbs are directed forward and the upper limbs 
are to the body’s side with palms facing forward (supinated) as shown in Figure 2.1. In 
accordance with this position, universal frames of reference have been established to 
describe specific areas of the body accordingly as in Table 2.1 and Figure 2.1. These 
terms will be used throughout this thesis to explain anatomical landmarks or areas of 
injuries. 
Table 2.1 Anatomical position terms and their meanings 
Term Meaning 
Superior Above (towards the head) 
Inferior Below (away from the head) 
Anterior The front of the body 
Posterior The back of the body 
Medial Towards the midline of the body 
Lateral Away from the midline of the body 
Proximal Close to the centre of the body 
Distal Away from the centre of the body 
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Figure 2.1. Anatomical position with reference terms 
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The wrist has three positions: Supine, neutral, and prone as shown in Figure 2.2: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Positions of wrist: Supine (top), neutral (middle), and prone 
(bottom) 
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2.2 Osteology and Articulations 
The elbow, a compound synovial joint in the centre of the arm, is one of the most 
commonly used joints in the body [9]. It is classified as trochoginglymoid joint possessing 
two degrees of freedom (DOF) [10][11]. A trochoid joint is a pivot joint that allows rotary 
motion while a ginglymoid joint is a hinge joint that allows a back and forth motion. 
However, there is a valgus–varus motion that occurs during elbow flexion of about 3 to 4 
degrees [11]. In normal circumstances, the elbow flexion ranges from 0 or slightly 
hyperextended to about 150 degrees in flexion. As a result, this joint allows the arm to 
be more adaptable to multiple movements, yet is very prone to injury. It is a contact point 
of trauma and repetitive stress injuries. There are three main bones that make up the 
complex elbow joint: humerus, radius, and ulna as shown in Figures 2.3 and 2.4. 
Distal Humerus: 
The humerus is the sole bone in the upper arm as well as the largest in the entire 
arm. The humerus motion initiates various arm motions such as lifting, carrying, writing, 
and throwing. Muscles that move the upper arm and the forearm are attached to the 
humerus. For purposes of this thesis, the focus will be on the muscles that move the 
forearm; shoulder motions are excluded. Approaching the elbow joint, the humerus 
widens in a gradual manner while doubling in width. At the end of the humerus, towards 
the elbow joint, also referred to as the distal end, there are two joint-forming processes 
known as the capitulum and the trochlea [12].  
Ulnohumeral Joint [11] [12]: 
Medially, the trochlea interlocks with the ulna of the forearm to form the first 
articulation of the elbow joint: the humeroulnar joint. This joint resembles a simple 
uniaxial hinge movement allowing the ulna to angle with respect to the humerus. The 
trochlea is asymmetrical, with its axis of motion pointing superolateral to inferomedial. 
This allows for full range of motion using joint play. As a result, the carrying angle of the 
elbow is formed when the arms are at the side of the body. This angle is 10–15 degrees 
in men and 20–25 degrees in women. 
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Radiohumeral Joint [11] [12]: 
Posteriorly, there is a small cavity in the humerus called the olecranon fossa in 
which the tip of the ulna, called the olecranon, locks into the humerus preventing further 
extension of the elbow beyond 180 degrees. On the lateral side of the arm, a convex 
shaped process in the humerus called the capitulum articulates with the concave shaped 
head of the radius in the forearm creating the second contact of the elbow joint called 
the humeroradial joint. This joint allows the forearm to passively rotate. 
Proximal Radioulnar Joint [11] [12]: 
  The head of the radius interacts with the radial notch in the ulna making the 
proximal radioulnar joint. This joint allows the forearm to pronate and supinate.  
Distal Radioulnar Joint [11] [12]: 
Distally, the radius and ulna anchor to form the distal radioulnar joint. This joint is 
critical in forearm rotation. 
Middle Radioulnar Joint [11] [12]: 
Between the shafts of the radius and ulna lays the interosseous membrane and 
the oblique cord forming a syndesmosis, a slightly moveable joint. This area is affected 
by injury and immobilization of the elbow; as a result, the mechanics of the elbow can be 
affected when this area is injured. The soft tissue between the bones provides 
resistance to distal displacement of the radius during pulling movements, stabilizes the 
elbow by resisting proximal displacement of the radius on the ulna during pushing, 
provides stability to the other radioulnar joints, and transmits forces from the hand and 
the distal end of radius to the ulna. 
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Figure 2.3. Anterior view of the arm bones and articulations 
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Figure 2.4. Posterior view of the arm bones and articulations 
Metacarpals 
Phalanges 
Radiohumeral Joint 
Radial Head 
Humerus 
Olecranon Fossa 
Radioulnar Joint 
Ulnohumeral 
Joint 
Ulna 
Carpals 
Olecranon 
Radius 
  
 
14 
14 
2.2.1 Acute Traumatic Injuries of Bone and Ligaments 
MSK disorders and injuries of the elbow may occur in muscles that move the 
elbow, bones, tendons, cartilages, ligaments, and the joint capsule [1]. The elbow is the 
second most commonly dislocated joint in adults and the first most common in children 
[13]. These fractures are most commonly prevalent in contact sports such as football 
and wrestling or from falls. Hyperextension of the elbow, falling on the outstretched 
hand, or a combination of supination, valgus, and external rotation of the forearm during 
axial loading can all cause elbow dislocations [14]. The structures that are affected by 
the dislocation vary according to the impact and the individual. Ligaments, muscles, 
tendons, and bones can all be involved and injured by trauma.  
  Radial head fractures are the most common fractures in the elbow [15]. The 
mechanism of injury is very similar to that of the dislocations previously mentioned. 
Generally, stable fractures and dislocations can be managed conservatively with casting 
or bracing while complicated fractures require surgery [16]. 
Trauma to the elbow may affect intrinsic and/or extrinsic structures. Intrinsic 
structures include bone, joint capsule, and ligament while extrinsic structures are skin, 
nerves, tendons, and muscles [17]. The long-term consequences of these fractures or 
dislocations include loss of range of motion, loss or decrease in force production, 
instability of the joint, and chronic pain. 
2.2.2 Receptors 
Joint receptors convey information to the CNS about the position of the joint. This 
information is then interpreted by the CNS, which uses it to coordinate muscle activity 
about the joint in a stable manner [12]. This is achieved by determining a balance 
between the synergistic and antagonistic muscular forces. Additionally, the CNS guides 
the motion away from the pathologic ROM, in other words, the CNS protects the joint 
from performing motions that are unsafe.  
Muscle spindles monitor the outcome of gravity acting upon a person and adjust 
the muscle tone in order for the person to be balanced [8]. If the muscle tone is too high 
or too low, the timing and effort of the motion is thrown off balance. Goodwin et al. 
conducted an experiment proving that signals from the muscle spindles produce the 
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sensation of limb movement [18]. Gandevia and Proske argued that muscle spindles are 
responsible for the sense of position and movement, tendon organs are responsible for 
tension, the sense of effort is generated within the CNS, and sense of balance is by the 
vestibular system[19][20][21].  
There are a few nerves that innervate the muscles crossing the elbow joint. Their 
receptors detect changes in position, tension, compression, speed, muscle length, and 
force. When a change occurs, it is relayed to the CNS. According to the signals received 
by the CNS, integrated signals are then sent to modify the activations of motor units 
(MUs) to generate the suitable muscle tension for the desired motion [22]. Following 
elbow injury or trauma, this system may be compromised. Moreover, immobilization or 
limited mobility also causes abnormal programming of the receptor system function 
[22][23]. 
2.2.3 Proprioception and Neuromuscular Control 
Proprioception contributes to the “motor programming” of neuromuscular control 
needed for motion, muscle reflex, and dynamic joint stability [24]. Lephart et al. argued 
that the neuromuscular feedback mechanism is compromised with injury and 
abnormalities. As a result of the proprioceptive deficits, the individual becomes more 
susceptible to re-injury and enters a relentless cascade of re-injury and functional 
instability as shown in Figure 2.5. 
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A study by Wyke showed a patient that depicted changes in posture after an 
injury to the ankle capsule despite a complete recovery [25]. Normal strength and range 
of motion was restored with no pain. However, the patient complained of the ankle 
“giving away”. This proves that due to the injury, the neural input to the CNS (see Figure 
2.6) was compromised resulting in a decrease in neuromuscular control [24]. 
Consequently, in addition to pain-free range of motion and regaining strength, the 
retrieval of neuromuscular control is crucial in order for the patient to function optimally in 
a normal manner. Figure 2.6 reiterates that if any of the mechanoreceptors are 
compromised, the CNS will no longer relay proper information to the motor control and 
thus results in incorrect muscle activation. 
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2.3 Muscle Anatomy and Physiology of the Upper Limb 
To understand the mechanisms of injury and rehabilitation, a full understanding of the 
muscles involved in this mechanism is crucial. The next section will include an 
explanation of muscle anatomy such as the origin and insertion of the muscles. 
Additionally, a description of how movement is produced on a macro and micro level is 
conducted.  
2.3.1 Muscles of Interest 
The muscles that were explored in this thesis are mentioned in Table 2.2. The table 
mentions the muscle group each muscle belongs to along with the origin, insertion, and 
function of the muscle. 
 
Muscle Muscle 
Group 
Origin Insertion Function 
Biceps 
Brachii 
Elbow Flexor 
and 
Supinator 
Coracoid Process 
of Scapula and 
Supraglenoid 
Tubercle  
Radial 
Tuberosity 
and bicipital 
aponeurosis 
Major Flexor and 
Strong Supinator 
Extensor 
Carpi 
Ulnaris 
Elbow Flexor 
and Wrist 
Extensor  
Supracondylar 
Bony Column 
Dorsal base 
of second 
metacarpal 
Primarily a wrist 
extensor, however its 
orientation suggests it 
might function as an 
elbow flexor in 
pronation 
Pronator 
Teres 
Elbow Flexor 
and Pronator 
Medial 
Supracondylar 
Ridge of Humerus 
and Coronoid 
Process of Ulna 
Middle of 
the Lateral 
Surface of 
Radius  
Strong Pronator of 
Arm and Weak Elbow 
Flexor 
Table 2.2. A list of the muscles of interest, their origins, insertions, and their 
function [11] 
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Flexor 
Carpi 
Ulnaris 
Elbow Flexor 
and Pronator 
Medial Epicondyle 
and Medial Margin 
on Olecranon of 
Ulna  
Pisiform 
(Carpal) 
Wrist Flexor, Ulnar 
Deviator, and Weak 
Elbow Extensor 
Triceps 
Brachii 
Elbow 
Extensor 
Infraglenoid 
Tubercle, Proximal 
Lateral 
Intramuscular 
Septum on 
Posterior Surface 
of Humerus, and 
Distal half of the 
Posteromedial 
Surface of the 
Humerus 
Olecranon 
Process of 
Ulna 
Primary Elbow 
Extensor 
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Figure 2.7. Anterior arm muscles 
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2.3.2 Muscle Fibre 
Macroscopically, muscle fibres are grouped together and are identified by their line of 
action, origins and insertions, and direction of pull. However, on a deeper level, one 
muscle can be broken down to several compartments (fascicles) with fibres running in 
the same direction or a different one. Each of these muscle fibre-containing 
compartments can be further broken down into clusters of individual fibres called 
myofibrils. Each myofibril contains myosin (thick fibres) and actin filaments (thin fibres), 
which make the basic single unit anatomical structure of a muscle called the sarcomere 
(see Figures 2.10 and 2.11). During an action potential propagation, the filaments slide 
on top of each other forming myosin-actin cross bridges causing the muscle contraction. 
The maximum strength is obtained in the middle range where the most amount of 
bridges are formed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Myofibril 
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Figure 2.9. Breakdown of skeletal muscle showing the fascicles and myofibrils 
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2.3.3 Motor Units and Action Potentials  
As described in Section 2.4.2, a muscle is comprised of bundles of cells specialized 
for contraction and relaxation [26]. The main function of these specialized cells is to 
generate forces and motions. The contraction of skeletal muscle is commenced by 
voluntary impulses in the neurons to the muscle. Each bundle of these fibres is 
innervated by a single motor neuron, called a Motor Unit (MU) as shown in Figure 2.12 
below [27]. 
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Figure 2.11. Motor unit 
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A MU is the smallest neurological functional unit that controls muscles in contraction 
and relaxation. Muscle fibre contraction occurs when the action potential reaching the 
motor neuron and axon terminal surpasses the threshold of depolarization (Figure 2.13) 
[28]. This initiates a propagation of action potentials along the length of the muscle fibre 
causing tension. At rest, the α-motor neuron becomes inactive causing relaxation of the 
muscle fibres. A single muscle fibre receives input from only one MU [29]. During 
contraction of a muscle, the smallest fibres are recruited first [8]. As the exertion 
increases, the larger fibres and MUs are then employed. Normally, the firing rate is 
between 8 and 50 Hz. As the demand increases, the firing rate increases to higher 
frequencies. Additionally, as the demand increases, a shift towards a synchronous 
pattern of activation occurs. Asynchronous patterns are what provide a smooth 
movement.  
 
 
 
 
 
 
 
 
 
The summation of 
muscle fibre action potentials from the contacted muscle of a single 
MU is called a Motor Unit Action Potential (MUAP) [26]. MUAPs can be measured by 
surface EMG electrodes. These are “little microphones which listen for MUAPs” [30] . 
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These electrodes measure the voltage of the summation of the active MUs depolarizing 
and repolarizing during the movement (see Figures 2.14 and 2.15).  
 
 
 
 
 
 
  
Figure 2.13. Superimposition of MU Recruitment 
Figure 2.14. Depolarization Wave 
Electrodes 
Direction of propagation 
Skin 
Differential 
Amplifier 
Display 
Unit 
Depolarized 
Membrane Area 
  
 
26 
26 
2.3.4  Types of Contraction 
After explaining how muscles contract on a micro level, it is important to note what type 
of contractions this organ system can produce. There are four types of muscle 
contractions [8]. The first type of contraction is concentric. This occurs when a muscle 
shortens during a contraction and has enough force to overcome the external resistance. 
An example of this contraction is during elbow flexion while lifting a dumbbell. The 
biceps shortens during flexion overcoming the resistance of the weight being carried. 
Next there is eccentric, which occurs when a muscle lengthens during a contraction of 
an already shortened muscle and the external force is greater than the tension in the 
muscle. An example of this is when a person carrying a dumbbell extends his or her arm 
to achieve elbow extension. The person’s biceps lengthens as the weight forces the 
elbow in the direction of extension. There is a special class of contraction that is a 
subset of both concentric and eccentric called isotonic. This occurs during either 
concentric or eccentric contractions however the muscle force being generated is 
constant throughout. Lastly, isometric contraction occurs when the muscle length 
remains constant during a contraction. Isometric contraction can be achieved through 
any static exercise such as holding a pushup halfway through. 
2.3.5 Biomechanics and Kinetic Chain of the Elbow 
Muscles are the active elements of the body acting upon static elements, i.e., our bones, 
to produce movement. According to the origin and insertion of each muscle, its 
contraction and relaxation can contribute significantly or minimally to move a joint. 
Forces and moments created at the elbow are stabilized by a series of structures such 
as the muscles, tendons, ligaments, and articular surfaces [11]. Similarly, the magnitude 
and direction of forces in the elbow along with the muscle tension is dependent on the 
external loading conditions and the muscle response. In order to calculate these forces 
produced by muscles about the elbow joint, a two-dimensional force analysis through a 
free-body analysis is required.  The following set of equilibrium equations were displayed 
in an analysis by Morrey [11]: 
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∑|𝐹𝑖|𝑓𝑥𝑖 + 𝑅𝑥 + 𝑃𝑥 = 0 
∑|𝐹𝑖|𝑓𝑦𝑖 + 𝑅𝑦 + 𝑃𝑦 = 0 
∑|𝐹𝑖|. 𝑟𝑖 + 𝑃 + 𝑟𝑝 = 0 
where |Fi| is the magnitude of the tension in the muscle i; fxi and fyi are components in the 
x and y directions for the unit vector alongside the line of action of muscle; Rx and Ry are 
the x and y components of the joint contact force; P, Px, and Py are the magnitudes of 
the applied forces on the forearm and its associated components; and ri and rp are the 
moment arms of the muscle force and the applied force to the elbow joint centre, 
respectively. 
Table 2.3 provides a summary of the forces produced and the lines of actions by 
muscles of interest around the elbow joint to allow for flexion and extension of the elbow.  
As shown, the biceps and Triceps provide the majority of the force contributions while 
the forearm muscles provide limited to no contribution according to the calculations. 
Nevertheless, their anatomical positions suggest that they do provide contributions but 
are inconsistently reported in literature.  
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Elbow Joint Flexion Angle 
(degree) 
0° 30° 
Muscle PCSA Moment Arm (r*) Fx Fy Moment Arm 
(r) 
Fx Fy 
BB 4.6 20.7 0.86 0.5 20.7 .86 .5 
FCU 1.6 0 1 0.04 0 .99 0.04 
ECU 1.7 -0.2 .99 .16 -9.0 .99 .16 
TB 18.8 -23.0 1.0 0.09 -26.0 .81 .59 
Elbow Joint Flexion Angle 
(degree) 
90° 120° 
Muscle PCSA Moment Arm (r) Fx Fy Moment Arm 
(r) 
Fx Fy 
BB 4.6 45.5 .17 .99 0 1 .04 
FCU 1.6 0 1 0.04 -8.0 .98 .19 
ECU 1.7 -9.0 .98 .19 -17.0 0.05 1.0 
TB 18.8 -20.0 .05 1.0 40 .35 .93 
r* = mm, Physiologic Cross-Sectional Area (PCSA) = cm2 
Table 2.3. Physiological cross-sectional area, unit force vector, and moment arm 
of elbow muscles in sagittal plane 
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2.3.6 Muscle Coactivation and Recruitment Pattern 
Muscle tone is the state of constant low-level contraction that is shown by the 
muscles at rest [29].  This is crucial in order to stabilize the entire skeleton and maintain 
the joint positions, providing a basis for resistance to gravity and movement. If the MUs 
are all continuously firing, the body will become exhausted very quickly; therefore the 
body smoothly rotates contractions throughout the various MUs to maintain a constant 
resting contraction throughout. This is referred to as an asynchronous contraction 
pattern. Emotional stress and anxiety can affect this resting muscle tone. When motions 
are executed they are superimposed upon the resting muscle tone. If the muscle tone is 
higher or lower than normal levels, the timing of actions becomes distorted.  
Muscle coactivation is the activation of agonist and antagonist muscle groups 
simultaneously around a joint [31]. It is a common strategy to control voluntary motion 
while moderating the impedance of the joint to stabilize it [32]. A study by Glousman et 
al. depicted changes in kinematics through the use of EMG in baseball pitchers with 
shoulder instability [33]. A reduction in neuromuscular activation was observed in the 
muscles of the chest and back which provided anterior stability to the shoulder.  As a 
result, a compensatory over-activation of muscles in the arm was discovered in an 
attempt to provide the shoulder with anterior stability. The loss in healthy synchronized 
patterns of muscle activation has been attributed to the altered kinematics and 
proprioception resulting in continuous microtrauma. Similarly, evidence also suggests 
reduced activity of the forearm flexor and pronator muscles and increased activity of the 
extensor muscles with ulnar collateral ligament injuries in baseball players [34]. 
2.3.7  Normal vs. Compromised Function 
An understanding of normal functioning movement is important to health care 
professionals such as physicians and therapists. Normal function is defined as the ability 
of the body to move and interact within its environment [7]. Panjabi introduced a concept 
of integrated systems in describing spinal function [35]. He discussed that the normal 
function requires a chain of systems functioning together. The “control system” which is 
the CNS of the body is the first component of this integrated system followed by the 
“active elements” which are the muscles and the “passive elements” which are the 
vertebrae and discs. He then argued that if any of these “systems” were to malfunction, it 
could lead to one of the following responses: 
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1- A compensatory immediate response from the other functional systems 
2- A long-term adaptive response of the other systems 
3- An injury to one or more of the other systems 
In the first response, function would be compromised in comparison to the second 
response, which would appear normal, however the mechanism of stabilization would be 
different. In the third and last response, an obvious dysfunction would be depicted in the 
form of pain and limited ROM. Since our understanding of the “control system” is limited, 
extensive research is required to understand the mechanics of movement in both active 
and passive perspectives [7].   
2.4 EMG Signals 
Biomedical signals are a collection of electrical signals obtained from physiological 
activities of living organisms. They can be acquired from a wide range of activities 
starting from protein and genetic sequences, to neural and cardiac rhythms, and finally 
to tissue and organ images [36].  These signals are usually a function of time and can be 
quantified through their amplitude, frequency, and phase [30]. By processing these 
signals, health care professionals can detect and monitor specific illnesses or diseases. 
Since the nervous system is responsible in controlling the muscle activity of the body, 
the EMG signal demonstrates the electrical currents of the area being measured during 
muscle contraction thus providing data describing muscular morphology and 
neuromuscular activity [27]. As a result, the analysis and interpretation of EMG signals is 
crucial in the field of management and rehabilitation of motor disabilities and 
musculoskeletal injuries.  
2.4.1 EMG Signals Assessment 
Dynamic Surface EMG is the assessment of how muscular energy is used to provide 
support against gravity, how it executes movements, and how it rests. Through EMG 
assessment, one can look at the timing of muscle firing, i.e., if it fires early or late in the 
recruitment pattern. Moreover, looking at if a particular motion is activating the muscle 
that it is intended to or if there is a substitution in the pattern. In addition to looking at 
muscle dysfunction within a motion, it is important to note how previous baseline levels 
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affect the movements and how the motions might disrupt the capacity to return to resting 
levels.  
When health care providers examine muscles, they routinely perform muscle testing 
where they isolate the strength of a given muscle. The practitioner needs to position the 
limb in an abnormal position in order to separate the strength of the muscle of interest. 
These tests do not follow natural movement patterns since they are “slices of a unique 
movement pattern, taken out of a normal muscle contraction context and frozen in time” 
[8]. As a result, manual tests are not a good representation of the health or damage of 
the muscle function. They are only pertinent to the degree that the information obtained 
can be placed within a more functional context.  
The use of surface EMG objective findings can provide information to clinicians and 
researchers regarding the mechanisms of muscle function and dysfunction and 
consequently, improve therapy methods [8]. In addition to muscle testing, EMG can be 
used to monitor the muscles involved or suspected to be involved in a particular 
movement. Therefore, practitioners can evaluate not only muscle’s strength, but also 
their synergy with other muscles.   
2.4.1.1 Baseline Level 
The baseline level is a part of the signal can be an important marker for presenting 
muscle dysfunction prior to and following a motion. When the muscles are resting, the 
muscle tone should be minimal. However, with injuries, some individuals may have an 
elevated baseline signal indicating high muscle tone activity, or a disturbance in muscle 
spindles secondary to a trigger point [8]  
2.4.1.2 Recovery of Baseline Level 
Between repetitions of a motion and after the motion is completed, the resting tone 
should go back to the baseline level during the recovery period. If a muscle fails to return 
to pre-baseline levels, it is termed post-movement irritability. Failure to return to resting 
amplitude is a sign of disturbance in muscle spindles secondary to a trigger point [8][29]. 
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2.4.2 EMG Signals and Clinical Syndromes 
Atypical EMG signals may arise from different types of MSK dysfunctions. These 
dysfunctions are briefly explained below [8] [29]:  
 Learned guarding or bracing: This causes heightened muscle activity in reaction 
to pain or discomfort upon motion.  
 Learned inhibition/weakness: A decreased muscle activity in reaction to pain or 
discomfort upon motion is depicted 
 Acute, reflexive spasm/inhibition: This can cause either an increase or decrease 
in muscle tension induced by pain or effusion. 
 Peripheral weakness or deconditioning: Weakness or deconditioning causes 
impaired muscle activity due to disuse commonly caused after immobilization, 
surgery, or a very sedentary lifestyle and poor motor habits. It may result in  
muscle atrophy, ineffective vascularization, and compromised biochemical and 
physiological function. Symptoms may include a decrease in peak torque, power 
deficits, and fatigue. Maximal efforts will probably show decreased muscular 
activity while submaximal efforts will show increased activity. 
 Compensation for joint hypomobility or hypermobility: Excessive laxity or stiffness 
may cause the neuromuscular system to compensate accordingly by over or 
under-activating specific muscles. 
 Chronic faulty motor programs: The CNS learns to cope with muscle weakness, 
instability, trigger points, pain, and various other aspects of injury through the 
disruption normal muscle co-activation patterns (agonist-antagonist-synergist 
relationships). 
2.4.3 EMG Amplitude and Force Relationship 
Various pathologies can affect the EMG-Force relationship [37]. MUAPs amplitude 
cancellation, synergistic muscles, co-contractions, and passive elements contribute to 
the linearity of the EMG amplitude and force relationships. EMG models often simplify 
the relationship by assuming that it is linear [38] 
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When additional force is required, more MUs are activated [37]. MUs are 
activated by increasing size, starting with the smallest. This process of increasing the 
number of active MUs is called recruitment. The number of MUs recruited have an effect 
on the EMG signal; the larger the number of MUs are recruited, the larger the signal 
amplitude. Moreover, there is an alternative way of increasing muscular force. This can 
be achieved through increasing the rate of firing — the frequency of the MUs. This is 
referred to as firing rate and also has an effect on EMG signal amplitudes. The minimum 
firing rate is dependent on the muscle but it can range between 5 and 10 impulses per 
second. As the request for force increases, the firing rate increases up to a maximum 
firing rate surpassing 60 impulses per second in some muscles [39].  
2.4.4 EMG and Force-Velocity Relationship 
The velocity of a muscle contraction can affect the amount of force produced. The speed 
of a muscle contraction is dependent on the rate of cross-bridging at the sarcomere level 
[8]. Less force is produced when the contractions are faster.    
2.4.5 EMG and Fatigue Relationship 
When the muscle contraction is sustained for an extended period of time, the 
conduction velocities of the action potentials decrease and the muscle begins to 
discharge less frequently [29]. Muscle fatigue effects are related to insufficient blood flow 
to the tissue, the exhaustion of energy sources, and the accumulation of metabolites in 
the muscles. This accumulation of metabolites includes hydrogen ions, which ultimately 
slows down the MUAP. Moreover, a shift of dominance from fast-twitch to slow-twitch 
fibres may occur [8]. As a result, increased amplitude is often associated with fatigue 
due to the increased synchronization of the motor unit in maximal sustained contractions 
while motor units decrease in firing leading to smaller amplitudes of the submaximal 
contractions [37]. Finally, a reduction in median frequency of the signal power is 
exhibited with fatigue 
As muscle fatigues, the frequency of the firing drops; however, the mean amplitude 
may stay the same. As a consequence, using the time domain alone as a fatigue 
indicator may be very difficult. A shift to the frequency domain is crucial where two 
important measures of muscle fatigue are examined: median and mean frequency. As 
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muscles fatigue, both mean and median frequencies decrease. However, these 
indicators have been primarily applied in isometric contractions [40]. 
2.5 Factors Affecting EMG Signals 
It is important to note the limitations of the thesis. Surface EMG is an evolving field and 
there is a need for further advancements, as plentiful research remains undone. Factors 
affecting EMG signals are briefly discussed in this section. 
2.5.1 EMG Noise 
One of the most significant factors that affect the EMG signal is noise. Noise may 
arise from the imprecision of the equipment which cannot be eliminated, it can be 
reduced by using high quality electrodes [26]. Noise is also created from our own bodies, 
referred to as “ambient noise”, which is due to electromagnetic radiations emitted from 
the human body. This type of noise is also virtually impossible to avoid. Another source 
of noise is motion artifacts, which skew the data and cause irregularities. The electrode 
interface or electrode cable can cause this. Motion artifacts can be decreased by an 
appropriate design of the electronic circuitry and set-up.  
2.5.2 Movement of Skin in Dynamic Motion 
Another influencer of EMG signals is the sliding of skin on top of muscles. Recordings 
obtained in dynamic conditions are more problematic than in static conditions as the 
muscles change their resting length and move under the skin, as shown in Figure 2.16 
on the next page. Consequently, the dominant muscle belly portion is selected as much 
as possible in order to prevent the electrodes from being away from the muscle during 
motions. 
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2.5.3  Cross Talk  
Muscle crosstalk also contributes to the contamination of pure EMG from the muscles of 
interest. Cross talk are signals picked up by the surface EMG electrodes produced by 
neighboring muscles to the one under investigation [40]. It is minimized by placing the 
electrodes on the middle of the muscle belly with an inter-electrode distance of 2 cm.  
Figure 2.15. Biceps muscle shifting medially during flexion 
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2.5.4 Causative Factors 
In addition to the previously mentioned influencers, the following factors also have an 
elemental effect on the signal [41]: 
Extrinsic Factors: These are those factors that are influenced by the experimental 
setup, and include the following: 
 Electrode configuration: 
o Distance between electrodes [41] 
o Surface area of electrodes [41] 
o Shape of electrodes [41] 
 Electrode placement in reference to: 
o Motor points [30] 
o Orientation of muscle fibres [30] 
o Lateral edge of the muscles [30] 
 Electrical noise: 
o Inherent noise – general equipment noise [26][37] 
o Ambient noise – electromagnetic radiation [26] 
o Motion artifact – motion causing data skewing [42] 
o Power line noise [42] [37] 
 Skin preparation and impedance [43] 
 Perspiration  
 Temperature [44] [45] 
Intrinsic Factors: Includes all anatomical, physiological, and biochemical 
characteristics, such as the following: 
 Number of active MUs [41] 
 Fibre type composition [41] 
 Blood flow [41] 
 Muscle fibre diameter [41] 
 Amount of tissue between electrode and muscle [41] 
 Muscle and fibre length [46] [47] 
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2.5.5 Conclusions  
Considering all the possible contaminating and limiting factors described, dynamic EMG 
recordings still provide a degree of consistency between the readings. Surface EMG 
allows for reliable [48], predictive, and descriptive information that is of high value for 
researchers and health care professionals.   
2.6 General Principles of Rehabilitation of Elbow and Upper 
Arm 
In order for the mechatronics brace to provide treatment to its wearer, an understanding 
of current rehabilitation protocols is required. There is a plethora of research in the 
rehabilitation field, however there are no set distinct literature guidelines or randomized 
clinical trials for elbow trauma patients [49]. Additionally, rehabilitation protocols are 
often inadequately described and therefore non reproducible. Health care professionals 
often depend on the methods and protocols they were trained to do by a senior health 
care provider and consequently they use their own subjective judgment to treat each 
patient.  
2.6.1 Classification 
The elbow and forearm are crucial parts of the upper body kinetic chain which 
executes the activities of daily living as well as activities of work, sports, and leisure [7]. 
In comparison with other fractures and injuries, the elbow has a higher complication rate 
and poorer outcomes with a trend to rapidly develop intra-articular and periarticular 
adhesions, which results in loss of motion [11] [17]. The goal of elbow rehabilitation is to 
restore optimal, pain-free function within the limitations of the patient, anatomically and 
physiologically. Functional restoration of the elbow joint is mainly achieved through 
exercise therapy. Initially, an assessment must be made to identify performance level 
and deficits or impairments in the motions [7]. In the follow up assessments, it is crucial 
to establish a phase of healing and the degree of severity of the condition in terms of 
neuromusculoskeletal and sensorimotor impairment. Early motion is desired to decrease 
or prevent the adhesions, mitigate against the effects of rigidity, assist the lymphatic 
system and venous return, and control pain though proprioceptive mechanisms[11]. 
These advantages must be compared to the risk of irritating healing tissues. 
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According to Morrey and Smith, the principles to guide the rehabilitation process 
are as follows: 1) establish a complete and accurate diagnosis; 2) control pain and 
inflammation; 3) implement early, atraumatic motion; 4) re-establish neuromuscular 
control about the elbow; 5) rehabilitate the elbow in the context of the kinetic chain.  
Vicenzio et al. argued that therapy is broken down into 4 categories. 1) 
improvement of general aerobic fitness; 2) restoration of muscle length and ROM; 3) 
strength, endurance, and power improvements; 4) normalization of elbow and forearm 
coordination and proprioception [13].  
Wilk et al. discussed the basic principles of rehabilitation and grouped them into 
four stages: 1) stage of early mobilization; 2) intermediate stage of recovery; 3) stage of 
advanced strengthening; and finally 4) stage of return to working/sports activity.   
Currently, there are no randomized clinical trials or consensus on literature 
guidelines about elbow rehabilitation for traumatic pathologies [49]. Therapists are 
conducting a wide range of non-operative treatment regimens and rehabilitation 
programs. Traditionally, clinical techniques to assess muscle function are mechanically 
based to measure strength, endurance, and ROM [50]. Conversely, this form of 
mechanical testing has a major drawback: if the patient is able to over work other 
“systems” or aspects of his or her body to achieve the desired motion, the patient will 
appear fully recovered. These tests do no provide muscle-specific information; they 
simply group all the muscles that move a particular joint as one large muscle while 
overlooking any synergistic interactions as the muscles co-activate to achieve the motion 
[50] . Advanced imaging methods such as CTs and MRIs provide a more objective 
measure than the mechanical methods, but provide limited information on the dynamic 
muscle function. In contrast, EMG provides the required method to access the 
physiological properties of the muscles that causes them to generate force, produce 
motions, and execute activities of daily living [51]. 
  
2.7 Modalities of Therapy 
In the clinical setting, there are numerous forms of therapy administered according to the 
subjective view of the therapist or health care practitioner. The most common forms of 
therapy are listed below [11] [12]: 
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1. Protection and Relative Rest: This is when the joint is immobilized to protect its 
healing tissues from further damage. 
2. Ice: Placing ice on the injured area reduces inflammation, lessens pain, and 
controls muscle spasms. 
3. Compression and Elevation: The placement of a compressive band along with 
elevation helps reduce swelling of the injured area. 
4. Medications: Drugs are prescribed by the physician according to the patient’s 
injury and symptoms.  
5. Passive Range of Motion (PROM): This is the movement of the joint by an 
external force without the patient exerting any effort to produce movement. It is 
important to induce tissue length change to eventually gain motion after the 
injury. 
6. Active Assisted Range of Motion (AAROM): AAROM is the movement of the joint 
initiated by the patient with external help to assist the full motion intended. This 
prevents intra-articular and peri-articular adhesions, controls edema, promotes 
cartilage healing, and modulates pain. 
7. Active Range of Motion (AROM): This motion is fully performed by the patient 
with no external help like in AAROM. Movement of the joint achieves the same 
effects as AAROM with the addition of the stimulation of neuromuscular control  
8. Resisted Range of Motion (RROM) [12] [11]: RROM occurs when an external 
force is resisting the motion produced by the patient, which helps in the 
restoration of neuromuscular control. 
2.8 Exoskeleton Robots for Upper Limb Rehabilitation 
 
Robotic neurorehabilitation is an attractive form of therapy as it is easy to implement can 
be applied to a broad assortment of motor impairment, and is greatly reliable. 
Rehabilitative exoskeletons currently available are aimed for neurorehabilitation of 
stroke, brachial plexus injuries, traumatic brain injuries, spinal cord injuries, and 
neurological disorders (multiple sclerosis, amytrophic lateral sclerosis) patients [52]. In 
comparison to manual therapy, exoskeletons can provide long intensive rehabilitation 
that are not dependent on the skills or fatigue levels of the therapist providing the 
treatment [53]. The therapist does not need to be present allowing for more frequent 
treatment eventually reducing cost. Virtual games can be implemented to provide a more 
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engaging exercise experience for the patients.  In addition to the constant treatment, the 
exoskeletons can be used to quantitatively evaluate the patient and his or her progress 
through the measurement of physical parameters such as speed and strength of the 
movements [54]. Robotics in the rehabilitation field is gradually being recognized by the 
therapist community as being as a strong competitor, or even better than manual 
therapy. 
 
There are a few commercially available upper arm rehabilitation devices and others that 
are not commercially available but that are relevant to this work. These have been 
summarized in Table 2.4. 
Table 2.4. Arm rehabilitation devices with descriptions 
Device Description DOF Actuated/Passi
ve 
Portability Assessment 
of Patient 
Progress 
ArmeoPower Full upper 
arm 
exoskeleton 
6 Actuated Not portable Yes 
ArmeoSpring Elbow and 
shoulder 
passive 
exoskeleton 
N/A Passive Not portable Yes 
ArmeoBoom Full upper 
arm sling 
suspension 
system 
N/A Passive Portable No 
MyoPro Elbow and 
wrist 
myoelectric 
driven 
orthoses 
4 Active Portable Yes 
NEUROExos Elbow 
exoskeleton 
4 Active and 
passive 
No N/A 
Wear-Me EMG driven 
elbow 
exoskeleton 
2 Active Yes No 
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In order for these exoskeletons to be controlled properly, advanced control systems are 
crucial. The control system must be able to use information coming from the sensors on 
the patient such as EMG, position, force, etc. and provide the support needed by the 
actuation system accordingly. Moreover, the control system is required to go through a 
decision making process according to the database of EMG signals available and the 
input from the sensors to provide the assistance at the right time and in the right 
direction regardless of health status or injury. In addition to the sensors’ input, a 
therapist’s input is also essential. After assessment of the patient, the therapist can 
program the brace to provide the correct therapy according to each patient’s needs. 
These decisions include deciding on what sort of movements are safe and how many 
repetitions are required for optimal therapy. This is depicted in Figure 2.16. 
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Figure 2.16. Control system inputs and outputs  
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In summary, this chapter reviewed the relevant anatomy and biomechanics of the upper 
limb in which the bones and muscles investigated were presented. In addition to the 
anatomy of the limb depicted on a macro level, the internal physiology of the muscle 
fibres and how they contract was explained. Following a firm understanding of muscle 
contraction, patterns of activation in normal and compromised functioning was 
discussed. EMG signals were then explained in terms of structure, relevance to health, 
and the factors that affect the signals. Finally, chapter 2 examined the current modalities 
of therapy in the rehab field in both the traditional hospital setting and the robotics field. 
3 Signal Collection and Processing 
The previous chapter outlined and explained all of the necessary information regarding 
the anatomy of the elbow and EMG signals, as background knowledge. Based on this, 
this chapter presents the work that was performed in order to quantify health using EMG 
signals. The following sections outline the materials, methods of data collection, and 
signal processing techniques that were implemented in order to meet the objectives of 
this thesis.  
3.1 Materials and Specifications of Instruments Used 
EMG signals were acquired by a Standard Electrophysiological Amplifier System with 
Signal Conditioning (Model 2024F, Intronix Technologies Corporation, Bolton, Ontario, 
Canada) running in parallel with a host personal computer equipped with Intronix 
Myoguide™ System (Model 8008, Intronix Technologies Corporation, Bolton, Ontario, 
Canada) for raw signal data acquisition. The signals recorded were converted from 
analog to digital with a 16-bit accuracy in the ±10 V range sampled at 4 kHz. Prior to 
sampling, the signals were analog low-pass filtered at 500 Hz and high-pass filtered at 
10 Hz to remove noise and possible movement artifacts.  
The following instruments and devices were used for the data collection: 
1. Standard Mechanical Brace (OSSUR®):  The OSSUR brace limits the motion of the 
wearer in ranges of 0° to 120° in flexion and 0° to 90° in extension. This brace was used 
to examine muscle signals within specific ranges of motion in the pilot study. An image 
of the brace is shown below in Figure 3.1.  
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2. Standard 
Electrophysiological Amplifier System with Signal Conditioning (Intronix Model 2024F): 
The Intronix Model 2024F provides EMG recording with a low impedance output of 10 
Ohms. This device has 4 channels where two boxes are shown in Figure 3.2 on the 
right. 
3. A standard NI DAQ NI9205:  A National Instruments NI9205 32 channel ± 10V, 
250kS/s 16 bit analog input module is used with the Standard Electrophysiological 
Amplifier System with Signal Conditioning “Intronix Model 2024F” for data recording and 
sending to a PC as displayed in Figure 3.2 on the far left.  
Figure 3.2. Intronix Data Acquisition System 
4. Standard Intronix Model 8008 (Myoguide™ System): The “Myoguide Software System 
is designed to amplify the EMG signals from muscles (see Figure 3.3). 
Figure 3.1. OSSUR brace 
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Figure 3.3. Myoguide system Intronix model 8008 
5. Standard Web Camera (Logitech®): The camera was used to records videos of the 
patient motions in widescreen Full HD 1080p at 30 frames per second. This was needed 
in order to have visual input to see the motions performed and how they were performed 
(see Figure 3.4). 
 
 
 
 
 
6. Load Cell (American Archery Products® M110 Digital Bow Hang Scale 110lbs):  A 
digital scale that measures both peak weight and holding weight, while providing 
superior accuracy to 0.05 lbs. was needed for measuring the maximum force produced 
during the flexion MVC and extension MVC (see Figure 3.5). 
Figure 3.4. Logitech camera used in the study 
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7. Inertial 
Measurement Unit (STEVAL-MKI108V2, STMicroelectronics®): A 9-axis inertial 
measurement units (IMU) was used for measuring the angle of the elbow during flexion 
and extension (see Figure 3.6). 
 
 
 
 
 
 
 
Figure 3.5. Digital scale used to measure force of subjects 
 
Figure 3.6. IMU 
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8. Bipolar Electrodes (Ambu® Blue Sensor NF): Sets of single use bipolar single patient 
use floating electrodes were used to detect potential differences within the muscles (see 
Figure 3.7). Details of the electrodes and how they were placed are described in the next 
section. 
 
 
 
 
 
 
 
 
3.1.1 Electrode Placement 
The electrodes used are “floating electrodes,” which are ideal for dynamic movements 
as they are housed in gel or electrode paste creating a bridge between the electrode and 
the skin. This potentiates the EMG signal from the surface of the skin to the electrode 
while providing a cushioning mechanism that absorbs the movement of the electrode 
thus reducing motion artifact. 
The electrodes were placed in correspondence with the SENIAM project (Surface EMG 
for Non-invasive Assessment of Muscles) [55]. This project illustrates recommendations 
for sensor placement used by various researchers around the world. The distance 
between the electrodes was kept at approximately 2 centimeters for all muscle groups 
as suggested by SENIAM. Some of the muscles that were not included in SENIAM were 
placed in accordance with literature guidelines. The placement of electrodes is shown in 
Figures 3.8 and 3.9. 
Figure 3.7. Ambu bipolar electrodes 
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Key 
 Biceps 
 Pronator Teres 
 Flexor Carpi Ulnaris 
Figure 3.8. Anterior Arm Electrode Placement 
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Key 
 Long Head of Triceps 
 Lateral Head of Triceps 
 Extensor Carpi Ulnaris 
Figure 3.9. Posterior Arm Electrode Placement 
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3.2 Skin Preparation 
Proper electrode-skin contact is crucial for good quality EMG signals to reduce noise 
and artefacts [55]. In order for the electrodes to have optimum skin contact, proper skin 
preparation is required. The SENIAM project recommends cleaning the skin with alcohol 
to remove any surface dirt from the skin in order for the electrodes to stick properly. This 
was executed for this work. 
3.3 Experimental Protocol 
3.3.1 Pilot Studies 
Two separate pilot studies were conducted to collect data from healthy individuals and 
patients. Approval from the Human Research Ethics Board at Western University was 
obtained prior to the start of the trials. The instruments used, EMG placement 
techniques, and skin preparation were kept constant throughout the two studies. Sagittal 
movements were executed in a supine position. The upper arm was aligned with the 
trunk. The shoulder was not fixed to increase comfort; however, the subjects were 
instructed to stay as still as possible.  The details of the two studies are presented 
below. 
3.3.1.1 Healthy Individuals Pilot Study 
The first study involved only healthy individuals performing the elbow flexion–extension 
motion only. They executed the motions while carrying a 5 pound-weight while wearing a 
mechanical brace that limited their angles of flexion and extension to a particular range. 
Since motions performed at different arm positions are proven to affect the activation 
patterns of the arm muscles, all the motions were carried out with the wrist in neutral 
position [56]. 
The data collection protocol consisted of the following steps:  
1. The patient was seated on a comfortable chair. 
2. The patient was asked to report their weight and height. 
3. The length of their arm and hand was measured. 
4. The circumference of their arm and hand was measured. 
5. The areas of interest were wiped with alcohol pads. 
6. The electrodes were attached about 2 cm apart in the direction of the muscle 
fibres. 
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7. The ground electrode was placed on the olecranon. 
8. The mechanical brace was placed on the arm and secured with padded straps. 
This brace limits the arm motion to one of the natural directions of motion 
(flexion–extension). 
9. The system is initiated while the subject is at rest and the channels are examined 
to make sure a baseline signal is being collected.  
10. Following the baseline check, the subject is asked to contract some muscles to 
make sure the software shows EMG bursts in order to be certain all the 
electrodes are in the correct place. 
11. The subject was given a 5-pound weight to be carried on their hand. 
12. The subject was instructed to perform elbow flexion–extension tasks (biceps-
curls) requiring them to move their lower arm through a specified range at a low 
speed. 
13. The subject was instructed to perform 3 sets of 3 repetitions at 6 different ranges 
of motion (for a total of 54 repetitions). The ranges were as follows: 0–45 
degrees, 0–60 degrees, 0–90 degrees, 0–120 degrees, 45–105 degrees, and 
90–120 degrees. 
14. Subjects performed an un-resisted maximum voluntary contraction (MVC) where 
they tensed up their arm as hard as they can to activate all the muscles at once. 
3.3.1.2 Patient Pilot Study 
The second study involved patients performing numerous motions including elbow 
flexion–extension, pronation–supination, and wrist flexion–extension. The motions were 
carried out with the wrist in neutral position. Unlike the healthy pilot study, patients were 
not carrying any weights and were not placed in the mechanical brace.  
3.3.1.2.1 Pilot Data Collection Protocol for Patients 
1. The patient was seated on a comfortable chair. 
2. The patient was asked to report their weight and height. 
3. The length of their arm and hand was measured. 
4. The circumference of their arm and hand was measured, 
5. The areas of interest were wiped with alcohol pads. 
6. The electrodes were attached about 2 cm apart in the direction of the muscle 
fibres. 
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7. The ground electrode was placed on the olecranon. 
8. The system is initiated while the subject is at rest and the channels are examined 
to make sure a baseline signal is being collected.  
9. Following the baseline check, the subject is asked to contract some muscles to 
make sure the software shows EMG bursts in order to be certain all the 
electrodes are in the correct place. Patients performed 3 repetitions of the 
following motions: 
 Unresisted MVC 
 Elbow Flexion–Extension  
 Pronation–Supination 
 Wrist Flexion–Extension 
 Ulnar–Radial Deviation 
 Hand Open–Close 
3.3.2 Iterations 
Following the first pilot study trials, the protocol was modified in order to accommodate 
patients’ capabilities. Since not all patients had full range of motion, it was unsafe to 
place their arms in the OSSUR brace and ask them to reach specific angles set by the 
brace. Therefore, the OSSUR brace was removed from the protocol. After the removal of 
the brace, the range of motion of the subjects became unknown. An IMU was placed on 
the wrist of each subject to calculate the elbow position and determine the elbow angle. 
Moreover, a resisted MVC was implemented to provide a more realistic measure of the 
maximum contraction. The motion was incorporated in both the flexion and extension 
directions in order to obtain the MVC of both the biceps and triceps. While doing so, the 
force produced through these motions was also measured using a force sensor. This 
was done through the placement of the wrist of the subjects in a cuff connected to a 
scale. They were then asked to move in both the flexion and extension motions as hard 
as they could and they were asked to hold the contraction for about 5 seconds. In 
addition to the motions of the elbow and wrist presented in the second pilot study of 
patients, another motion was prescribed where the subject was asked to press their 
hand down as hard as they could on a ball, and to hold the contraction for about 5 
seconds. This motion provides an unstable surface for the joint so that the muscles work 
together to try and stabilize the arm in place. This assesses the neuromuscular control of 
the arm and allows for the evaluation of firing patterns. Furthermore, in addition to the 
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general biometric data collected, information about the injury was obtained, in order to 
assess if different injuries cause different trends of activation. Finally, to check that the 
electrodes were placed on the correct areas of the muscles, a baseline check was 
incorporated into the protocol. This involved recording the EMG while the individual was 
at rest. If there were irregularities in the signal of a specific channel, the ground 
electrode was checked along with the electrodes of the channel to assure that it was 
attached properly to the individual. Additionally, EMG burst checks were done by asking 
the individual to contract all arm muscles and relax them multiple times to ensure that 
the bursts were showing on the screen, thus confirming that the electrodes were in the 
proper areas of the muscles.  
3.3.3 Final Experimental Protocol  
As mentioned in the iterations section previously, some modifications were made to the 
pilot trials in order to encompass motions that a variety of individuals can perform within 
their own limits or restrictions set by their therapists. The following protocol was the final 
protocol used to carry out the trials, with removal of specific motions if considered unsafe 
by the patient’s therapist: 
1. The subject was seated on a comfortable chair 
2. If the subject was a patient, he or she was asked to provide biometric data such 
as age, height, source of trauma, and what type of injury they sustained. If not, 
age and height was collected from healthy individuals. 
3. The length of their arm and hand was measured. 
4. The circumference of their arm and hand was measured. 
5. The areas of interest were wiped down with alcohol pads. 
6. The electrodes were attached about 2 cm apart in direction of the muscle fibres. 
7. The dominant belly portion was used for best selectivity. 
8. The ground electrode was placed on the olecranon.  
9. A baseline check was conducted. 
10. An EMG bursts check was also performed.  
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The subjects completed 3 repetitions of the following motions except for the MVCs: 
Maximum Voluntary Contraction of Biceps 
Biceps MVC was performed by placing the wrist in a cuff connected to a load cell with 
the elbow at 90 degrees and the wrist is in neutral position. The subject was then asked 
to pull upwards in the direction of flexion as hard as they can; however, the cuff does not 
allow them to achieve full flexion as depicted in Figure 3.10 below. Subjects were asked 
to hold this contraction for 5 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Subject performing Biceps MVC 
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Maximum Voluntary Contraction of Triceps 
Triceps MVC was performed by placing the wrist in a cuff connected to a load 
cell with the elbow at 90 degrees and the wrist is in neutral position. The subject 
was then asked to pull downwards in the direction of extension as hard as they 
can; nevertheless, the cuff does not allow them to achieve full extension as 
depicted in Figure 3.11 below. Subjects were asked to hold this contraction for 5 
seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11. Subject performing Triceps MVC 
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Elbow Flexion–Extension  
The flexion–extension motion of the elbow is simply achieved by keeping the 
shoulder aligned with the torso and solely moving the lower arm (see Figure 3.12 
below). Subjects were asked to do this motion within their maximum capable 
range with their wrist in neutral position. For healthy individuals this is from 0°–
120° with a functional range of 75°–120° [57]. A functional range is the minimum 
required range to perform activities of daily living.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. Person with right elbow extended (left), flexed at 90 degrees (middle), 
and fully flexed (right) 
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Wrist Flexion–Extension  
In addition to elbow flexion–extension, wrist motions were also explored. 
Subjects performed flexion and extension of the wrist within their capable range 
with their wrist in neutral position (see Figure 3.13).  
 
 
 
 
 
 
 
 
Hand Open–Close  
The simple closing and opening of the hand of interest was also executed. This 
entails having the fingers spread out and opened followed by the closing of the 
fingers through making a fist with their wrist in neutral position as portrayed in 
Figure 3.14 on the next page. 
 
Figure 3.13. Left wrist flexed (left) and extended (right) 
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Ulnar–Radial Deviation 
The next motion performed was ulnar–radial deviation. This is where the hand 
deviates towards the ulna in a downward motion for the ulnar deviation then 
moves upwards towards the radius to achieve radial deviation (Figure 3.15). This 
motion was executed with the wrist in neutral position. 
Figure 3.14. Left hand open (top) and closed in a fist (bottom) 
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Figure 3.15. Left wrist in radial deviation (top), neutral (middle), 
and in ulnar deviation (bottom) 
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Pronation–Supination  
Pronation is achieved when the lower arm is turned to make the palm face 
downwards. In contrast, supination occurs when the lower arm is turned to make 
the palm face upwards.  These motions are represented below in Figure 3.16. 
 
 
 
 
 
 
 
 
 
 
Pressing on a Ball 
Lastly, pressing down on a ball is the last motion the subjects were asked to do. 
The subject was asked to place their palm around a ball with the elbow at a 90-
degree angle. The subject then pressed down as hard as they can while 
stabilizing the ball in place without having it roll to either side (see Figure 3.17). 
 
 
Figure 3.16. Left arm pronated (left) and supinated (right) 
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Figure 3.17. Right hand pressing down on a ball 
This concludes the motions performed by the subjects. The signals obtained from these 
motions will be discussed next. Pure biological signals are almost impossible to obtain, if 
not impossible [58]. Consequently, it is essential for the signals to go through a series of 
processing phases in order to remove the maximum amount of noise leaving only the 
biological signal. This allows the signal to be quantified through various means 
discussed in detail in this thesis. Data analysis was performed off-line using MATLAB 
(MathWorks, Version R2014b). 
3.3.4 Differential Amplification 
Following action potential propagation recorded by the electrodes, the first step is for the 
signal to be amplified or made larger. The amplification factor is called gain. The signal 
size is dependent on how big the gain is set to. The gain was adjusted to achieve the 
best possible signal resolution within the limited time of the subject. 
3.3.5 Filtering 
After signal amplification, the signal goes through multiple levels of processing. The first 
level of processing is noise removal. This is a series of steps aimed at decreasing noise 
as much as possible. A band pass filter is a filter that only allows a specific range of 
frequencies to pass through. According to the literature, a band-pass filter of 20 to 500 
Hz was most commonly used [8][29][59]. In accordance with the literature 
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recommendations, an analog band-pass filter of 20 to 500 Hz was used where the raw 
signal is filtered prior to being digitized. The lower cutoff mainly removes electrical noise 
as well as biological and movement artifacts while the upper cutoff excludes noise at the 
site of the electrode. The other dominant source of the electrical noise available within 
the signal is at 60 Hz because of the power line radiation [60]. Although a notch filter can 
be applied and theoretically only remove the power line frequency, in practical 
implementations, a notch filter also removes portions of adjacent frequency components. 
Since the dominant energy of the signal is within the 50–100 Hz range, using a notch 
filter will remove important information within the important information range and 
therefore is not advisable. 
3.3.6 Full Wave Signal Rectification 
Regardless of what processing the signal must undergo, all processing begins with a 
common step: signal rectification. This is where the absolute value of the signal is taken 
and all the negative values become positive causing the signal to exclusively reside 
above the zero point [26][61] (see Figure 3.18). This technique maintains the energy 
level of the signal [58]. Since the signal oscillates about zero, the mean will be near zero 
if an average is taken of a raw signal without rectification. Therefore it is a crucial initial 
step to rectify the signal before any calculation can be made. 
Figure 3.18. Raw Biceps contraction in elbow flexion and extension signal (top) 
and rectified (bottom) 
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3.3.7 Linear Envelope 
The next step is creating a linear envelope (see Figure 3.19). The linear envelope is the 
most common demodulation technique used to extract information from EMG [37] . A 
discrete version of a traditional low pass filter, called the Butterworth filter, was used in 
this thesis [61] [62]. This is an infinite impulse response filter that was applied in both 
forward and backward directions resulting in a zero phase shift. The literature 
recommends between 5 and 100 Hz as the cutoff frequency. The lower limit of this 
range, 5, was used in this thesis.  
 
3.3.8 Normalization 
After the signals are collected, they must be in a state to be compared to other signals 
for analysis. To do so, a process called normalization must be conducted. Normalization 
is a method of relative measure of individual muscles’ activity in comparison with the 
maximum muscle activity obtained at a similar angle [41] [29] [8] [30] [63]. This is 
necessary when a comparison is to be made on the same muscle on different days, 
between different individuals, or between different muscles. This is usually done by 
Figure 3.19. Raw biceps contraction in elbow flexion and extension signal (top), 
rectified (middle), and linear envelope of signal (bottom) 
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dividing the EMG signals of the task by a reference EMG value obtained from that same 
muscle. This reference value can be obtained through several ways, as follows:  
1. Maximum Voluntary Contraction (MVC): The most common method involves having 
a person perform an isometric contraction where the maximum effort is exerted and 
recorded. All muscle functions are then reduced to this common value as a 
percentage from 0% to 100% 
2. Submaximal Contraction: The second most common method involves the subject 
performing a dynamic motion while peak values are obtained from it. The average of 
the peaks is then used as the reference for all muscle functions. 
Normalization using MVC is considered to be more sensitive in contractions that require 
more effort, while submaximal contractions are more sensitive with lower levels of 
activation [29].  The MVC method was used for all subjects except for patients who were 
not allowed to perform resisted motions at the time of the data collection. Instead, 
submaximal contraction normalization was executed for those subjects. 
Following the normalization of the signals obtained from the various motions, different 
metrics, as explained in the next section, were extracted from the signals and compared 
within each muscle group between healthy individuals and patients.  
3.3.9 EMG Based Metrics  
The previous sections described the signal processing techniques in order to prime the 
signal for information to be extracted. Accordingly, the following sections present the 
metrics examined and used to extract information from the processed signals, in both 
the time and frequency domain. Feature extraction is a method to extract the valuable 
information within a surface EMG signal and remove the undesirable EMG data[64]. 
EMG based metrics can be divided into three main groups: time domain, frequency 
domain, and time-frequency or time-scale representation [65][66]. In this thesis, the first 
two groups have been examined as features in the last group, time-frequency/time-scale 
features, cannot be reported on their own as they require reduction of high dimensions 
before being classified [67]. Whereas the first two groups have been used as 
dimensionality reduction methods [64]. Data analysis was performed off-line using 
MATLAB (The MathWorks Inc., Natick, MA, USA, Version R2014b). 
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3.3.9.1 Time Domain  
Metrics in the time domain are fast and easily implemented. This is because they are 
calculated based on raw EMG time series [65] [68] [69]. Features in this domain have 
been used widely in both the medical and engineering fields of researches and 
practices. Although the EMG signal is non-stationary, meaning it changes in statistical 
properties over time, it is assumed to be stationary in this domain [70]. This is a 
disadvantage as it can cause variations when dynamic motions are recorded. 
Additionally, as a lot of the metrics in this domain heavily depend on amplitude values, 
any interference in the collection process can negatively affect the signal and thus 
filtering is important. This section outlines the features extracted in the time domain. 
Formulae for each metric are presented; all of these calculations were done using 
MATLAB functions.  
3.3.9.1.1 Average Rectified Value (ARV) [37] [66] [68] [69] 
The first metric examined is ARV. ARV is used to quantify magnitude of muscle activity 
by detecting changes due to MU recruitment, firing rate, or muscle fibre conduction 
velocity. This method is fits well for low contractions and fatigues muscles [71]. The 
equation of ARV is as follows:  
𝐴𝑅𝑉 =  
1
𝑇
∑ |𝐸𝑀𝐺 (𝑡𝑖)|
𝑇
𝑡=1
 
where 𝐸𝑀𝐺(𝑡𝑖) is the absolute value of a datum of EMG in a data window and T 
is the interval. This calculation is done using the absolute value of the data 
window and is similar to integration.  
3.3.9.1.2  Root Mean Square (RMS) [37] [66] [71] 
Next, RMS was examined. This method is dependent on amplitude and has been shown 
to fit better at high levels of contraction. During each repetition of motion, the RMS 
amplitude was calculated and averaged throughout. RMS is calculated using the 
succeeding function:  
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𝑅𝑀𝑆 =  √
1
𝑇
∑ 𝐸𝑀𝐺2(𝑡𝑖)
𝑇
𝑡=1
 
where 𝐸𝑀𝐺(𝑡𝑖) is the absolute value of a datum of EMG in a data window and T is the 
interval. This calculation is done on the raw data for a data window and is used 
quantify magnitude of muscle activity through squaring the data, summing the squares 
dividing the sum by the number of observations, and then taking the square root.  
3.3.9.1.3  Mean Spike Amplitude (MSA) [37] 
Another metric examined in the time domain is MSA. To obtain the mean value, single 
spike amplitude must be first defined and determined. An EMG spike is a pair of upward 
and downward deflections that cross the isoelectric line and are greater than 95% 
confidence interval. A peak on the other hand, is a pair of upward and downward 
deflections that occur within a spike. These are ignored in MSA calculations denoted 
with an “X” in Figure 3.20. 
 
 
 
 
 
 
 
 
 
Figure 3.20. Single Spike Amplitude Example 
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Single Spike Amplitude (SA)  is calculated using the following equation:  
𝑆𝐴𝑖 =
(𝐵𝑦 − 𝐴𝑦) + (𝐵𝑦 − 𝐶𝑦) 
2
 
where Y is the amplitude value at time (t). The mean of the SA across the signal is then 
calculated using the equation below. 
On the other hand, MSA is simply obtaining the mean of the SA as shown in the 
following equation: 
𝑀𝑆𝐴 =  
1
𝑁𝑆
∑ 𝑆𝐴𝑖
𝑁𝑆
𝑖=1
 
where NS is total number of spikes within a data window. This method of analysis also is 
used to quantify the magnitude of the muscle activity and is highly correlated with RMS 
amplitude. Additionally, it is a highly stable method of calculation during dynamic 
contractions.   
3.3.9.1.4 Zero Crossings (ZC) [64] [68] [69] 
Finally, ZC is the last metric to be discussed in the time domain. Zero crossings are 
simply the number of times the signal crosses the baseline x-axis i.e. reaches 0 
millivolts. The thicker the tracing of the raw EMG signal, the stronger the contraction.  
3.3.9.2 Frequency Domain 
The following section will outline the features extracted in the frequency domain. 
Formulae shown here are just for understanding purposes. Data analysis was performed 
off-line using MATLAB (The MathWorks Inc., Natick, MA, USA, Version R2014b). 
3.3.9.2.1 Power Spectral Density (PSD) Analysis [37] [66] 
The other metric examined is PSD. The following is the formula describing is: 
𝑃𝑆𝐷 = 𝜙(𝜔) = 𝑋(𝜔)𝑋∗(𝜔) = |𝑋(𝜔)|2 
where 𝑋(𝜔) is  the Fourier transform of 𝑥(𝑡) and 𝑋∗(𝜔) is the complex conjugate of 
𝑋(𝜔), the two are multiplied giving the squared magnitude of the Fourier transform. 
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The frequency spectrum is not used in the literature due to its stochastic properties; the 
spectral mean value is zero [37]. The solution to this problem is similar to that of the 
summing of deviation scores by squaring the values. Obtaining the power spectral 
density function of the signal through squaring the magnitude of each frequency 
component of the Fourier series demonstrates the power spectrum. Frequency shifts in 
the power spectrum can distinguish between normal muscle function and impaired 
muscle function [50].  
It has been shown in literature that the PSD function can be characterized by two 
parameters: mean power frequency (MNF) and median power frequency (MDF). These 
parameters are thought to be sensitive to conduction velocity-motor unit recruitment and 
rate coding [37]. MNF and MDF were extracted from the signals. 
The method of data collection and analysis was explained in this chapter. The pilot study 
was explained in detail as well as the iterations that followed based on the trial run. 
Moreover, all the instrumentation used was portrayed. Following the data collection 
protocol, the data analysis protocol was discussed. The formulae and methods used in 
pre-processing and processing of the signals were described. There were five metrics 
applied in this thesis; the time domain metrics were RMS, ARV, MSA, and ZC while the 
frequency domain metric was PSD, which included MNF and MDF. The next section will 
report the results of these metrics explored. 
 
4 Results and Discussion 
According to the analysis of the time domain and frequency domain metrics presented in 
the previous chapter, two analyses were executed. Firstly, a general comparison 
between the healthy population and the patient population was done with all of the 
metrics mentioned. Secondly, a comparison within the patient population between 
subjects in the early rehabilitation group (0–1 month) and a late stage (4+ months) 
rehabilitation group. 
The statistical analysis performed was a general linear model repeated measures study. 
Each repetition within each motion was considered the repeated measure for a total of 3 
repetitions. The analysis was done within subjects using the values of the metrics in 
repetitions and between subjects using health. A Post Hoc Tukey test was applied 
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during the second type of analysis within the patient population. The Statistical Package 
for Social Sciences (SPSS) was used to run all of these analyses. Statistical significance 
of the 0.05 level was considered. 
In the first analysis, 16 healthy individuals and 17 patients were analyzed. However, due 
to some trial errors, some subjects were removed from the individual analyses when the 
raw data was deemed compromised. A maximum of 4 subjects were removed. In most 
metrics, an average of 2 subjects were removed. Likewise, in the second analysis within 
patients, there were about 5 patients in each group. The least amount in a group was 2 
subjects. In the tables of results, the letter “N” shows the number of subjects analyzed 
during each motion. 
The following chapter will focus on the analysis of the metrics that showed multiple 
cases of significance. For further information on the non-significant metrics, see 
Appendix C. The frequency domain metrics seldom showed statistical significance and 
thus have been excluded from the following discussion. The metrics that proved to 
discriminate between the healthy and the patient population were used in the second 
analysis to assess whether they were able to distinguish between patients at the start of 
their therapy within a month after injury or surgery and those at four or more months post 
injury or surgery.  
4.1 Root Mean Square  
RMS is a very widespread metric of analyzing EMG. It was initially used to distinguish 
between healthy individuals and patients. Statistically significant information is shown in 
Table 5 below. A further analysis to distinguish between patients in the first month of 
their versus those towards the end of the therapy at 4+ months was conducted. Likewise 
the statistically significant cases are summarized and presented in Table 4.1 and shown 
in details in Table 4.2, 4.3, 4.4, 4.5, 4.5, 4.7, and 4.7. These detailed tables depict 
information about each repetition individually. The number of subjects the data was 
drawn from is shown as (N). The statistically significant values are reported and 
discussed in this section.  
 
 
  
 
69 
69 
Table 4.1. Statistical analysis comparing healthy individuals to patients using RMS 
Motion Muscle 
Mean 
Healthy/ 
mV 
Mean 
Patients/ 
mV 
SE 
Healthy 
SE 
Patients p Value 
F 
statistic  
EFE ECU 0.021 0.104 0.028 0.025 0.037 4.836 
PS ECU 0.015 0.095 0.019 0.018 0.005 9.281 
PS PT 0.028 0.103 0.023 0.023 0.028 5.348 
HOC PT 0.025 0.083 0.02 0.019 0.045 4.497 
HOC FCU 0.031 0.215 0.056 0.054 0.026 5.635 
HOC ECU 0.019 0.15 0.035 0.033 0.012 7.395 
Ball FCU 0.051 0.135 0.026 0.025 0.03 5.281 
 
Table 4.2. Statistical analysis of FCU in EFE motion within each repetition 
comparing healthy individuals to patients using RMS 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 Elbow Flexion Healthy .104 .153 13 
Patient .126 .119 16 
Total .116 .133 29 
Flexor Carpi Ulnaris in Rep 1 Elbow 
Extension 
Healthy .0721 .108 13 
Patient .126 .154 16 
Total .102 .136 29 
Flexor Carpi Ulnaris in Rep 2 Elbow Flexion Healthy .0684 .100 13 
Patient .158 .176 16 
Total .118 .151 29 
Flexor Carpi Ulnaris in Rep 2 Elbow 
Extension 
Healthy .092 .131 13 
Patient .113 .139 16 
Total .104 .134 29 
Flexor Carpi Ulnaris in Rep 3 Elbow Flexion Healthy .111 .162 13 
Patient .134 .137 16 
Total .124 .147 29 
Flexor Carpi Ulnaris in Rep 3 Elbow 
Extension 
Healthy .0619 .0953 13 
Patient .182 .220 16 
Total .128 .183 29 
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Table 4.3. Statistical analysis of ECU in PS motion within each repetition 
comparing healthy individuals to patients using RMS 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Pronation  Healthy .014 .011 16 
Patient .098 .116 17 
Total .057 .093 33 
Extensor Carpi Ulnaris in Rep 1 in Supination Healthy .017 .015 16 
Patient .094 .102 17 
Total .057 .083 33 
Extensor Carpi Ulnaris in Rep 2 in Pronation Healthy .016 .014 16 
Patient .098 .112 17 
Total .058 .090 33 
Extensor Carpi Ulnaris in Rep 2 in Supination Healthy .015 .014 16 
Patient .092 .096 17 
Total .055 .079 33 
Extensor Carpi Ulnaris in Rep 3 in Pronation Healthy .014 .012 16 
Patient .094 .108 17 
Total .055 .087 33 
Extensor Carpi Ulnaris in Rep 3 in Supination Healthy .015 .015 16 
Patient .093 .097 17 
Total .055 .080 33 
 
Table 4.4. Statistical analysis of PT in PS motion within each repetition comparing 
healthy individuals to patients using RMS 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 Pronation Healthy .046 .046 16 
Patient .118 .143 17 
Total .083 .112 33 
Pronator Teres in Rep 1 Supination Healthy .021 .019 16 
Patient .078 .119 17 
Total .050 .090 33 
Pronator Teres in Rep 2 Pronation Healthy .029 .024 16 
Patient .129 .151 17 
Total .081 .119 33 
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Pronator Teres in Rep 2 Supination Healthy .019 .019 16 
Patient .078 .122 17 
Total .049 .092 33 
Pronator Teres in Rep 3 Pronation Healthy .033 .030 16 
Patient .129 .149 17 
Total .082 .118 33 
Pronator Teres in Rep 3 Supination Healthy .018 .014 16 
Patient .085 .133 17 
Total .052 .100 33 
 
Table 4.5. Statistical analysis of PT in HOC motion within each repetition 
comparing healthy individuals to patients using RMS 
 
 Health Mean Std. Deviation N 
Pronator Teres in Rep1 in Hand Open Healthy .026 .032 12 
Patient .084 .089 13 
Total .056 .073 25 
Pronator Teres in Rep 1 in Hand Close Healthy .021 .029 12 
Patient .084 .096 13 
Total .054 .077 25 
Pronator Teres in Rep 2 in Hand Open Healthy .029 .034 12 
Patient .085 .090 13 
Total .058 .074 25 
Pronator Teres in Rep 2 in Hand Close Healthy .021 .032 12 
Patient .085 .094 13 
Total .054 .077 25 
Pronator Teres in Rep 3 in Hand Open Healthy .033 .036 12 
Patient .082 .089 13 
Total .058 .072 25 
Pronator Teres in Rep 3 in Hand Close Healthy .018 .026 12 
Patient .082 .092 13 
Total .051 .075 25 
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Table 4.6. Statistical analysis of FCU in HOC motion within each repetition 
comparing healthy individuals to patients using RMS 
 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 in Hand Open Healthy .036 .035 12 
Patient .248 .400 13 
Total .146 .304 25 
Flexor Carpi Ulnaris in Rep 1 in Hand Close Healthy .023 .018 12 
Patient .197 .287 13 
Total .113 .222 25 
Flexor Carpi Ulnaris in Rep 1 in Hand Open Healthy .038 .038 12 
Patient .224 .319 13 
Total .134 .246 25 
Flexor Carpi Ulnaris in Rep 1 in Hand Close Healthy .025 .027 12 
Patient .220 .351 13 
Total .126 .268 25 
Flexor Carpi Ulnaris in Rep 1 in Hand Open Healthy .043 .048 12 
Patient .218 .288 13 
Total .134 .225 25 
Flexor Carpi Ulnaris in Rep 1 in Hand Close Healthy .023 .022 12 
Patient .184 .253 13 
Total .107 .197 25 
 
Table 4.7. Statistical analysis of ECU in HOC motion within each repetition 
comparing healthy individuals to patients using RMS 
 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Hand 
Open 
Healthy .020 .021 12 
Patient .148 .161 13 
Total .087 .132 25 
Extensor Carpi Ulnaris in Rep 1 in Hand 
Close 
Healthy .016 .016 12 
Patient .118 .143 13 
Total .069 .114 25 
Extensor Carpi Ulnaris in Rep 2 in Hand 
Open 
Healthy .024 .022 12 
Patient .187 .242 13 
Total .109 .191 25 
Extensor Carpi Ulnaris in Rep 2 in Hand Healthy .018 .012 12 
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Close Patient .144 .163 13 
Total .083 .132 25 
Extensor Carpi Ulnaris in Rep 3 in Hand 
Open 
Healthy .022 .018 12 
Patient .161 .176 13 
Total .094 .144 25 
Extensor Carpi Ulnaris in Rep 3 in Hand 
Close 
Healthy .017 .012 12 
Patient .141 .160 13 
Total .081 .130 25 
 
Table 4.8. Statistical analysis of FCU in Ball Press motion within each repetition 
comparing healthy individuals to patients using RMS 
 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 Ball Press Healthy .084 .094 14 
Patient .187 .158 15 
Total .137 .139 29 
Flexor Carpi Ulnaris in Rep 1 Ball Relax Healthy .028 .041 14 
Patient .087 .108 15 
Total .058 .086 29 
Flexor Carpi Ulnaris in Rep 2 Ball Press Healthy .080 .093 14 
Patient .185 .158 15 
Total .134 .139 29 
Flexor Carpi Ulnaris in Rep 2 Ball Relax Healthy .019 .016 14 
Patient .087 .112 15 
Total .054 .087 29 
Flexor Carpi Ulnaris in Rep 3 Ball Press Healthy .071 .080 14 
Patient .179 .165 15 
Total .127 .140 29 
Flexor Carpi Ulnaris in Rep 3 Ball Relax Healthy .026 .035 14 
Patient .085 .108 15 
Total .057 .085 29 
 
 
In the elbow flexion extension motion (EFE) within the comparison of healthy individuals 
and patients, the RMS mean of healthy individuals across the muscles was lower than 
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those of the patients. However, the extensor carpi ulnaris (ECU) muscle is the only one 
that showed significance between subjects with respect to health 0.021 ± 0.015 vs. 
0.104 ± 0.159, p = 0.037. F (1, 27) = 4.836. This is shown in Graph A in Figure 4.1.  
The higher RMS value in patients indicates that the muscle is being recruited with a 
higher demand than healthy individuals. Although the ECU is primarily a wrist moving 
muscle, its anatomy suggests it may play a role in elbow flexion. Due to the patients’ 
injuries, neuromuscular coordination may be compromised leading the body to activate 
other nearby muscles to achieve the same motion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 
A 
Figure 4.1 RMS means of ECU in EFE (A) motion in healthy 
individuals and patients with a standard deviation +/- 1 
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Figure 4.2 RMS means of PT in PS (B) and ECU in PS (C) motions in healthy 
individuals and patients with a standard deviation +/- 1 
 
B 
C 
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Figure 4.3. RMS means of PT in HOC (D) and FCU in HOC (E) motion in healthy 
individuals and patients with a standard deviation +/- 1 
 
D 
E 
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Figure 4.4. RMS means of ECU in HOC (F) and FCU in Ball Pressing (G) motion 
in healthy individuals and patients with a standard deviation +/- 1 
 
F 
G 
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In the pronation–supination motion, the healthy individuals’ means were also lower than 
those of the patient population. Two muscles showed statistical significance in difference 
between healthy individuals and the patient population.  The first muscle is the PT 
showing healthy individuals at 0.028 ± 0.046 vs. 0.103 ± 0.142, p = 0.028, F (1,31) = 
5.348 (Graph B in Figure 4.2). The second muscle is the ECU showing healthy 
individuals at 0.015 ± 0.011 vs. 0.095 ± 0.1155, p = 0.005. F (1,31) = 9.281 (Graph C in 
Figure 4.2). As displayed in graph B in Figure 4.2, the PT is activated at a higher 
magnitude in patients than healthy individuals despite being the correct muscle to be 
activated in pronation. Due to the injuries and possible muscle atrophy, the body recruits 
a higher number of motor units to achieve the same motion as the healthy population. 
The ECU is not a primary mover in pronation and supination, however this muscle was 
over active in the patient population. Again, since the neuromuscular control may be 
compromised in the patients, over activation of non-required muscles is possible.  
In the wrist flexion–extension motion, the mean of healthy individuals is lower than that 
of the patient average. However, none of the muscles showed statistical significance 
within this motion. Similarly, in the ulnar–radial deviation motion, the mean of healthy 
individuals is lower than that of the patient average. However, none of the muscles 
showed statistical significance within this motion. For further details, please see Table 
C.5 in Appendix C.  
Just like the previous motion, the hand open–close motion also showed a general trend 
in the mean showing healthy individuals lower than the patient population. Conversely, in 
this motion, three muscles showed statistical significance. The first muscle was the PT 
with a healthy mean of 0.025 ± 0.032 vs. 0.083 ± 0.089, p = 0.045, F (1,23) =4.497 
(Graph D in Figure 4.3). Secondly, the FCU showed a healthy mean of 0.031 ± 0.035 vs. 
0.215 ± 0.40, p = 0.026, F (1,23) =5.635 (Graph E in Figure 4.3). Lastly, the ECU 
portrayed a healthy mean of 0.019 ± 0.021 vs. 0.15 ± 0.16, p = 0.012, F (1,23) =7.395, 1 
degree (Graph F in Figure 4.4). 
The electrodes were directly placed on the muscles responsible for moving the fingers. 
Nevertheless, the forearm muscles are very tightly packed; therefore, the electrodes 
close to these muscles may have picked them up leading to the statistical significant 
differences obtained. The PT and the FCU are both near the flexor digitorum profundus, 
flexor digitorum superficialis, and palmaris longus, which are all flexors of the fingers. 
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Furthermore, the ECU is near the extensor digitorum muscle, which is responsible for 
extending the fingers. This could explain the differences in these muscles in the HOC 
motion.  
Likewise, the ball pressing motion exhibited a general lower mean trend in healthy 
individuals compared to the patient population. This was only statistically significant in 
the FCU with a healthy mean of 0.051 ± 0.09 vs. 0.135 ± 0.156, p = 0.03, F (1,27) 
=5.281 (Graph G in Figure 4.4). 
Next, the second type of analysis between early and late stage patients is reported and 
discussed (see Table 4.9, 4.10, 4.11, 4.12, 4.13, 4.14, 4.15, 4.16, 4.17, 4.18, 4.19, 4.20, 
and 4.21). A higher number of statistical significances were observed in this type of 
analysis.  
Table 4.9. Pairwise comparison between patients at 0–1 months of injury and 4+ 
months of injury using RMS 
Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month  
SE 4+ 
Months Sig 
EFE TB 1.35 0.4 0.28 0.19 0.01 
EFE TB2 5.29 0.34 1.46 0.96 0.01 
WFE TB 0.90 0.11 0.19 0.10 0.002 
PS TB 0.86 0.14 0.24 0.14 0.014 
PS PT 0.05 0.20 0.06 0.03 0.04 
URD TB 5.38 0.12 1.59 1.42 0.022 
URD TB2 4.27 0.09 1.50 1.34 0.049 
HOC BB 0.25 0.08 0.06 0.04 0.035 
HOC TB 4.20 0.11 1.00 0.65 0.003 
HOC TB2 4.26 0.08 1.30 0.86 0.015 
Ball TB2 4.42 0.39 1.24 1.24 0.031 
Ball FCU 0.34 0.06 0.04 0.037 0.000026 
Ball ECU 0.02 0.44 0.13 0.13 0.032 
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Table 4.10. Pairwise comparison of TB in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Elbow Flexion Healthy .274 .297 13 
4+ months .201 .108 6 
0-1 months 2.912 2.897 3 
Triceps Long in Rep 1 in Elbow Extension Healthy .247 .213 13 
4+ months .155 .096 6 
0-1 months 1.062 1.222 3 
Triceps Long in Rep 2 in Elbow Flexion Healthy .250 .255 13 
4+ months .192 .089 6 
0-1 months 1.094 1.382 3 
Triceps Long in Rep 2 in Elbow Extension Healthy .214 .227 13 
4+ months .164 .092 6 
0-1 months 1.051 1.199 3 
Triceps Long in Rep 3 in Elbow Flexion Healthy .279 .309 13 
4+ months .204 .105 6 
0-1 months 1.067 1.327 3 
Triceps Long in Rep 3 in Elbow Extension Healthy .162 .084 13 
4+ months .122 .063 6 
0-1 months .936 .824 3 
 
Table 4.11. Pairwise comparison of TB2 in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Elbow Flexion Healthy .055 .060 13 
4+ months .366 .382 6 
0-1 months 5.270 8.880 3 
Triceps Lateral in Rep 1 in Elbow 
Extension 
Healthy .069 .058 13 
4+ months .403 .382 6 
0-1 months 5.199 8.760 3 
Triceps Lateral in Rep 2 in Elbow Flexion Healthy .045 .038 13 
4+ months .394 .389 6 
0-1 months 5.282 8.906 3 
Triceps Lateral in Rep 2 in Elbow 
Extension 
Healthy .052 .041 13 
4+ months .370 .401 6 
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0-1 months 5.361 9.059 3 
Triceps Lateral in Rep 3 in Elbow Flexion Healthy .072 .080 13 
4+ months .427 .384 6 
0-1 months 5.296 8.928 3 
Triceps Lateral in Rep 3 in Elbow 
Extension 
Healthy .066 .074 13 
4+ months .358 .397 6 
0-1 months 5.358 9.107 3 
 
Table 4.12. Pairwise comparison of TB2 in WFE motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Wrist Flexion Healthy .091 .117 13 
4+ Months .103 .0867 7 
0-1 Months 1.01 1.245 2 
Triceps Long in Rep 1 in Wrist Extension Healthy .092 .115 13 
4+ Months .106 .0815 7 
0-1 Months .992 1.234 2 
Triceps Long in Rep 2 in Wrist Flexion Healthy .095 .116 13 
4+ Months .109 .091 7 
0-1 Months 1.006 1.23 2 
Triceps Long in Rep 2 in Wrist Extension Healthy .092 .114 13 
4+ Months .108 .0881 7 
0-1 Months .992 1.223 2 
Triceps Long in Rep 3 in Wrist Flexion Healthy .096 .115 13 
4+ Months .116 .101 7 
0-1 Months .995 1.204 2 
Triceps Long in Rep 3 in Wrist Extension Healthy .085 .068 13 
4+ Months .092 .073 7 
0-1 Months .407 .490 2 
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Table 4.13. Pairwise comparison of TB in PS motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Pronation Healthy .198 .517 16 
4+ Months .127 .070 6 
0-1 Months .955 1.252 2 
Triceps Long in Rep 1 in Supination Healthy .133 .258 16 
4+ Months .122 .044 6 
0-1 Months .950 1.216 2 
Triceps Long in Rep 2 in Pronation Healthy .126 .242 16 
4+ Months .157 .051 6 
0-1 Months .945 1.237 2 
Triceps Long in Rep 2 in Supination Healthy .130 .241 16 
4+ Months .137 .057 6 
0-1 Months .945 1.237 2 
Triceps Long in Rep 3 in Pronation Healthy .129 .244 16 
4+ Months .152 .064 6 
0-1 Months .950 1.245 2 
Triceps Long in Rep 3 in Supination Healthy .089 .122 16 
4+ Months .103 .057 6 
0-1 Months .420 .481 2 
Table 4.14. Pairwise comparison of PT in PS motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Pronation Healthy .046 .046 16 
4+ Months .230 .191 6 
0-1 Months .050 .028 2 
Pronator Teres in Rep 1 in Supination Healthy .021 .019 16 
4+ Months .165 .174 6 
0-1 Months .035 .007 2 
Pronator Teres in Rep 2 in Pronation Healthy .029 .024 16 
4+ Months .240 .207 6 
0-1 Months .060 .014 2 
Pronator Teres in Rep 2 in Supination Healthy .019 .019 16 
4+ Months .158 .186 6 
0-1 Months .040 .014 2 
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Pronator Teres in Rep 3 in Pronation Healthy .033 .030 16 
4+ Months .238 .210 6 
0-1 Months .065 .007 2 
Total .086 .123 30 
Pronator Teres in Rep 3 in Supination Healthy .018 .014 16 
4+ Months .173 .203 6 
0-1 Months .050 .014 2 
 
Table 4.15. Pairwise comparison of TB in URD motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Ulnar Deviation Healthy .104 .129 13 
4+ Months .128 .100 5 
0-1 Months 6.243 10.387 4 
Triceps Long in Rep 1 in Radial Deviation Healthy .102 .124 13 
4+ Months .130 .101 5 
0-1 Months 5.850 9.533 4 
Triceps Long in Rep 2 in Ulnar Deviation Healthy .105 .128 13 
4+ Months .130 .109 5 
0-1 Months 6.295 10.453 4 
Triceps Long in Rep 2 in Radial Deviation Healthy .104 .125 13 
4+ Months .130 .107 5 
0-1 Months 6.128 10.088 4 
Triceps Long in Rep 3 in Ulnar Deviation Healthy .105 .129 13 
4+ Months .128 .0971 5 
0-1 Months 6.255 10.356 4 
Triceps Long in Rep 3 in Radial Deviation Healthy .0831 .0616 13 
4+ Months .0920 .0577 5 
0-1 Months 1.490 2.043 4 
Table 4.16. Pairwise comparison of TB2 in URD motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Ulnar 
Deviation 
Healthy .029 .035 13 
4+ Months .082 .091 5 
0-1 Months 4.285 8.324 4 
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Triceps Lateral in Rep 1 in Radial 
Deviation 
Healthy .028 .035 13 
4+ Months .068 .086 5 
0-1 Months 4.245 8.251 4 
Triceps Lateral in Rep 2 in Ulnar 
Deviation 
Healthy .030 .037 13 
4+ Months .098 .093 5 
0-1 Months 4.258 8.269 4 
Triceps Lateral in Rep 2 in Radial 
Deviation 
Healthy .029 .036 13 
4+ Months .100 .089 5 
0-1 Months 4.290 8.334 4 
Triceps Lateral in Rep 3 in Ulnar 
Deviation 
Healthy .029 .038 13 
4+ Months .104 .105 5 
0-1 Months 4.285 8.337 4 
Triceps Lateral in Rep 3 in Radial 
Deviation 
Healthy .030 .040 13 
4+ Months .078 .091 5 
0-1 Months 4.248 8.262 4 
Table 4.17. Pairwise comparison of BB in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Biceps in Rep 1 in Hand Open Healthy .085 .089 12 
4+ Months .093 .066 7 
0-1 Months .253 .202 3 
Biceps in Rep 1 in Hand Close Healthy .083 .089 12 
4+ Months .084 .055 7 
0-1 Months .250 .203 3 
Biceps in Rep 2 in Hand Open Healthy .088 .088 12 
4+ Months .093 .065 7 
0-1 Months .253 .202 3 
Biceps in Rep 2 in Hand Close Healthy .084 .089 12 
4+ Months .087 .064 7 
0-1 Months .260 .207 3 
Biceps in Rep 3 in Hand Open Healthy .086 .089 12 
4+ Months .093 .064 7 
0-1 Months .253 .202 3 
Biceps in Rep 3 in Hand Close Healthy .083 .087 12 
4+ Months .086 .054 7 
0-1 Months .250 .207 3 
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Table 4.18. Pairwise comparison of TB in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Hand Open Healthy .124 .141 12 
4+ Months .123 .164 7 
0-1 Months 4.843 6.376 3 
Triceps Long in Rep 1 in Hand Close Healthy .121 .142 12 
4+ Months .119 .162 7 
0-1 Months 4.883 6.444 3 
Triceps Long in Rep 2 in Hand Open Healthy .128 .142 12 
4+ Months .126 .159 7 
0-1 Months 4.877 6.441 3 
Triceps Long in Rep 2 in Hand Close Healthy .123 .144 12 
4+ Months .121 .170 7 
0-1 Months 4.467 5.721 3 
Triceps Long in Rep 3 in Hand Open Healthy .128 .147 12 
4+ Months .120 .166 7 
0-1 Months 4.917 6.453 3 
Triceps Long in Rep 3 in Hand Close Healthy .094 .062 12 
4+ Months .071 .048 7 
0-1 Months 1.227 1.320 3 
 
Table 4.19. Pairwise comparison of TB2 in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Hand Open Healthy .051 .092 12 
4+ Months .067 .061 7 
0-1 Months 4.267 7.182 3 
Triceps Lateral in Rep 3 in Hand Close Healthy .049 .090 12 
4+ Months .069 .062 7 
0-1 Months 4.277 7.200 3 
Triceps Lateral in Rep 1 in Hand Open Healthy .051 .092 12 
4+ Months .084 .062 7 
0-1 Months 4.257 7.174 3 
Triceps Lateral in Rep 3 in Hand Close Healthy .051 .093 12 
4+ Months .071 .061 7 
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0-1 Months 4.270 7.188 3 
Triceps Lateral in Rep 1 in Hand Open Healthy .051 .095 12 
4+ Months .087 .064 7 
0-1 Months 4.250 7.153 3 
Triceps Lateral in Rep 3 in Hand Close Healthy .058 .115 12 
4+ Months .080 .069 7 
0-1 Months 4.257 7.165 3 
 
Table 4.20. Pairwise comparison of TB2 in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Ball Press Healthy .269 .204 14 
4+ Months .693 .501 3 
0-1 Months 4.427 7.373 3 
Triceps Lateral in Rep 1 in Ball Relax Healthy .118 .142 14 
4+ Months .437 .562 3 
0-1 Months 4.417 7.555 3 
Triceps Lateral in Rep 2 in Ball Press Healthy .306 .210 14 
4+ Months .373 .309 3 
0-1 Months 4.427 7.391 3 
Triceps Lateral in Rep 2 in Ball Relax Healthy .091 .123 14 
4+ Months .090 .089 3 
0-1 Months 4.447 7.607 3 
Triceps Lateral in Rep 3 in Ball Press Healthy .298 .208 14 
4+ Months .650 .372 3 
0-1 Months 4.460 7.431 3 
Triceps Lateral in Rep 3 in Ball Relax Healthy .096 .131 14 
4+ Months .083 .085 3 
0-1 Months 4.317 7.347 3 
Table 4.21. Pairwise comparison of FCU in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 in Ball 
Press 
Healthy .084 .094 14 
4+ Months .087 .058 3 
0-1 Months .413 .140 3 
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Flexor Carpi Ulnaris in Rep 1 in Ball 
Relax 
Healthy .028 .041 14 
4+ Months .027 .006 3 
0-1 Months .253 .133 3 
Flexor Carpi Ulnaris in Rep 2 in Ball 
Press 
Healthy .080 .093 14 
4+ Months .117 .085 3 
0-1 Months .420 .165 3 
Flexor Carpi Ulnaris in Rep 2 in Ball 
Relax 
Healthy .019 .016 14 
4+ Months .030 .010 3 
0-1 Months .260 .140 3 
Flexor Carpi Ulnaris in Rep 3 in Ball 
Press 
Healthy .071 .080 14 
4+ Months .093 .064 3 
0-1 Months .427 .176 3 
Flexor Carpi Ulnaris in Rep 3 in Ball 
Relax 
Healthy .026 .035 14 
4+ Months .030 .010 3 
0-1 Months .237 .165 3 
Table 4.22. Pairwise comparison of ECU in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using RMS 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Ball 
Press 
Healthy .026 .030 14 
4+ Months .433 .632 3 
0-1 Months .023 .006 3 
Extensor Carpi Ulnaris in Rep 1 in Ball 
Relax 
Healthy .016 .014 14 
4+ Months .410 .608 3 
0-1 Months .017 .006 3 
Extensor Carpi Ulnaris in Rep 2 in Ball 
Press 
Healthy .025 .026 14 
4+ Months .453 .667 3 
0-1 Months .020 .000 3 
Extensor Carpi Ulnaris in Rep 2 in Ball 
Relax 
Healthy .015 .014 14 
4+ Months .420 .626 3 
0-1 Months .020 .010 3 
Extensor Carpi Ulnaris in Rep 3 in Ball 
Press 
Healthy .026 .029 14 
4+ Months .463 .692 3 
0-1 Months .023 .006 3 
Extensor Carpi Ulnaris in Rep 3 in Ball 
Relax 
Healthy .014 .011 14 
4+ Months .430 .659 3 
0-1 Months .027 .012 3 
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Both long and lateral heads of the triceps had a higher mean in the EFE movement in 
patients at their first month of therapy compared to patients in their 4th month 0.35 ± 2.9 
vs. 0.4 ± 0.85, p = 0.01 (see Graphs A and B in Figures 4.5 and 4.6) This shows that 
healthier individuals tend to depend more on gravity to obtain elbow extension while 
patients have to actively contract their triceps at a great extent to obtain the movement 
required. In wrist flexion and extension, the long head of the triceps also exhibited higher 
activation levels in the 0–1 month rehabilitation population 0.90 ± 0.09 vs. 0.11±1.24, p 
= 0.002 (Graph C in Figure 4.6). The long head is responsible for extending the elbow 
and adducting the shoulder. The injury may cause the patients to actively stimulate the 
muscle in order to keep the arm stable at a 90-degree angle when they are performing 
the wrist motions. Moreover, subjects were asked to keep their arm to their side at all 
times. This could be effortless for healthy individuals, while patients with fresh injuries 
have uncoordinated neuromuscular control leading to the over-activation observed. 
Similarly, in the pronation and supination motion, the long head of the triceps showed 
almost the same mean difference as shown in the wrist flexion–extension motion with a 
0–1 month mean of 0.86 ± 0.07 vs. 0.14 ± 1.25, p = 0.014 (Graph D in Figure 4.7). 
Again, this could be related to stabilizing the elbow at 90 degrees and keeping the arm 
close to the body. In contrast, the PT displayed a higher mean in patients towards the 
end of their therapy compared to those in the beginning 0.05 ± 0.03 vs. 0.20 ± 0.19, p = 
0.04 (Graph E in Figure 4.7). This finding does not align with the trend of higher means 
in first-month patients. Nevertheless, it could be explained by the incapability of 
contracting the muscle by patients, and therefore, it does not show high levels of 
activation.  
Again, in the URD (Graphs F and G in Figure 4.8) and HOC (Graph H and I in Figure 
4.9) movement, both TB and TB2 in URD showed statistical differences of 5.38 ± 0.1 vs. 
1.59 ± 0.051, p = 0.022 and 4.27 ± 0.09 vs. 1.50 ± 8.2, p = 0.49 respectively. They could 
be explained by the previous explanations in WFE and PS. In addition to the TB and 
TB2 showing differences in HOC (Graphs J and K in Figure 4.10), 4.2 ± 0.1 vs. 1.00 ± 
0.016, p = 0.003 and 4.26 ± 7.18 vs. 0.08 ± 0.06, p = 0.015, the biceps showed a higher 
mean in 0–1 month patients versus the 4+ months patients 0.25 ± 0.11 vs. 0.08 ± 0.06, p 
= 0.022 (Graph I in Figure 4.9). The biceps should be activated enough to stabilize the 
elbow in place, however it seemed to activate even when the 0–1 months individuals 
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closed their hand. This is another example showing neuromuscular control being 
compromised enough to cause inappropriate activations of muscles.  
In the ball pressing motion, 3 muscles showed significant differences. Firstly, the lateral 
head of the triceps showed a mean of 4.42 ± 0.5 vs. 0.39 ± 7.37, p = 0.031 (Graph L in 
Figure 4.11). The activation of this muscle is normal in this case, as the motion requires 
elbow extension. The higher magnitude of activation in the 0–1 patient group is the 
common trend and therefore aligns with the findings previously mentioned in this thesis 
explaining that injured people may require higher activation to achieve the same output 
as healthier individuals. Next, the FCU also showed a much greater mean then the late 
stage rehabilitation patients 0.34 ± 0.14 vs. 0.06 ± 0.056, p = 0.000026 (Graph M in 
Figure 4.11). Although the wrist should not have moved much, it is possible that some 
individuals used their wrist flexors to stabilize their hand on top of the ball thus showing 
these differences between the groups. Lastly, the ECU showed noteworthy differences 
in the mean 0.02 ± 0.006 vs. 0.44 ± 0.63, p = 0.032 (Graph N in Figure 4.12).  Unlike the 
general trend of higher mean in the first group of patients, the ECU depicted a much 
larger mean in the later group than the early group. This is very unusual as the ECU is a 
wrist extensor and the wrist was not extended at any point. Conversely, the anatomical 
origin of the ECU suggests it may play a role in elbow motion. This may be the reason 
this difference is observed. The incoordination of muscle activation is no longer 
contracting the muscles that will expend the least energy in the movement but it appears 
that the body will contract whichever muscle it can contract.    
  
Figure 4.5. RMS means of TB in EFE (A) in early patient group and late patient group 
with a standard deviation +/- 1 
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Figure 4.6. RMS means of TB2 in EFE (B) and TB in WFE (C) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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Figure 4.7. RMS means of TB in PS (D) and PT in PS (E) motions in early patient 
group and late patient group with a standard deviation +/- 1 
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Figure 4.8. RMS means of TB2 in PS (F) and TB in URD (G) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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Figure 4.9. RMS means of TB2 in URD (H) and BB in HOC (I) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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Figure 4.10. RMS means of TB in HOC (J) and TB2 in HOC (K) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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Figure 4.11. RMS means of TB2 in Ball Press (L) and FCU in Ball Press (M) 
motions in early patient group and late patient group with a standard deviation 
+/- 1 
 
  
 
96 
96 
 
 
 
 
 
 
4.2 Average Rectified Signal 
The next section will report the results of the ARV in a comparison of healthy individuals 
versus patients and within the patient population in the early rehabilitation group and the 
late stage rehabilitation group. Table 4.23, 4.24, 4.25, and 4.26 below portray the result 
of the first analysis. 
Table 4.23. Statistical analysis comparing healthy individuals to patients using 
ARV 
Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic  
PS ECU -0.005 -0.036 0.006 0.006 0.001 12.545 
WFE ECU -0.002 -0.018 0.004 0.005 0.019 6.426 
N
 
Figure 4.12. RMS mean of ECU in Ball Press (L) motion in early patient group 
and late patient group with a standard deviation +/- 1 
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Ball TB -0.006 0.079 0.027 0.027 0.036 4.88 
 
Table 4.24. Statistical analysis of ECU in PS motion within each repetition 
comparing healthy individuals to patients using ARV 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Pronation Healthy -.004 .006 16 
Patient -.031 .034 14 
Total -.017 .027 30 
Extensor Carpi Ulnaris in Rep 1 in Supination Healthy -.004 .006 16 
Patient -.031 .034 14 
Total -.017 .027 30 
Extensor Carpi Ulnaris in Rep 2 in Pronation Healthy -.005 .006 16 
Patient -.039 .036 14 
Total -.021 .030 30 
Extensor Carpi Ulnaris in Rep 2 in Supination Healthy -.004 .006 16 
Patient -.037 .033 14 
Total -.020 .028 30 
Extensor Carpi Ulnaris in Rep 3 in Pronation Healthy -.005 .006 16 
Patient -.039 .036 14 
Total -.021 .030 30 
Extensor Carpi Ulnaris in Rep 3 in Supination Healthy -.005 .006 16 
Patient -.037 .037 14 
Total -.020 .030 30 
 
Table 4.25. Statistical analysis of ECU in WFE motion within each repetition 
comparing healthy individuals to patients using ARV 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Wrist 
Flexion 
Healthy -.002 .014 14 
Patient -.018 .020 11 
Total -.009 .018 25 
Extensor Carpi Ulnaris in Rep 1 in Wrist 
Extension 
Healthy -.003 .014 14 
Patient -.018 .020 11 
Total -.010 .018 25 
Extensor Carpi Ulnaris in Rep 2 in Wrist 
Flexion 
Healthy -.001 .013 14 
Patient -.021 .022 11 
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Total -.010 .020 25 
Extensor Carpi Ulnaris Rep 2 in Wrist 
Extension 
Healthy -.002 .014 14 
Patient -.020 .021 11 
Total -.010 .019 25 
Extensor Carpi Ulnaris in Rep 3 in Wrist 
Flexion 
Healthy -.002 .014 14 
Patient -.015 .015 11 
Total -.008 .015 25 
Extensor Carpi Ulnaris Rep 3 in Wrist 
Extension 
Healthy -.002 .013 14 
Patient -.018 .018 11 
Total -.009 .017 25 
 
Table 4.26. Statistical analysis of TB in Ball Press motion within each repetition 
comparing healthy individuals to patients using ARV 
 
Health Mean 
Std. 
Deviation N 
Triceps Long in Rep 1 in Ball Press Healthy -.025 .116 14 
Patient .077 .107 15 
Total .028 .121 29 
Triceps Long in Rep 1 in Ball Relax Healthy -.027 .129 14 
Patient .075 .100 15 
Total .026 .124 29 
Triceps Long in Rep 2 in Ball Press Healthy -.029 .119 14 
Patient .077 .107 15 
Total .026 .123 29 
Triceps Long in Rep 2 in Ball Relax Healthy -.026 .128 14 
Patient .077 .119 15 
Total .027 .132 29 
Triceps Long in Rep 3 in Ball Press Healthy -.027 .116 14 
Patient .079 .104 15 
Total .028 .121 29 
Triceps Long in Rep 3 in Ball Relax Healthy .101 .065 14 
Patient .089 .087 15 
Total .094 .076 29 
 
 
 
  
 
99 
99 
Statistical significances were observed in the ARV metric during three instances 
between the general healthy population and the patient population. The first two 
instances were in the ECU during pronation and supination with a healthy mean of 0.005 
± 0.00629 vs. 0.036 ± 0.03416, p = 0.001, F (1,28) = 12.545 (Graph A in Figure 4.13) 
and during WFE healthy mean 0.002 ± 0.004 vs. -0.018 ± 0.005, p = 0.019, F (1,23) = 
6.426 (Graph B in Figure 4.14). The ECU is not responsible for pronation or supination; 
however, it showed higher levels of activation, which leads to the same possible 
conclusion: a compromised neuromuscular system causes contractions in unrequired 
muscles. In contrast, the ECU is a required muscle in the ulnar and radial deviation 
motion. The higher mean simply aligns with the previously mentioned observation in the 
trend of higher means in patients when compared to healthy individuals. Lastly, a 
significant difference was portrayed in the ball pressing action showing a healthy mean 
of the long head of the triceps at 0.006 ± 0.11621 vs. 0.079 ± 0.10694, p = 0.036, F 
(1,27) = 4.88 (Graph C in Figure 4.14). This also supports the statement showing 
patients requiring extra activation to achieve the same motion as healthy individuals. 
 
 
 
 
 
 
 
 
 
A 
Figure 4.13. ARV mean of ECU in PS (A) motion in healthy individuals and 
patients with a standard deviation +/- 1 
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 Figure 4.14. ARV means of ECU in WFE (B) and TB in Ball Pressing (C) motions 
in healthy individuals and patients with a standard deviation +/- 1 
B 
C 
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As mentioned earlier, further analysis was done by comparing patients at the start of 
their therapy (first month post surgery or injury) to those towards the end (4 months post 
surgery or injury). This is shown in Table 4.27, 4.28, 4.29, 4.30, 4.31, 4.32, 4.33, 4.34, 
4.35, 4.36, 4.37, 4.38, 4.39, 4.40, and 4.41. Just like RMS, a higher number of statistical 
significances were observed in this type of analysis as well. Moreover, most of the 
differences observed in RMS are also observed in ARV.   
 
Table 4.27 Pairwise comparison between patients at 0–1 months of injury and 4+ 
months of injury using ARV 
Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month 
SE 4+ 
Months Sig. 
EFE TB 0.72 -0.017 0.151198 0.106913 0.001 
EFE TB2 -3.42 -0.25 0.998956 0.706369 0.016 
EFE ECU -0.04 -0.004 0.008534 0.006035 0.017 
PS TB 0.39 -0.001 0.136510 0.096527 0.029 
WFE TB 0.71 -0.02 0.159137 0.112527 0.001 
WFE TB2 -3.5 -0.07 1.025719 0.725293 0.012 
URD TB -4.3 -0.03 1.362541 1.218694 0.03 
URD ECU 0.68 -0.02 0.237164 0.212126 0.036 
HOC TB 2.3 -0.02 0.492705 0.322551 0.001 
HOC TB2 -2.84 0.016 0.892079 0.584003 0.014 
BALL TB2 1.53 0.014 0.767844 1.172901 0.001 
BALL PT -0.008 0.06 0.012209 0.018650 0.005 
BALL FCU -0.09 0.002 0.032452 0.049571 0.002 
 
Table 4.28. Pairwise comparison of TB in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Elbow Flexion Healthy .053 .184 15 
4+ Months -.043 .082 6 
0-1 Month .570 1.076 3 
Triceps Long in Rep 1 in Elbow Extension Healthy .066 .190 15 
4+ Months -.032 .085 6 
0-1 Month .747 .955 3 
Triceps Long in Rep 2 in Elbow Flexion Healthy .062 .181 15 
4+ Months -.045 .079 6 
0-1 Month .758 .943 3 
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Triceps Long in Rep 2 in Elbow Extension Healthy .061 .196 15 
4+ Months -.038 .088 6 
0-1 Month .742 .942 3 
Triceps Long in Rep 3 in Elbow Flexion Healthy .049 .196 15 
4+ Months -.045 .081 6 
0-1 Month .782 .939 3 
Triceps Long in Rep 3 in Elbow Extension Healthy .139 .125 15 
4+ Months .098 .067 6 
0-1 Month .731 .774 3 
 
Table 4.29. Pairwise comparison of TB2 in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Elbow Flexion Healthy -.015 .036 15 
4+ Months -.248 .434 6 
0-1 Month -3.424 6.080 3 
Triceps Lateral in Rep 1 in Elbow 
Extension 
Healthy -.012 .035 15 
4+ Months -.255 .436 6 
0-1 Month -3.228 5.763 3 
Triceps Lateral in Rep 1 in Elbow Flexion Healthy -.012 .037 15 
4+ Months -.258 .436 6 
0-1 Month -3.438 6.117 3 
Triceps Lateral in Rep 1 in Elbow 
Extension 
Healthy -.012 .031 15 
4+ Months -.259 .436 6 
0-1 Month -3.371 5.999 3 
Triceps Lateral in Rep 1 in Elbow Flexion Healthy -.014 .035 15 
4+ Months -.260 .433 6 
0-1 Month -3.563 6.348 3 
Triceps Lateral in Rep 1 in Elbow 
Extension 
Healthy -.015 .031 15 
4+ Months -.253 .438 6 
0-1 Month -3.500 6.160 3 
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Table 4.30. Pairwise comparison of ECU in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Elbow 
Flexion 
Healthy -.004 .012 15 
4+ Months .000 .009 6 
0-1 Month -.037 .023 3 
Extensor Carpi Ulnaris in Rep 1 in Elbow 
Extension 
Healthy -.004 .012 15 
4+ Months -.001 .009 6 
0-1 Month -.023 .052 3 
Extensor Carpi Ulnaris in Rep 2 in Elbow 
Flexion 
Healthy -.003 .013 15 
4+ Months -.004 .016 6 
0-1 Month -.033 .028 3 
Extensor Carpi Ulnaris in Rep 2 in Elbow 
Extension 
Healthy -.004 .012 15 
4+ Months -.007 .014 6 
0-1 Month -.020 .046 3 
Extensor Carpi Ulnaris in Rep 3 in Elbow 
Flexion 
Healthy -.004 .012 15 
4+ Months -.009 .014 6 
0-1 Month -.031 .026 3 
Extensor Carpi Ulnaris in Rep 3 in Elbow 
Extension 
Healthy -.004 .012 15 
4+ Months -.003 .011 6 
0-1 Month -.039 .033 3 
 
Table 4.31. Pairwise comparison of PT in PS motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Pronation Healthy -.028 .073 16 
4+ Months -.017 .073 6 
0-1 Months .427 .670 3 
Triceps Long in Rep 1 in Supination Healthy -.082 .258 16 
4+ Months -.017 .074 6 
0-1 Months .423 .664 3 
Triceps Long in Rep 2 in Pronation Healthy -.079 .244 16 
4+ Months -.017 .074 6 
0-1 Months .433 .681 3 
Triceps Long in Rep 2 in Supination Healthy -.079 .244 16 
4+ Months -.017 .080 6 
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0-1 Months .427 .670 3 
Triceps Long in Rep 3 in Pronation Healthy -.081 .245 16 
4+ Months -.013 .075 6 
0-1 Months .413 .647 3 
Triceps Long in Rep 3 in Supination Healthy .044 .032 16 
4+ Months .072 .033 6 
0-1 Months .197 .263 3 
 
Table 4.32. Pairwise comparison of TB in WFE motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Wrist Flexion Healthy .006 .168 13 
4+ Months -.039 .084 6 
0-1 Months .598 1.065 3 
Triceps Long in Rep 1 in Wrist Extension Healthy .009 .165 13 
4+ Months -.034 .085 6 
0-1 Months .751 .950 3 
Triceps Long in Rep 2 in Wrist Flexion Healthy .010 .166 13 
4+ Months -.044 .080 6 
0-1 Months .761 .943 3 
Triceps Long in Rep 2 in Wrist Extension Healthy .010 .174 13 
4+ Months -.050 .076 6 
0-1 Months .754 .938 3 
Triceps Long in Rep 3 in Wrist Flexion Healthy .008 .167 13 
4+ Months -.048 .078 6 
0-1 Months .781 .942 3 
Triceps Long in Rep 3 in Wrist Extension Healthy .094 .062 13 
4+ Months .080 .042 6 
0-1 Months .611 .579 3 
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Table 4.33. Pairwise comparison of TB2 in WFE motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Wrist Flexion Healthy -.013 .038 13 
4+ Months -.058 .157 6 
0-1 Months -3.427 6.099 3 
Triceps Lateral in Rep 1 in Wrist 
Extension 
Healthy -.010 .036 13 
4+ Months -.065 .165 6 
0-1 Months -3.278 5.854 3 
Triceps Lateral in Rep 2 in Wrist Flexion Healthy -.012 .038 13 
4+ Months -.060 .160 6 
0-1 Months -3.468 6.170 3 
Triceps Lateral in Rep 2 in Wrist 
Extension 
Healthy -.012 .036 13 
4+ Months -.069 .175 6 
0-1 Months -3.495 6.212 3 
Triceps Lateral in Rep 3 in Wrist Flexion Healthy -.007 .037 13 
4+ Months -.073 .164 6 
0-1 Months -3.559 6.341 3 
Triceps Lateral in Rep 3 in Wrist 
Extension 
Healthy -.010 .035 13 
4+ Months -.072 .171 6 
0-1 Months -3.528 6.213 3 
 
Table 4.34. Pairwise comparison of TB in URD motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Ulnar Deviation Healthy -.013 .114 13 
4+ Months -.050 .093 5 
0-1 Months -5.440 9.618 4 
Triceps Long in Rep 1 in Radial 
Deviation 
Healthy -.012 .108 13 
4+ Months -.050 .085 5 
0-1 Months -4.703 8.134 4 
Triceps Long in Rep 2 in Ulnar Deviation Healthy -.013 .105 13 
4+ Months -.048 .091 5 
0-1 Months -5.515 9.755 4 
Triceps Long in Rep 2 in Radial 
Deviation 
Healthy -.015 .106 13 
4+ Months -.052 .087 5 
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0-1 Months -5.180 9.095 4 
Triceps Long in Rep 3 in Ulnar Deviation Healthy -.015 .106 13 
4+ Months -.040 .094 5 
0-1 Months -5.430 9.580 4 
Triceps Long in Rep 3 in Radial 
Deviation 
Healthy .049 .038 13 
4+ Months .058 .037 5 
0-1 Months .735 .946 4 
 
Table 4.35. Pairwise comparison of ECU in URD motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Extensor Carpi Ulnaris in Rep 1 in Ulnar 
Deviation 
Healthy -.005 .008 13 
4+ Months -.024 .152 5 
0-1 Months .683 1.305 4 
Extensor Carpi Ulnaris in Rep 1 in Radial 
Deviation 
Healthy -.005 .008 13 
4+ Months -.022 .155 5 
0-1 Months .685 1.310 4 
4+ Months -.026 .152 5 
0-1 Months .678 1.289 4 
Extensor Carpi Ulnaris in Rep 2 in Radial 
Deviation 
Healthy -.005 .008 13 
4+ Months -.024 .155 5 
0-1 Months .683 1.292 4 
Extensor Carpi Ulnaris in Rep 3 in Ulnar 
Deviation 
Healthy -.005 .008 13 
4+ Months -.022 .158 5 
0-1 Months .688 1.302 4 
Extensor Carpi Ulnaris in Rep 3 in Radial 
Deviation 
Healthy -.005 .008 13 
4+ Months -.022 .158 5 
0-1 Months .690 1.307 4 
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Table 4.36. Pairwise comparison of TB in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Hand Open Healthy .028 .146 12 
4+ Months -.040 .132 7 
0-1 Months 2.653 3.087 3 
Triceps Long in Rep 1 in Hand Close Healthy .032 .149 12 
4+ Months -.037 .120 7 
0-1 Months 2.690 3.158 3 
Triceps Long in Rep 2 in Hand Open Healthy .029 .146 12 
4+ Months -.036 .130 7 
0-1 Months 2.687 3.152 3 
Triceps Long in Rep 2 in Hand Close Healthy .032 .148 12 
4+ Months -.039 .133 7 
0-1 Months 2.287 2.470 3 
Triceps Long in Rep 3 in Hand Open Healthy .033 .150 12 
4+ Months -.039 .128 7 
0-1 Months 2.703 3.188 3 
Triceps Long in Rep 3 in Hand Close Healthy .049 .030 12 
4+ Months .049 .033 7 
0-1 Months .850 1.009 3 
 
Table 4.37. Pairwise comparison of TB2 in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Hand Open Healthy .017 .100 12 
4+ Months .016 .071 7 
0-1 Months -2.837 4.862 3 
Triceps Lateral in Rep 1 in Hand Close Healthy .018 .098 12 
4+ Months .016 .071 7 
0-1 Months -2.833 4.856 3 
Triceps Lateral in Rep 2 in Hand Open Healthy .018 .099 12 
4+ Months .017 .069 7 
0-1 Months -2.850 4.876 3 
Triceps Lateral in Rep 2 in Hand Close Healthy .018 .102 12 
4+ Months .017 .069 7 
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0-1 Months -2.840 4.859 3 
Triceps Lateral in Rep 3 in Hand Open Healthy .018 .098 12 
4+ Months .016 .068 7 
0-1 Months -2.870 4.928 3 
Triceps Lateral in Rep 3 in Hand Close Healthy .019 .108 12 
4+ Months .016 .068 7 
0-1 Months -2.853 4.891 3 
 
 
Table 4.38. Pairwise comparison of TB2 in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Ball Press Healthy -.011 .056 14 
4+ Months -.027 .105 3 
0-1 Months 1.524 4.051 7 
Total .359 1.991 29 
Triceps Lateral in Rep 1 in Ball Relax Healthy -.015 .060 14 
4+ Months .023 .051 3 
0-1 Months 1.544 4.073 7 
Triceps Lateral in Rep 2 in Ball Press Healthy -.011 .058 14 
4+ Months .020 .044 3 
0-1 Months 1.526 4.054 7 
Triceps Lateral in Rep 2 in Ball Relax Healthy -.014 .060 14 
4+ Months .020 .036 3 
0-1 Months 1.546 4.076 7 
Triceps Lateral in Rep 3 in Ball Press Healthy -.014 .066 14 
4+ Months .030 .026 3 
0-1 Months 1.541 4.087 7 
Triceps Lateral in Rep 3 in Ball Relax Healthy -.016 .062 14 
4+ Months .017 .046 3 
0-1 Months 1.531 4.030 7 
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Table 4.39. Pairwise comparison of PT in Ball Press motion between patients at 0–
1 months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Ball Press  Healthy -.004 .011 14 
4+ Months .063 .101 3 
0-1 Months -.007 .024 7 
Total .004 .038 29 
Pronator Teres in Rep 1 in Ball Relax Healthy -.008 .011 14 
4+ Months .060 .095 3 
0-1 Months -.010 .022 7 
Pronator Teres in Rep 2 in Ball Press Healthy -.005 .012 14 
4+ Months .057 .098 3 
0-1 Months -.007 .024 7 
Pronator Teres in Rep 2 in Ball Relax Healthy -.006 .009 14 
4+ Months .060 .095 3 
0-1 Months -.010 .022 7 
Pronator Teres in Rep 3 in Ball Press Healthy -.005 .012 14 
4+ Months .057 .098 3 
0-1 Months -.006 .025 7 
Pronator Teres in Rep 3 in Ball Relax Healthy -.006 .012 14 
4+ Months .060 .095 3 
0-1 Months -.011 .022 7 
 
Table 4.40. Pairwise comparison of FCU in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using ARV 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 in Ball Press Healthy -.001 .012 14 
4+ Months .000 .000 3 
0-1 Months -.094 .138 7 
Flexor Carpi Ulnaris in Rep 1 in Ball Relax Healthy .001 .012 14 
4+ Months .000 .000 3 
0-1 Months -.083 .142 7 
Flexor Carpi Ulnaris in Rep 2 in Ball Press Healthy .000 .013 14 
4+ Months .003 .006 3 
0-1 Months -.094 .142 7 
Flexor Carpi Ulnaris in Rep 2 in Ball Relax Healthy .001 .012 14 
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4+ Months .000 .000 3 
0-1 Months -.086 .149 7 
Flexor Carpi Ulnaris in Rep 3 in Ball Press Healthy -.001 .011 14 
4+ Months .003 .006 3 
0-1 Months -.097 .146 7 
Flexor Carpi Ulnaris in Rep 3 in Ball Relax Healthy .001 .012 14 
4+ Months .003 .006 3 
0-1 Months -.087 .149 7 
 
Identical to RMS, the long and lateral heads of the triceps had a higher mean in the EFE 
movement in patients at their first month of therapy compared to patients in their 4th 
month (see Graphs A and B in Figure 4.15): long head 0–1 month mean of 0.72 ± 1.07 
vs. -0.017 ± 0.08, p = 0.001 and the lateral head 0–1 month mean of -3.42 ± 6.08 vs. -
0.255 ± 0.43, p = 0.016. This shows that healthier individuals use gravity to achieve 
elbow extension while patients opt to actively contract their triceps at a great extent to 
obtain the movement required. Additionally, the ECU showed significant differences with 
a healthy mean of -0.004 ± 0.02 vs. 0.03 ± -0.009, p = 0.017 (see Graph C in Figure 
4.16). This goes with the notion that ECU’s position suggests it may play a role in elbow 
motion however it is an inefficient way of moving it due to the almost non-existent torque 
production in the muscle with this motion. However, with injury, patients are more likely 
to recruit improper muscles to achieve the motion required. Similar to RMS, in PS, the 
long head of the triceps displayed greater stimulation levels in the 1-month rehabilitation 
population 0.39 ± 0.67 vs. -0.001 ± 0.07, p = 0.029 (Graph D in Figure 4.16). As 
mentioned earlier, the long head is responsible for extending the elbow and adducting 
the shoulder. The injury may have caused the patients to actively stimulate the triceps in 
order to keep the arm secured at a 90-degree angle when they were performing the wrist 
motions or due to keeping their arm adducted to their side.  In a similar manner to PS 
motion in this metric and other motions in the RMS metric, the WFE motion in ARV also 
portrayed difference between the groups in TB and TB2 0.71 ± 1.06 vs. -0.02 ± 0.08, p = 
0.001 and 3.45 ± 6.1 vs. -0.067 ± 0.16, p = 0.012 (Graph E and F in Figure 4.17). Again, 
this could be related to stabilizing the elbow at 90 degrees and keeping the arm close to 
the body.   
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Exactly like RMS, the URD movement, showed similar mean differences in TB 2.31 ± 
9.6 vs. 0.02 ± 0.09, p = 0.3 (Graph G in Figure 4.18). In addition, the ECU depicted 
statistical significant differences showing patients 0–1 month at average of .68 ± 1.3 vs. 
0.02 ± 1.5, p = 0.036 (Graph H in Figure 4.18). The ECU is used as a primary muscle in 
the URD, however, following the same conclusions previously mentioned, patients at the 
beginning of their therapy seem to exert more effort in recruitment to obtain the same 
movement as a healed or healthy individual. Analogous results are shown in the HOC 
with differences in TB and TB2: 2.31 ± 3.1 vs. -0.024 ± 0.13, p = 0.001 and 1.54 ± 4.86 
vs. 0.014 ± 0.07, p = 0.014 (Graphs I and J in Figure 4.19). In the ball pressing motion, 3 
muscles also showed significant differences. The first 2 muscles are identical to the 
muscles from the RMS metric and thus will not be further explained here (Graphs K and 
L in Figure 4.20). The muscle that showed statistical differences not presented in RMS 
was PT, 0.0086 ± 0.05 vs. 0.059 ± 0.10, p = 0.002 (Graph M in Figure 4.21). In a similar 
manner to ECU, the PT also shows anatomical relevance to moving the elbow, which 
allows it to agree with the notion of neuromuscular, comprise and ineffective activation of 
muscles.  
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Figure 4.15. ARV means of TB in EFE (A) and TB2 in EFE (B) in early patient 
group and late patient group with a standard deviation +/- 1 
A 
B 
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Figure 4.16. ARV means of ECU in EFE (C) and TB in PS (D) in early patient 
group and late patient group with a standard deviation +/- 1 
C 
D 
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Figure 4.17. ARV means of TB in WFE (E) and TB2 in WFE (F) in early patient 
group and late patient group with a standard deviation +/- 1 
E 
F 
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Figure 4.18. ARV means of TB in URD (G) and ECU in URD (H) motions in 
healthy individuals and patients with a standard deviation +/- 1 
G 
H 
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Figure 4.19. ARV means of TB in HOC (I) and TB2 in HOC (J) motions in healthy 
individuals and patients with a standard deviation +/- 1 
I 
J 
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Figure 4.20. ARV means of TB2 in Ball Press (K) and FCU in Ball Press (L) 
motions in healthy individuals and patients with a standard deviation +/- 1 
K 
L 
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Figure 4.21. ARV means of FCU in Ball Press (M) motion in healthy individuals 
and patients with a standard deviation +/- 1 
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4.3 Zero Crossings 
The ZC metric measures the number of times the raw signal crosses the zero line, i.e., 
the x-axis. This represents the level of activation, the larger the number the higher the 
activation in the muscle. In the first phase of analysis between patients and healthy 
individuals, only the elbow flexion–extension motion presented statistical significance. 
This was shown in the biceps and extensor carpi ulnaris as shown in Table 4.42, 4.43, 
4.44, and 4.45.   
Table 4.41. Statistical analysis comparing healthy individuals to patients using ZC 
Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic  
EFE BB 278 616 72.013 60.503 0.005 9.177 
EFE PT 271 849 189.862 159.516 0.028 5.428 
EFE ECU 303 895 167.503 140.731 0.012 7.318 
 
Table 4.42. Statistical analysis of BB in EFE motion within each repetition 
comparing healthy individuals to patients using ZC 
 Health Mean Std. Deviation N 
Biceps in Rep 1 in Elbow Flexion Healthy 277.917 92.600 12 
Patient 616.353 397.330 17 
Total 476.310 349.795 29 
Biceps in Rep 1 in Elbow Extension Healthy 269.833 119.741 12 
Patient 488.118 365.630 17 
Total 397.793 306.586 29 
Biceps in Rep 2 in Elbow Flexion Healthy 236.417 73.190 12 
Patient 625.059 388.424 17 
Total 464.241 355.337 29 
Biceps in Rep 2 in Elbow Extension Healthy 210.833 84.992 12 
Patient 411.294 292.157 17 
Total 328.345 248.411 29 
Biceps in Rep 3 in Elbow Flexion Healthy 246.000 86.749 12 
Patient 563.118 348.053 17 
Total 431.897 312.161 29 
Biceps in Rep 3 in Elbow Extension Healthy 222.667 111.753 12 
Patient 469.294 278.350 17 
Total 367.241 253.892 29 
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Table 4.43. Statistical analysis of PT in EFE motion within each repetition 
comparing healthy individuals to patients using ZC 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Elbow Flexion Healthy 459.333 570.643 12 
Patient 1031.588 1103.285 17 
Total 794.793 951.716 29 
Pronator Teres in Rep 1 in Elbow 
Extension 
Healthy 347.833 262.330 12 
Patient 738.235 858.322 17 
Total 576.690 697.357 29 
Pronator Teres in Rep 2 in Elbow Flexion Healthy 216.583 164.907 12 
Patient 1074.824 1112.491 17 
Total 719.690 950.240 29 
Pronator Teres in Rep 2 in Elbow 
Extension 
Healthy 196.917 164.934 12 
Patient 650.471 742.581 17 
Total 462.793 614.385 29 
Pronator Teres in Rep 3 in Elbow Flexion Healthy 190.417 150.425 12 
Patient 860.647 671.848 17 
Total 583.310 616.178 29 
Pronator Teres in Rep 3 in Elbow 
Extension 
Healthy 215.167 195.805 12 
Patient 736.824 718.984 17 
Total 520.966 615.485 29 
 
Table 4.44. Statistical analysis of ECU in EFE motion within each repetition 
comparing healthy individuals to patients using ZC 
 
Health Mean 
Std. 
Deviation N 
Extensor Carpi Ulnaris in Rep 1 in 
Elbow Flexion 
Healthy 393.833 343.948 12 
Patient 959.471 821.360 17 
Total 725.414 715.793 29 
Extensor Carpi Ulnaris in Rep 1 in 
Elbow Extension 
Healthy 339.250 418.067 12 
Patient 1139.647 1517.912 17 
Total 808.448 1243.469 29 
Extensor Carpi Ulnaris in Rep 12 in 
Elbow Flexion 
Healthy 306.417 241.262 12 
Patient 944.765 852.162 17 
Total 680.621 734.983 29 
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Extensor Carpi Ulnaris in Rep 2 in 
Elbow Extension 
Healthy 249.500 253.235 12 
Patient 733.235 808.325 17 
Total 533.069 676.274 29 
Extensor Carpi Ulnaris in Rep 3 in 
Elbow Flexion 
Healthy 289.583 279.659 12 
Patient 904.059 631.589 17 
Total 649.793 594.584 29 
Extensor Carpi Ulnaris in Rep 3 in 
Elbow Extension 
Healthy 240.917 328.972 12 
Patient 689.294 534.634 17 
Total 503.759 506.318 29 
 
In the biceps, the mean of healthy individuals was 277.9 ± 92.6 vs. 616.3 ± 397.3, p = 
0.005, F (1,27) = 9.177 (Graph A in Figure 4.22). This is the first instance that this 
significance is observed in this muscle. Although an overall trend has been displayed 
showing higher means in patients, it was never high enough in the BB in EFE to show 
significance except in ZC. This metric is not amplitude dependent, as were the previous 
ones. As a result, more motor units could have been recruited but activated at the same 
level, and thus were not captured by the amplitude dependant metrics. Moreover, the 
pronator teres displayed a healthy mean of 271.042 ± 570.64 vs. 848.765 ± 1103.2, p = 
0.028, F (1,27) = 5.42 (Graph B in Figure 4.22). Again, this has not been witnessed 
before in the other metrics. A similar explanation to the BB in EFE can be applied in this 
case. Although the PT is not a primary mover of the elbow, as mentioned before, its 
anatomy suggests it may play a role in the elbow joint. Lastly, the ECU showed a healthy 
mean of 303.25 ± 343.9 vs. 895.078 ± 821.36047, p = 0.028, F (1,27) = 5.428 (Graph C 
in Figure 4.23). The explanation of this is again related to the compromise of the 
neuromuscular function of the patient population, which leads to these muscles being 
activated at rate it should not be within the specified motion.  
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Figure 4.22. ZC Means of BB in EFE (A) and PT in EFE (B) motions in 
healthy individuals and patients with a standard deviation +/- 1 
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Figure 4.23. ECU in EFE (C) in healthy individuals and patients with a 
standard deviation +/- 1 
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The second part of the analysis was conducted and more instances of significances 
have been observed just like the previous metrics, as shown in Table 4.46, 4.47, 4.48, 
4.49, 4.50, 4.51, and 4.52. 
Table 4.45. Pairwise comparison between patients at 0–1 months of injury and 4+ 
months of injury using ZC 
Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month  
SE 4+ 
Months Sig 
PS TB2 864 230 220 118 0.018 
PS PT 1000 503 196 105 0.035 
URD PT 1487 374 414 271 0.035 
HOC TB2 174 703 199 130 0.038 
HOC PT 698 282 124 81 0.011 
HOC FCU 1436 475 329 215 0.024 
 
Table 4.46. Pairwise comparison of TB2 in PS motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Pronation Healthy 546.063 376.754 16 
4+ Months 257.571 327.094 7 
0-1 Months 801.000 335.169 2 
Triceps Lateral in Rep 1 in 
Supination 
Healthy 621.375 427.345 16 
4+ Months 252.571 343.164 7 
0-1 Months 1152.000 380.423 2 
Triceps Lateral in Rep 2 in Pronation Healthy 522.625 344.202 16 
4+ Months 290.286 349.744 7 
0-1 Months 552.500 386.787 2 
Triceps Lateral in Rep 2 in 
Supination 
Healthy 529.063 340.334 16 
4+ Months 198.857 287.086 7 
0-1 Months 968.500 422.143 2 
Triceps Lateral in Rep 3 in Pronation Healthy 486.813 337.517 16 
4+ Months 212.000 264.406 7 
0-1 Months 781.000 445.477 2 
Triceps Lateral in Rep 3 in 
Supination 
Healthy 535.313 361.933 16 
4+ Months 168.857 246.971 7 
0-1 Months 929.000 565.685 2 
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Table 4.47. Pairwise comparison of PT in PS motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Pronation Healthy 422.625 233.896 16 
4+ Months 535.286 264.836 7 
0-1 Months 847.000 779.232 2 
Total 524.867 321.715 30 
Pronator Teres in Rep 3 in Supination Healthy 385.188 296.242 16 
4+ Months 502.286 287.191 7 
0-1 Months 1429.500 856.306 2 
Total 525.767 414.129 30 
Pronator Teres in Rep 1 in Pronation Healthy 419.438 292.712 16 
4+ Months 556.143 185.098 7 
0-1 Months 739.000 719.835 2 
Total 500.333 301.341 30 
Pronator Teres in Rep 3 in Supination Healthy 326.438 267.052 16 
4+ Months 441.714 350.676 7 
0-1 Months 1307.500 893.076 2 
Total 469.633 403.746 30 
Pronator Teres in Rep 1 in Pronation Healthy 387.438 265.395 16 
4+ Months 530.429 262.507 7 
0-1 Months 647.000 370.524 2 
Total 480.933 273.918 30 
Pronator Teres in Rep 3 in Supination Healthy 309.688 235.495 16 
4+ Months 453.857 359.589 7 
0-1 Months 1031.500 488.611 2 
Total 435.400 325.959 30 
 
Table 4.48. Pairwise comparison of PT in URD motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Ulnar 
Deviation 
Healthy 875.077 1103.841 13 
4+ Months 426.143 276.977 7 
0-1 Months 1778.333 1634.373 3 
Total 805.321 958.476 28 
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Pronator Teres in Rep 1 in Radial 
Deviation 
Healthy 703.846 753.559 13 
4+ Months 342.286 222.073 7 
0-1 Months 1726.000 1408.337 3 
Total 676.893 758.666 28 
Pronator Teres in Rep 2 in Ulnar 
Deviation 
Healthy 777.538 969.752 13 
4+ Months 451.857 302.153 7 
0-1 Months 1500.667 956.202 3 
Total 729.714 777.343 28 
Pronator Teres in Rep 2 in Radial 
Deviation 
Healthy 697.308 938.688 13 
4+ Months 256.286 143.746 7 
0-1 Months 1144.000 817.669 3 
Total 590.964 721.530 28 
Pronator Teres in Rep 3 in Ulnar 
Deviation 
Healthy 814.692 784.590 13 
4+ Months 394.143 257.537 7 
0-1 Months 1434.333 825.158 3 
Total 727.714 660.304 28 
Pronator Teres in Rep 3 in Radial 
Deviation 
Healthy 687.769 740.946 13 
4+ Months 374.714 258.971 7 
0-1 Months 1341.667 996.454 3 
Total 623.536 650.816 28 
 
Table 4.49. Pairwise comparison of TB2 in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 
Health Mean 
Std. 
Deviation N 
Triceps Lateral in Rep 1 in Hand Open Healthy 390.917 316.148 12 
4+ Months 811.714 609.895 7 
0-1 Months 171.333 139.848 3 
Total 490.960 436.556 25 
Triceps Lateral in Rep 1 in Hand Close Healthy 274.417 306.509 12 
4+ Months 617.714 470.109 7 
0-1 Months 159.333 135.633 3 
Total 366.120 359.531 25 
Triceps Lateral in Rep 2 in Hand Open Healthy 382.083 363.935 12 
4+ Months 782.714 495.615 7 
0-1 Months 175.000 144.087 3 
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Total 477.960 410.263 25 
Triceps Lateral in Rep 2 in Hand Close Healthy 291.250 318.730 12 
4+ Months 665.143 502.932 7 
0-1 Months 184.333 157.912 3 
Total 403.920 380.668 25 
Triceps Lateral in Rep 3 in Hand Open Healthy 367.333 361.268 12 
4+ Months 697.857 331.890 7 
0-1 Months 177.000 116.357 3 
Total 454.640 346.226 25 
Triceps Lateral in Rep 3 in Hand Close Healthy 246.250 253.671 12 
4+ Months 644.714 483.272 7 
0-1 Months 179.667 143.959 3 
Total 383.320 358.067 25 
 
Table 4.50. Pairwise comparison of PT in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Hand Open Healthy 569.833 231.247 12 
4+ Months 329.000 275.247 7 
0-1 Months 680.000 321.053 3 
Pronator Teres in Rep 1 in Hand Close Healthy 376.833 169.938 12 
4+ Months 274.714 256.992 7 
0-1 Months 700.333 397.588 3 
Pronator Teres in Rep 2 in Hand Open Healthy 523.167 204.453 12 
4+ Months 313.429 270.955 7 
0-1 Months 689.667 333.800 3 
Pronator Teres in Rep 2 in Hand Close Healthy 370.417 182.488 12 
4+ Months 209.286 165.755 7 
0-1 Months 710.333 453.202 3 
Pronator Teres in Rep 3 in Hand Open Healthy 556.833 187.869 12 
4+ Months 329.286 314.103 7 
0-1 Months 658.667 279.502 3 
Pronator Teres in Rep 3 in Hand Close
  
Healthy 332.000 165.723 12 
4+ Months 237.000 197.020 7 
0-1 Months 749.333 440.320 3 
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Table 4.51. Pairwise comparison of FCU in HOC motion between patients at 0–1 
months of injury and 4+ months of injury using ZC 
 Health Mean Std. Deviation N 
Flexor Carpi Ulnaris in Rep 1 in Hand 
Open 
Healthy 543.917 292.813 12 
4+ Months 509.286 658.178 7 
0-1 Months 1293.333 1471.633 3 
Flexor Carpi Ulnaris in Rep 1 in Hand 
Close 
Healthy 416.083 283.765 12 
4+ Months 475.571 733.207 7 
0-1 Months 1453.333 792.249 3 
Flexor Carpi Ulnaris in Rep 2 in Hand 
Open 
Healthy 517.250 300.763 12 
4+ Months 423.714 485.144 7 
0-1 Months 1373.000 1615.878 3 
Flexor Carpi Ulnaris in Rep 2 in Hand 
Close 
Healthy 391.750 247.399 12 
4+ Months 501.714 857.034 7 
0-1 Months 1634.333 1358.693 3 
Flexor Carpi Ulnaris in Rep 3 in Hand 
Open 
Healthy 545.167 283.157 12 
4+ Months 424.143 440.560 7 
0-1 Months 1372.667 1151.289 3 
Flexor Carpi Ulnaris in Rep 3 in Hand 
Close 
Healthy 350.667 271.769 12 
4+ Months 513.286 909.423 7 
0-1 Months 1494.667 1025.132 3 
In the TB2 in PS, the mean of 0–1 month individuals was 864 ± 335 vs. 230 ± 327, p = 
0.018 (Graph A in Figure 4.24). The higher value in the more recently injured population 
aligns with the conclusions that have been drawn thus far in this thesis. Moreover, the 0–
1 group also exhibited higher rate of crossings than the 4+ group in PT in PS as well 
1000 ± 779 vs. 503 ± 265, p = 0.035 (Graph B in Figure 4.25). This is analogous to the 
previous findings as well. Additionally, the PT and FCU also showed higher values in 
HOC in the 0–1 month group: 698 ± 321 vs. 282 ± 275, p = 0.011 and 1436 ± 1471 vs. 
475 ± 658, p = 0.024 respectively (Graphs E and F in Figures 4.26 and 4.27). Similar to 
the previous discussion, these muscles are not responsible for opening and closing the 
fingers yet show these statistical differences. In URD motion, the PT showed yet another 
higher mean in the early rehab patient group: 1487 ± 1634 vs. 374 ± 276, p = 0.035 
(Graph C in Figure 4.25). Finally, the TB2 in HOC also shows statistical differences but 
with a higher mean in healthier group: 174 ± 104 vs. 703 ± 610, p = 0.038 (Graph D in 
Figure 4.26). This is not in accordance with previous findings. This variation may be 
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attributed to the use of this different metric that measures rate rather than amplitude or it 
could be explained by the inability of patients to contract the muscle, and therefore it 
does not show high levels of activation.  
 
 
 
  
Figure 4.24. ZC measure of TB2 in PS (A) motion in early patient group and 
late patient group with a standard deviation +/- 1 
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Figure 4.25. ZC measure of PT in PS (B) and PT in URD (C) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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Figure 4.26. ZC measure of TB2 in HOC (B), PT in HOC (C) motions in early 
patient group and late patient group with a standard deviation +/- 1 
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4.4 MSA 
Another metric that revealed statistical significance was the MSA. During the first 
analysis, three instances exhibited significance as shown in Table 4.53, 4.54, 4.55, and 
4.56.  
 
Table 4.52. Statistical analysis comparing healthy individuals to patients using 
MSA 
Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic  
EFE TB2 0.122 0.392 0.089 0.093 0.046 4.397 
PS TB 0.154 0.416 0.083 0.086 0.037 4.838 
Ball BB 0.314 0.199 0.029 0.028 0.008 8.102 
 
F
 
Figure 4.27. ZC measure of FCU in HOC (F) motion in early patient group and 
late patient group with a standard deviation +/- 1 
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Table 4.53. Statistical analysis of TB2 in EFE motion within each repetition 
comparing healthy individuals to patients using MSA 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Elbow Flexion Healthy .118 .081 14 
Patient .358 .474 13 
Total .234 .349 27 
Triceps Lateral in Rep 1 in Elbow Extension Healthy .125 .089 14 
Patient .347 .500 13 
Total .232 .364 27 
Triceps Lateral in Rep 2 in Elbow Flexion Healthy .124 .091 14 
Patient .424 .489 13 
Total .268 .371 27 
Triceps Lateral in Rep 2 in Elbow Extension Healthy .101 .057 14 
Patient .308 .439 13 
Total .201 .319 27 
Triceps Lateral in Rep 3 in Elbow Flexion Healthy .127 .116 14 
Patient .538 .832 13 
Total .325 .608 27 
Triceps Lateral in Rep 3 in Elbow Extension Healthy .137 .110 14 
Patient .378 .512 13 
Total .253 .377 27 
 
Table 4.54. Statistical analysis of TB in PS motion within each repetition 
comparing healthy individuals to patients using MSA 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Pronation Healthy .151 .104 14 
Patient .412 .443 13 
Total .276 .337 27 
Triceps Long in Rep 1 in Supination Healthy .156 .103 14 
Patient .392 .423 13 
Total .270 .320 27 
Triceps Long in Rep 2 in Pronation Healthy .149 .100 14 
Patient .426 .429 13 
Total .282 .332 27 
Triceps Long in Rep 2 in Supination Healthy .158 .103 14 
Patient .406 .431 13 
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Total .277 .327 27 
Triceps Long in Rep 3 in Pronation Healthy .151 .100 14 
Patient .444 .444 13 
Total .292 .344 27 
Triceps Long in Rep 3 in Supination Healthy .161 .115 14 
Patient .417 .439 13 
Total .284 .336 27 
 
Table 4.55. Statistical analysis of BB in Ball Press motion within each repetition 
comparing healthy individuals to patients using MSA 
 Health Mean Std. Deviation N 
Biceps in Rep 1 in Ball Press Healthy .348 .142 14 
Patient .227 .127 15 
Total .285 .146 29 
Biceps in Rep 1 in Ball Relax Healthy .244 .151 14 
Patient .154 .060 15 
Total .198 .120 29 
Biceps in Rep 2 in Ball Press Healthy .371 .130 14 
Patient .237 .128 15 
Total .301 .144 29 
Biceps in Rep 2 in Ball Relax Healthy .234 .148 14 
Patient .148 .046 15 
Total .190 .115 29 
Biceps in Rep 3 in Ball Press Healthy .454 .310 14 
Patient .243 .146 15 
Total .345 .258 29 
Biceps in Rep 3 in Ball Relax Healthy .234 .122 14 
Patient .185 .072 15 
Total .209 .100 29 
In elbow flexion–extension only the lateral head of the triceps showed statistical 
significance with a healthy mean of 0.122 ± 0.08 vs. 0.392 ± 0.47, p = 0.046, F (1,25) = 
4.397 (Graph A in Figure 4.28). This aligns with the evaluations made in the previous 
metrics about using the muscle rather than gravity in patients. In pronation–supination, 
TB revealed a p value of significance with a healthy mean of 0.154 ± 0.1 vs. 0.416 ± 
0.44, p = 0.037, F (1,28) = 4.838 (Graph B in Figure 4.29). Again, the elbow is being 
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held at an angle of 90 degrees therefore this muscle is being activated in this manner. 
Finally, the BB revealed statistical differences in ball pressing motion between healthy 
individuals and the patient population 0.314 ± 0.1423 vs. 0.199 ± 0.12715, p = 0.008, F 
(1,27) = 8.102 (Graph C in Figure 4.29). Unlike the general trend of a greater mean in 
patients, it is greater in healthy individuals in this instance. This is probably due to the 
lack in strength in the triceps of most individuals so they shifted their arm in such a way 
that they activated the biceps to achieve a stronger press down on the ball. 
 
 
 
 
 
 
 
 
 
A
 
Figure 4.28. MSA measure of TB2 in EFE (A) motion in healthy individuals 
and patients with a standard deviation +/- 1 
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Figure 4.29. MSA measure of TB in PS (B) and BB in Ball Pressing (C) motion 
in healthy individuals and patients with a standard deviation +/- 1 
 
C
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Next, the second and final analysis done within the patient population in two groups of 
healing levels will be discussed. As Table 4.57, 4.58, 4.59, 4.60, 4.61, and 4.62 show, 
there were 5 instances of significant differences. 
Table 4.56. Pairwise comparison between patients at 0–1 months of injury and 4+ 
months of injury using MSA 
Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month 
SE 4+ 
Months Sig. 
EFE TB 0.600000 -0.040000 0.176879 0.136295 0.001 
EFE TB2 -3.426667 -0.060000 0.159437 0.112739 0.012 
PS PT 0.100000 0.693333 0.162585 0.114965 0.035 
URD TB 0.750000 0.283333 0.223235 0.157851 0.004 
BALL TB2 2.660000 0.466667 0.602308 0.491782 0.019 
 
Table 4.57. Pairwise comparison of TB in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using MSA 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Elbow Flexion Healthy .005 .167 13 
4+ Months -.040 .086 6 
0-1 Months .600 1.067 3 
Triceps Long in Rep 1 in Elbow 
Extension 
Healthy .009 .165 13 
4+ Months -.033 .088 6 
0-1 Months .750 .949 3 
Triceps Long in Rep 2 in Elbow Flexion Healthy .011 .167 13 
4+ Months -.043 .078 6 
0-1 Months .760 .943 3 
Triceps Long in Rep 2 in Elbow 
Extension 
Healthy .009 .173 13 
4+ Months -.048 .075 6 
0-1 Months .753 .939 3 
Triceps Long in Rep 3 in Elbow Flexion Healthy .008 .169 13 
4+ Months -.047 .078 6 
0-1 Months .783 .945 3 
Triceps Long in Rep 3 in Elbow 
Extension 
Healthy .092 .061 13 
4+ Months .080 .044 6 
0-1 Months .610 .580 3 
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Table 4.58. Pairwise comparison of TB2 in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using MSA 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Elbow 
Flexion 
Healthy -.013 .038 13 
4+ Months -.060 .157 6 
0-1 Months -3.427 6.101 3 
Triceps Lateral in Rep 1 in Elbow 
Extension 
Healthy -.009 .035 13 
4+ Months -.063 .164 6 
0-1 Months -3.280 5.856 3 
Triceps Lateral in Rep 2 in Elbow 
Flexion 
Healthy -.012 .038 13 
4+ Months -.060 .162 6 
0-1 Months -3.467 6.170 3 
Triceps Lateral in Rep 2 in Elbow 
Extension 
Healthy -.013 .036 13 
4+ Months -.070 .177 6 
0-1 Months -3.497 6.213 3 
Triceps Lateral in Rep 3 in Elbow 
Flexion 
Healthy -.008 .036 13 
4+ Months -.073 .164 6 
0-1 Months -3.560 6.341 3 
Triceps Lateral in Rep 3 in Elbow 
Extension 
Healthy -.010 .036 13 
4+ Months -.072 .169 6 
0-1 Months -3.530 6.210 3 
 
Table 4.59. Pairwise comparison of TB2 in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using MSA 
 Health Mean Std. Deviation N 
Pronator Teres in Rep 1 in Pronation Healthy .217 .134 13 
4+ Months .693 .563 6 
0-1 Month .100 .035 3 
Pronator Teres in Rep 1 in Supination Healthy .118 .102 13 
4+ Months .403 .505 6 
0-1 Month .100 .017 3 
Pronator Teres in Rep 2 in Pronation Healthy .218 .103 13 
4+ Months .743 .616 6 
0-1 Month .230 .210 3 
Pronator Teres in Rep 2 in Supination Healthy .107 .068 13 
4+ Months .465 .581 6 
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0-1 Month .110 .046 3 
Pronator Teres in Rep 3 in Pronation Healthy .229 .127 13 
4+ Months .780 .628 6 
0-1 Month .207 .195 3 
Pronator Teres in Rep 3 in Supination Healthy .099 .054 13 
4+ Months .510 .655 6 
0-1 Month .123 .047 3 
 
Table 4.60. Pairwise comparison of TB2 in EFE motion between patients at 0–1 
months of injury and 4+ months of injury using MSA 
 Health Mean Std. Deviation N 
Triceps Long in Rep 1 in Ulnar Deviation Healthy .174 .106 11 
4+ Months .283 .243 6 
0-1 Month .750 .988 3 
Triceps Long in Rep 1 in Radial Deviation Healthy .176 .109 11 
4+ Months .273 .236 6 
0-1 Month .817 1.094 3 
Triceps Long in Rep 2 in Ulnar Deviation Healthy .193 .115 11 
4+ Months .288 .249 6 
0-1 Month .750 .987 3 
Triceps Long in Rep 12 in Radial Deviation Healthy .186 .113 11 
4+ Months .277 .235 6 
0-1 Month .810 1.057 3 
Triceps Long in Rep 3 in Ulnar Deviation Healthy .193 .124 11 
4+ Months .285 .248 6 
0-1 Month .790 1.048 3 
Triceps Long in Rep 3 in Radial Deviation Healthy .186 .115 11 
4+ Months .267 .218 6 
0-1 Month .790 1.022 3 
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Table 4.61. Pairwise comparison of TB2 in Ball Press motion between patients at 
0–1 months of injury and 4+ months of injury using MSA 
 Health Mean Std. Deviation N 
Triceps Lateral in Rep 1 in Ball Press Healthy .689 .560 11 
4+ Months .467 .359 3 
0-1 Month 2.660 2.942 2 
Triceps Lateral in Rep 1 in Ball Relax Healthy .283 .365 11 
4+ Months .210 .161 3 
0-1 Month 2.430 3.380 2 
Triceps Lateral in Rep 2 in Ball Press Healthy .792 .575 11 
4+ Months .500 .484 3 
0-1 Month 2.695 2.934 2 
Triceps Lateral in Rep 2 in Ball Relax Healthy .138 .084 11 
4+ Months .163 .162 3 
0-1 Month 2.460 3.408 2 
Triceps Lateral in Rep 3 in Ball Press Healthy .793 .619 11 
4+ Months .450 .406 3 
3-4 Months .200 . 1 
1-2 Months .418 .235 4 
0-1 Month 2.675 3.033 2 
Triceps Lateral in Rep 3 in Ball Relax Healthy .176 .205 11 
4+ Months .143 .155 3 
0-1 Month 2.340 3.267 2 
The TB and TB2 muscles showed significant differences in EFE (Graph A and B in 
Figure 4.30) and in URD (Graph D in Figure 4.31). The TB in EFE showed a mean of 0.6 
± 1.907 vs. -0.04 ± 0.086, p = 0.037. TB2 in EFE exhibited a mean of -3.43 ± 6.1 vs. -
0.06 ± 0.157, p = 0.037. Once again, the TB showed significance in URD, 0.75 ± 0.99 
vs. 0.28 ± 0.24, p = 0.037, which was determined to be caused by holding the elbow at a 
right angle. In EFE and URD, an explanation that has been repeated through the various 
metrics was determined and was applied to this metric as well. Likewise, the PT being 
activated at a higher degree in healthier individuals than the earlier trauma patients has 
also been discussed and mentioned: 0.1 ± 0.035 vs. -0.06 ± 0.56, p = 0.035 (Graph C in 
Figure 4.31) Finally, as expected, the triceps showed a higher value in the 0–1 group 
versus the 4+ group, 2.66 ± 2.94 vs. 0.47 ± 0.36, p = 0.019, which aligns with the trend 
detected in higher values of less healthy patients (Graph E in Figure 4.32).  
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 Figure 4.30. MSA measure of TB in EFE (A) and TB2 in EFE (B) motions in 
early rehab group and late rehab patient group with a standard deviation +/- 1 
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Figure 4.31. MSA measure of PT in PS Pressing (C) and TB in URD (D) 
motions in early rehab group and late rehab patient group with a standard 
deviation +/- 1 
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4.5 PSD 
In the frequency domain metrics, there was a general trend showing slightly higher 
frequencies in the patient population versus the healthy population. Although a lower 
back pain study showed diagnostic potential of EMG frequency shifts in which it provided 
valuable information in discriminating between healthy individuals and patients, this was 
not seen in the trials on the elbow and thus not discussed [50].  For more information, 
please see Appendix C. 
 
 
Figure 4.32. MSA measure of TB2 in Ball Pressing (E) motion in early rehab 
group and late rehab patient group with a standard deviation +/- 1 
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5 Conclusions and Future Work 
 
The work presented in this thesis was aimed at analyzing and characterizing several 
EMG metrics in order to distinguish an injured person from a healthy person and to 
determine if an injured patient is healing. A literature search was executed to confirm the 
gaps in this knowledge of the human body. EMG was readily used to assess 
neuromuscular health in patients with nerve damage or with neuromuscular diseases 
such as multiple sclerosis in a clinical setting. In a research setting, EMG has been used 
to assess levels of activations of a variety of muscles during specific motions. However, 
EMG has not been used to quantify health, as discussed in this thesis. 
The design of the EMG study presented provided a way for deciding if EMG signals can 
be used to assess health in patients with MSK injuries that do not involve the nerves. 
This was shown to be true, as statistically significant differences were observed between 
the healthy and patient group in the first analysis and between the early and late 
rehabilitation patient groups on various occasions. These differences were observed in 
the recruitment of MUs of the intended muscles, as well as the hyper-recruitment of 
muscles not required for the motion to be executed in the patient population. Generally, 
MU recruitment, firing, and frequency are higher in patients than in healthy individuals. 
The knowledge of these general trends of activation is crucial for the use of these 
signals in the control of a smart rehabilitative brace, such that an activation of a certain 
muscle is not misinterpreted as an intent to produce a movement in that direction.   
 
 Additionally, numerous metrics were explored to identify a metric or a combination of 
metrics that best assesses people with these MSK conditions. Although frequency 
domain metrics are very popular in assessing neurological disorders, this was not the 
case in the studied MSK conditions. The frequencies were shown to be slightly higher in 
the patient population, but not statistically significant. The time domain metrics explored 
revealed differences in at least one instance. The best metric to be used cannot yet be 
determined, as more research with a larger number of subjects would be needed to 
make this decision. However, RMS seems to show most promise, as it is a reliable 
metric that exhibited the most statistical significant instances. 
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5.1 Contributions 
 
This work validates and justifies the use and further exploration of EMG signals as a 
whole new domain to quantify health. The specific contributions of this work are as 
follows: 
 A creation of a database of EMG signals from patients and healthy individuals 
that can be used by the control system of a smart rehabilitative brace. This 
database will allow the control system to make a decision making process based 
on the data being sensed by the wearer. The information fed into the control 
system will be used in a decision making process. Consequently, proper 
assistance required by the wearer according to the level of health they are at will 
be provided.  
 
 This work has advanced the use of EMG signals beyond the scope of nerve 
damage. The experiments conducted show that EMG can be used as a method 
for assessing MSK health. A normal range across the muscle groups has been 
identified to which the patient population was compared. This showed statistically 
significant differences in the magnitudes of muscle recruitment and activation 
between the two groups.  
 
 Furthermore, a comparison within the patient population at the beginning of their 
therapy versus at the end of their therapy was conducted. Statistical differences 
arose in this second analysis further proving that patients’ signals tend to change 
and showing trends closer to those of the healthy population.  
 
 
 Finally, different EMG metrics in the time domain and the frequency domain were 
explored. Since quantifying health by using EMG in MSK conditions had not been 
done, the best metric to do so had not been identified. Consequently, numerous 
metrics were applied in this study to help determine the best metric to be used. 
Time domain metrics such as RMS, MSA, and ZC, showed the most promise. 
The frequency domain metrics did not exhibit any differences, and a greater 
sample size will be required to identify if any of them will be relevant.  
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5.2 Future Work 
This study is by no means completed and it will take a much larger patient cohort to 
extract all of the relevant information. There are several research possibilities that may 
be studied in the future, as presented below: 
 
 Collecting data from each patient multiple times across the various months of 
therapy is the next most important step to be achieved. Due to the time 
commitment, patients were less willing to continually participate in the study 
during their follow up visits. A solution to this problem could be to provide an 
incentive, such as providing them with a monetary value of paying their parking 
ticket after each completed trial.  
 Due to the lack of patient availability, all data collected was combined into one 
cohort — elbow trauma patients. This included fractures and muscle tears. A 
more specific study where the types of injuries are separated and analyzed to 
see if specific injuries demonstrate changes in neuromuscular control and 
activation should be completed.  
 Additionally, a general increase in number of subjects will increase the power of 
the study. Further trials should be performed to add to the already created 
database and reassess significance between the groups.  
 Although collecting position data using an IMU was attempted in this thesis, most 
of the data collected was corrupt due to the low RAM of the laptop used. A better 
computer should be used and position data should be collected in order to detect 
changes in ROM of the subjects.  
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5.3 Appendix A: Ethics Permission and Approvals, Consent 
Form, and Trial Form 
Permissions and Approvals 
The following forms and permission statements are presented in this Appendix: 
 
• Ethics approval for the trials on healthy individuals from the Research Ethics Board for 
Health Sciences Research Involving Human Subjects at the University of Western 
Ontario 
• Ethics approval for the trials on patients from the Research Ethics Board for Health 
Sciences Research Involving Human Subjects at the University of Western Ontario 
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5.4 Appendix B: MATLAB Code 
This appendix will represent the MATLAB functions for one channel for simplicity.  
%%Channel Information 
  
%CHANNEL 1 Biceps 
  
%MOTION 
channel_1_0 = record(1,:); 
channel_1= channel_1_0-mean(channel_1_0(1,1:10)); %%%%%%%%%%% 
t1 = 1:numel(channel_1_0); 
rms_channel_1_0 = rms(channel_1_0); 
N1=length(channel_1_0); 
y2_1=detrend(channel_1_0); 
rec_y_1=abs(y2_1); 
[b,a]=butter(5,1/2000,'low'); 
filter_y_1=filtfilt(b,a,rec_y_1); 
  
 
%BB MVC 
channel_1_2 = record2(1,:); 
channel_1_2_BB=(channel_1_2-mean(channel_1_2(1,1:10))); %%%%%%%%%%; 
t1_2 = 1:numel(channel_1_2); 
rms_channel_1_2 = rms(channel_1_2); 
N2=length(channel_1_2); 
y2_1_=detrend(channel_1_2_BB); 
rec2_y_1=abs(y2_1_); 
[b,a]=butter(5,1/2000,'low'); 
filter2_y_1=filtfilt(b,a,rec2_y_1); 
BBmax=max(rec2_y_1);  
BBmin=min(rec2_y_1); 
Norm_BB=(channel_1-BBmin)/(BBmax-BBmin);     
  
  
%TB MVC 
channel_1_3 = record3(1,:); 
channel_1_3_TB= (channel_1_3 -mean(channel_1_3(1,1:10))); %%%%%% 
t1_3 = 1:numel(channel_1_3); 
rms_channel_1_3 = rms(channel_1_3); 
N3=length(channel_1_3); 
y2_1__=detrend(channel_1_3_TB); 
rec3_y_1=abs(y2_1__); 
[b,a]=butter(5,1/2000,'low'); 
filter3_y_1=filtfilt(b,a,rec3_y_1); 
  
%% Graph Plotting 
  
% Channel 1 
figure('name','Raw/Rectified/Low Pass of Biceps','numbertitle','off') 
  
subplot (5,1,1), plot (t1,channel_1) 
xlabel('Sample Number') 
ylabel('Raw EMG') 
  
subplot(5,1,2), plot(rec_y_1) 
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xlabel('sample number') 
ylabel('rectified EMG signal') 
  
subplot(5,1,3), plot(filter_y_1) 
xlabel('Sample Number') 
ylabel('Low Pass Filtered EMG Signal')  
  
subplot (5,1,4), plot (t1_2,channel_1_2_BB) 
xlabel('Sample Number') 
ylabel('BB MVC Raw')  
  
subplot(4,1,4), plot(Norm_BB) 
xlabel('Sample Number') 
ylabel('Normalized')  
% %  
% Flexion: 
Start1_1 = ginput(1) 
End1_1 = ginput(1) 
Start2_1 = ginput(1) 
End2_1 = ginput(1) 
Start3_1 = ginput(1) 
End3_1 = ginput(1) 
  
% Extension: 
Start1_2 = ginput(1) 
End1_2 = ginput(1) 
Start2_2 = ginput(1) 
End2_2 = ginput(1) 
Start3_2 = ginput(1) 
End3_2 = ginput(1) 
  
  
 
 
  
%% Mean RMS Rep Calculation 
  
% Subject Mean Biceps Channel Flexion 1 RMS 
Rep1_1_0_BB_1= rms(channel_1(round(Start1_1):round(End1_1))) 
Rep2_1_0_BB_1= rms(channel_1(round(Start2_1):round(End2_1))) 
Rep3_1_0_BB_1= rms(channel_1(round(Start3_1):round(End3_1))) 
  
Mean_RMS_BB_1=(Rep1_1_0_BB_1+Rep2_1_0_BB_1+Rep3_1_0_BB_1)/3 
  
% Subject Mean Biceps Channel Extension 1 RMS 
Rep1_1_0_BB_2= rms(channel_1(round(Start1_2):round(End1_2))) 
Rep2_1_0_BB_2= rms(channel_1(round(Start2_2):round(End2_2))) 
Rep3_1_0_BB_2= rms(channel_1(round(Start3_2):round(End3_2))) 
  
Mean_RMS_BB_2=(Rep1_1_0_BB_2+Rep2_1_0_BB_2+Rep3_1_0_BB_2)/3 
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%% Mean Average Rectified Value 
  
  
% Subject Mean Biceps Channel Flexion 1 RMS 
Rep1_1_0_BB_1_ARV= mean(rec_y_ 1(round(Start1_1):round(End1_1))) 
Rep2_1_0_BB_1_ARV= mean(rec_y_1(round(Start2_1):round(End2_1))) 
Rep3_1_0_BB_1_ARV= mean(rec_y_1(round(Start3_1):round(End3_1))) 
  
Mean_RMS_BB_1_ARV=(Rep1_1_0_BB_1_ARV+Rep2_1_0_BB_1_ARV+Rep3_1_0_BB_1_AR
V)/3 
  
% Subject Mean Biceps Channel Extension 1 RMS 
Rep1_1_0_BB_2_ARV= mean(rec_y_1(round(Start1_2):round(End1_2))) 
Rep2_1_0_BB_2_ARV= mean(rec_y_1(round(Start2_2):round(End2_2))) 
Rep3_1_0_BB_2_ARV= mean(rec_y_1(round(Start3_2):round(End3_2))) 
  
Mean_RMS_BB_2_ARV=(Rep1_1_0_BB_2_ARV+Rep2_1_0_BB_2_ARV+Rep3_1_0_BB_2_AR
V)/3 
 
%% Mean MSA Rep Calculation 
  
% Subject Mean Biceps Channel Flexion 1 MSA 
  
  
Rep1_1_0_BB_MSA=(channel_1(round(Start1_1):round(End1_1))) 
  
[pks,locs]=findpeaks(Rep1_1_0_BB_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
  
SA_1_1_1=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep1_1_0_BB_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
    temp=((pks(i)-min(Rep1_1_0_BB_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep1_1_0_BB_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_1_1=[SA_1_1_1,temp]; 
end 
 MSA_ch1_rep1_1=mean(SA_1_1_1);    
end 
  
  
Rep2_1_0_BB_MSA=(channel_1(round(Start2_1):round(End2_1))); 
  
  
[pks,locs]=findpeaks(Rep2_1_0_BB_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
  
SA_1_2_1=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep2_1_0_BB_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
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    temp=((pks(i)-min(Rep2_1_0_BB_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep2_1_0_BB_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_2_1=[SA_1_2_1,temp]; 
end 
 MSA_ch1_rep2_1=mean(SA_1_2_1);    
end 
  
Rep3_1_0_BB_MSA=(channel_1(round(Start3_1):round(End3_1))); 
  
  
[pks,locs]=findpeaks(Rep3_1_0_BB_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
  
SA_1_3_1=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep3_1_0_BB_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
    temp=((pks(i)-min(Rep3_1_0_BB_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep3_1_0_BB_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_3_1=[SA_1_3_1,temp]; 
end 
 MSA_ch1_rep3_1=mean(SA_1_3_1);    
end 
  
  
Mean_MSA_BB_1_MSA=(mean(SA_1_1_1)+mean(SA_1_2_1)+mean(SA_1_3_1))/3; 
  
% Subject Mean Biceps Channel Extension 1 MSA 
  
  
Rep1_1_0_BB_2_MSA= (channel_1(round(Start1_2):round(End1_2))); 
  
  
[pks,locs]=findpeaks(Rep1_1_0_BB_2_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
  
SA_1_1_2=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep1_1_0_BB_2_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
    temp=((pks(i)-min(Rep1_1_0_BB_2_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep1_1_0_BB_2_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_1_2=[SA_1_1_2,temp]; 
end 
 MSA_ch1_rep1_2=mean(SA_1_1_2);    
end 
  
  
Rep2_1_0_BB_2_MSA=(channel_1(round(Start2_2):round(End2_2))); 
  
[pks,locs]=findpeaks(Rep2_1_0_BB_2_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
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SA_1_2_2=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep2_1_0_BB_2_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
    temp=((pks(i)-min(Rep2_1_0_BB_2_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep2_1_0_BB_2_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_2_2=[SA_1_2_2,temp]; 
end 
 MSA_ch1_rep2_2=mean(SA_1_2_2);    
end 
  
Rep3_1_0_BB_2_MSA=(channel_1(round(Start3_2):round(End3_2))); 
  
  
[pks,locs]=findpeaks(Rep3_1_0_BB_2_MSA,'MINPEAKDISTANCE',50); 
% figure 
% plot(t5_2,channel_1,'r', t5_2(locs),pks,'*')    % show peaks on top 
of the EMG data  
  
SA_1_3_2=[]; 
for i=1:1:length(locs)-1 % 
if min(Rep3_1_0_BB_2_MSA(locs(i):locs(i+1)))<0 && pks(i)>0 && pks(i+1) 
    temp=((pks(i)-min(Rep3_1_0_BB_2_MSA(locs(i):locs(i+1))))+(pks(i+1)-
min(Rep3_1_0_BB_2_MSA(locs(i):locs(i+1)))))/2; 
         SA_1_3_2=[SA_1_3_2,temp]; 
end 
 MSA_ch1_rep3_2=mean(SA_1_3_2);    
end 
  
  
Mean_MSA_BB_2_MSA=(mean(SA_1_1_2)+mean(SA_1_2_2)+mean(SA_1_3_2))/3; 
 
 
%% Number of Zero Crossings 
  
%Channel 1 Biceps 
  
%Rep1 
ZC_1_1_1=0; 
count_1_1_1 =sign(channel_1(round(Start1_1):round(End1_1))); 
NZ= length(count_1_1_1); 
for i=1:1:NZ-1 
if count_1_1_1(i+1)~= count_1_1_1(i);  
    ZC_1_1_1 = ZC_1_1_1+1; 
end 
end 
  
     
%Rep2 
ZC_1_2_1=0; 
count_1_2_1 =sign(channel_1(round(Start2_1):round(End2_1))); 
NZ= length(count_1_2_1); 
for i=1:1:NZ-1 
if count_1_2_1(i+1)~= count_1_2_1(i);  
    ZC_1_2_1 = ZC_1_2_1+1; 
end 
end 
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%Rep3 
  
ZC_1_3_1=0; 
count_1_3_1 =sign(channel_1(round(Start3_1):round(End3_1))); 
NZ= length(count_1_3_1); 
for i=1:1:NZ-1 
if count_1_3_1(i+1)~= count_1_3_1(i);  
    ZC_1_3_1 = ZC_1_3_1+1; 
end 
end 
  
  
mean_ZC_1_1= (ZC_1_1_1+ZC_1_2_1+ZC_1_3_1)/3; 
  
  
%Rep1 
ZC_1_1_2=0; 
count_1_1_2 =sign(channel_1(round(Start1_2):round(End1_2))); 
NZ= length(count_1_1_2); 
for i=1:1:NZ-1 
if count_1_1_2(i+1)~= count_1_1_2(i);  
    ZC_1_1_2 = ZC_1_1_2+1; 
end 
end 
  
     
%Rep2 
ZC_1_2_2=0; 
count_1_2_2 =sign(channel_1(round(Start2_2):round(End2_2))); 
NZ= length(count_1_2_2); 
for i=1:1:NZ-1 
if count_1_2_2(i+1)~= count_1_2_2(i);  
    ZC_1_2_2 = ZC_1_2_2+1; 
end 
end 
  
%Rep3 
  
ZC_1_3_2=0; 
count_1_3_2 =sign(channel_1(round(Start3_2):round(End3_2))); 
NZ= length(count_1_3_2); 
for i=1:1:NZ-1 
if count_1_3_2(i+1)~= count_1_3_2(i);  
    ZC_1_3_2 = ZC_1_3_2+1; 
end 
end 
  
  
mean_ZC_1_2= (ZC_1_1_2+ZC_1_2_2+ZC_1_3_2)/3; 
  
 
%% Power Spectral Density Analysis 
P_1_1_1=fft (channel_1); 
P_1_1_1=abs(P_1_1_1); 
f=(0:N1-1)/(step*N1); 
Fs=1/samplef; 
windowsize = 1500; 
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window = hanning(windowsize); 
nfft = windowsize; 
noverlap = windowsize-1; 
  
 
%Channel 1 Flexion 
  
%Rep 1 
tempP_1_1_1=[]; 
[S_1_1_1,F_1_1_1,T_1_1_1,P_1_1_1] = 
spectrogram(channel_1(round(Start1_1(1)):round(End1_1(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_1_1(:,1))   % fat to slim 
tempP_1_1_1=[tempP_1_1_1; P_1_1_1(i,:)']; 
end 
if rem(length(tempP_1_1_1),2)==1 
 
Median_Freq_1_1_1=F_1_1_1(floor(find(tempP_1_1_1==median(tempP_1_1_1))/
length(P_1_1_1(1,:)))); 
else 
Median_Freq_1_1_1=F_1_1_1(floor(find(tempP_1_1_1(1:end-
1)==median(tempP_1_1_1(1:end-1)))/length(P_1_1_1(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_1_1, idx_1_1_1] = min(abs(tempP_1_1_1-mean(tempP_1_1_1))); 
%index of closest value 
Mean_Freq_1_1_1 = F_1_1_1(floor(idx_1_1_1/length(P_1_1_1(1,:)))); 
%closest value 
  
  
%Rep 2 
tempP_1_2_1=[]; 
[S_1_2_1,F_1_2_1,T_1_2_1,P_1_2_1] = 
spectrogram(channel_1(round(Start2_1(1)):round(End2_1(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_2_1(:,1))   % fat to slim 
tempP_1_2_1=[tempP_1_2_1; P_1_2_1(i,:)']; 
end 
if rem(length(tempP_1_2_1),2)==1 
 
Median_Freq_1_2_1=F_1_2_1(floor(find(tempP_1_2_1==median(tempP_1_2_1))/
length(P_1_2_1(1,:)))); 
else 
Median_Freq_1_2_1=F_1_2_1(floor(find(tempP_1_2_1(1:end-
1)==median(tempP_1_2_1(1:end-1)))/length(P_1_2_1(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_2_1, idx_1_2_1] = min(abs(tempP_1_2_1-mean(tempP_1_2_1))); 
%inde2 of closest value 
Mean_Freq_1_2_1 = F_1_2_1(floor(idx_1_2_1/length(P_1_2_1(1,:)))); 
%closest value 
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%Rep 3 
tempP_1_3_1=[]; 
[S_1_3_1,F_1_3_1,T_1_3_1,P_1_3_1] = 
spectrogram(channel_1(round(Start3_1(1)):round(End3_1(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_3_1(:,1))   % fat to slim 
tempP_1_3_1=[tempP_1_3_1; P_1_3_1(i,:)']; 
end 
if rem(length(tempP_1_3_1),2)==1 
 
Median_Freq_1_3_1=F_1_3_1(floor(find(tempP_1_3_1==median(tempP_1_3_1))/
length(P_1_3_1(1,:)))); 
else 
Median_Freq_1_3_1=F_1_3_1(floor(find(tempP_1_3_1(1:end-
1)==median(tempP_1_3_1(1:end-1)))/length(P_1_3_1(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_3_1, idx_1_3_1] = min(abs(tempP_1_3_1-mean(tempP_1_3_1))); 
%inde3 of closest value 
Mean_Freq_1_3_1 = F_1_3_1(floor(idx_1_3_1/length(P_1_3_1(1,:)))); 
%closest value 
  
  
%Channel 1 Extension 
  
%Rep 1 
tempP_1_1_2=[]; 
[S_1_1_2,F_1_1_2,T_1_1_2,P_1_1_2] = 
spectrogram(channel_1(round(Start1_2(1)):round(End1_2(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_1_2(:,1))   % fat to slim 
tempP_1_1_2=[tempP_1_1_2; P_1_1_2(i,:)']; 
end 
if rem(length(tempP_1_1_2),2)==1 
 
Median_Freq_1_1_2=F_1_1_2(floor(find(tempP_1_1_2==median(tempP_1_1_2))/
length(P_1_1_2(1,:)))); 
else 
Median_Freq_1_1_2=F_1_1_2(floor(find(tempP_1_1_2(1:end-
1)==median(tempP_1_1_2(1:end-1)))/length(P_1_1_2(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_1_2, idx_1_1_2] = min(abs(tempP_1_1_2-mean(tempP_1_1_2))); 
%inde1 of closest value 
Mean_Freq_1_1_2 = F_1_1_2(floor(idx_1_1_2/length(P_1_1_2(1,:)))); 
%closest value 
  
%Rep 2 
tempP_1_2_2=[]; 
  
 
172 
172 
[S_1_2_2,F_1_2_2,T_1_2_2,P_1_2_2] = 
spectrogram(channel_1(round(Start2_2(1)):round(End2_2(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_2_2(:,1))   % fat to slim 
tempP_1_2_2=[tempP_1_2_2; P_1_2_2(i,:)']; 
end 
if rem(length(tempP_1_2_2),2)==1 
 
Median_Freq_1_2_2=F_1_2_2(floor(find(tempP_1_2_2==median(tempP_1_2_2))/
length(P_1_2_2(1,:)))); 
else 
Median_Freq_1_2_2=F_1_2_2(floor(find(tempP_1_2_2(1:end-
1)==median(tempP_1_2_2(1:end-1)))/length(P_1_2_2(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_2_2, idx_1_2_2] = min(abs(tempP_1_2_2-mean(tempP_1_2_2))); 
%inde2 of closest value 
Mean_Freq_1_2_2 = F_1_2_2(floor(idx_1_2_2/length(P_1_2_2(1,:)))); 
%closest value 
  
%Rep 3 
tempP_1_3_2=[]; 
[S_1_3_2,F_1_3_2,T_1_3_2,P_1_3_2] = 
spectrogram(channel_1(round(Start3_2(1)):round(End3_2(1))),window,nover
lap,nfft,1/Fs); 
  
for i=1:1:length(P_1_3_2(:,1))   % fat to slim 
tempP_1_3_2=[tempP_1_3_2; P_1_3_2(i,:)']; 
end 
if rem(length(tempP_1_3_2),2)==1 
 
Median_Freq_1_3_2=F_1_3_2(floor(find(tempP_1_3_2==median(tempP_1_3_2))/
length(P_1_3_2(1,:)))); 
else 
Median_Freq_1_3_2=F_1_3_2(floor(find(tempP_1_3_2(1:end-
1)==median(tempP_1_3_2(1:end-1)))/length(P_1_3_2(1,1:end-1)))); 
end 
% rem(find(tempP_1_1_1==median(tempP_1_1_1)),length(P_1_1_1(1,:)));  % 
remainder 
  
[idx_1_3_2, idx_1_3_2] = min(abs(tempP_1_3_2-mean(tempP_1_3_2))); 
%inde3 of closest value 
Mean_Freq_1_3_2 = F_1_3_2(floor(idx_1_3_2/length(P_1_3_2(1,:)))); 
%closest value 
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5.5 Appendix C: Statistical Analyses Tables  
The following section shows comparisons of the healthy population to the patient 
population. 
Table C.1 RMS statistical analysis between patients and healthy individuals in 6 
motions 
Metri
c Motion 
Muscl
e 
Mean 
Healthy 
Mean 
Patient
s 
SE 
Health
y 
SE 
Patient
s 
p 
Valu
e 
F 
statisti
c 
RMS EFE BB 0.16832 0.22059 0.065 0.059 0.557 0.353 
RMS EFE TB 0.238 0.519 0.157 0.142 0.196 1.76 
RMS EFE TB2 0.085 0.14 0.035 0.031 0.315 1.371 
RMS EFE PT 0.083 0.084 0.022 0.02 0.973 0.001 
RMS EFE FCU 0.085 0.14 0.035 0.031 0.252 1.371 
RMS EFE ECU 0.021 0.104 0.028 0.025 0.037 4.836 
RMS PS BB 0.096 0.101 0.025 0.024 0.905 0.015 
RMS PS TB 0.134 0.38 0.105 0.102 0.102 2.844 
RMS PS TB2 0.054 0.084 0.025 0.024 0.394 0.749 
RMS PS PT 0.028 0.103 0.023 0.023 0.028 5.348 
RMS PS FCU 0.023 0.071 0.017 0.017 0.053 4.049 
RMS PS ECU 0.015 0.095 0.019 0.018 0.005 9.281 
RMS WFE BB 0.065 0.102 0.019 0.02 0.194 1.792 
RMS WFE TB 0.092 0.282 0.092 0.1 0.176 1.956 
RMS WFE TB2 0.026 0.162 0.059 0.064 0.13 2.479 
RMS WFE PT 0.033 0.063 0.016 0.017 0.22 1.594 
RMS WFE FCU 0.043 0.135 0.04 0.044 0.141 2.334 
RMS WFE ECU 0.034 0.119 0.028 0.031 0.053 4.195 
RMS URD BB 0.069 0.137 0.029 0.027 0.096 2.977 
RMS URD TB 0.101 1.58 0.961 0.894 0.27 1.27 
RMS URD TB2 0.029 1.18 0.875 0.814 0.345 0.927 
RMS URD PT 0.043 0.047 0.013 0.013 0.09 3.106 
RMS URD FCU 0.021 0.072 0.019 0.018 0.062 3.793 
RMS URD ECU 0.029 0.294 0.142 0.132 0.183 1.876 
RMS HOC BB 0.085 0.143 0.032 0.031 0.211 1.654 
RMS HOC TB 0.12 1.082 0.596 0.572 0.256 1.356 
RMS HOC TB2 0.052 1.034 0.722 0.694 0.337 0.962 
RMS HOC PT 0.025 0.083 0.02 0.019 0.045 4.497 
RMS HOC FCU 0.031 0.215 0.056 0.054 0.026 5.635 
RMS HOC ECU 0.019 0.15 0.035 0.033 0.012 7.395 
RMS Ball BB 0.085 0.14 0.035 0.031 0.252 1.371 
RMS Ball TB 0.382 0.477 0.084 0.082 0.425 0.655 
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RMS Ball TB2 0.225 1.073 0.636 0.614 0.346 0.92 
RMS Ball PT 0.085 0.14 0.035 0.031 0.252 1.371 
RMS Ball FCU 0.051 0.135 0.026 0.025 0.03 5.281 
RMS Ball ECU 0.085 0.14 0.035 0.031 0.252 1.371 
Table C.3 ARV statistical analysis between patients and healthy individuals in 6 
motions 
Metric Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic 
ARV EFE BB -0.017 0.02 0.068 0.068 0.705 0.147 
ARV EFE TB 0.072 0.181 0.087 0.087 0.381 0.791 
ARV EFE TB2 -0.013 -0.787 0.49 0.49 0.274 1.244 
ARV EFE PT -0.004 0.009 0.021 0.021 0.667 0.19 
ARV EFE FCU -0.005 0.011 0.017 0.017 0.527 0.411 
ARV EFE ECU -0.004 -0.011 0.004 0.004 0.24 1.44 
ARV PS BB 0.021 0.009 0.026 0.027 0.764 0.092 
ARV PS TB -0.051 0.047 0.066 0.07 0.321 1.02 
ARV PS TB2 0.001 0.044 0.02 0.022 0.155 2.139 
ARV PS PT 0.003 0.037 0.017 0.018 0.168 2.005 
ARV PS FCU -0.008 0.003 0.009 0.01 0.414 0.688 
ARV PS ECU -0.005 -0.036 0.006 0.006 0.001 12.545 
ARV WFE BB 0.006 -0.011 0.011 0.012 0.317 1.045 
ARV WFE TB 0.011 0.113 0.059 0.067 0.267 1.296 
ARV WFE TB2 -0.014 -0.087 0.059 0.066 0.42 0.673 
ARV WFE PT -0.002 -0.002 0.005 0.006 0.957 0.003 
ARV WFE FCU -0.006 -0.006 0.003 0.004 0.993 0 
ARV WFE ECU -0.002 -0.018 0.004 0.005 0.019 6.426 
ARV URD BB 0.007 0.042 0.029 0.027 0.383 0.788 
ARV URD TB -0.003 -1.149 0.813 0.757 0.312 1.063 
ARV URD TB2 -0.014 0.87 0.694 0.646 0.36 0.869 
ARV URD PT -0.002 0.02 0.014 0.013 0.256 1.348 
ARV URD FCU 0 0.001 0.01 0.009 0.924 0.009 
ARV URD ECU -0.005 0.172 0.14 0.13 0.364 0.853 
ARV HOC BB -0.054 -0.054 0.032 0.031 0.987 0 
ARV HOC TB 0.034 0.519 0.313 0.301 0.276 1.245 
ARV HOC TB2 0.018 -0.654 0.491 0.472 0.334 0.973 
ARV HOC PT -0.007 0.002 0.015 0.015 0.668 0.189 
ARV HOC FCU -0.008 -0.023 0.026 0.025 0.663 0.195 
ARV HOC ECU -0.006 -0.032 0.021 0.02 0.379 0.804 
ARV Ball BB -0.001 -0.016 0.012 0.011 0.345 0.924 
ARV Ball TB -0.006 0.079 0.027 0.027 0.036 4.88 
ARV Ball TB2 -0.013 0.718 0.534 0.516 0.334 0.969 
  
 
175 
175 
ARV Ball PT -0.006 0.01 0.01 0.009 0.262 1.312 
ARV Ball FCU 0 -0.041 0.024 0.023 0.223 1.553 
ARV Ball ECU -0.001 -0.064 0.029 0.028 0.132 2.406 
 
Table C.2 ZC statistical analysis between patients and healthy individuals in 6 
motions 
Metric Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic 
ZC EFE BB 278 616 72.01 60.5 0.005 9.177 
ZC EFE TB 332 862 288.9 242.7 0.214 1.623 
ZC EFE TB2 464 755 177.1 148.8 0.219 1.585 
ZC EFE PT 271 849 189.9 159.5 0.028 5.428 
ZC EFE FCU 591 590 174 146.2 0.994 0 
ZC EFE ECU 303 895 167.5 140.7 0.012 7.318 
ZC PS BB 319 349 49.6 55 0.692 0.16 
ZC PS TB 425 348 57.9 64.3 0.382 0.789 
ZC PS TB2 540 336 86.9 96.4 0.127 2.478 
ZC PS PT 375 554 61 67.6 0.06 3.845 
ZC PS FCU 744 1434 367 392.7 0.21 1.644 
ZC PS ECU 481 503 67 71.2 0.822 0.052 
ZC WFE BB 329 346 66 71.9 0.865 0.029 
ZC WFE TB 272 310 43 46.9 0.586 0.305 
ZC WFE TB2 422 564 104 112.91 0.364 0.86 
ZC WFE PT 525 577 91.9 99.9 0.705 0.147 
ZC WFE FCU 488 913 269 293 0.296 1.145 
ZC WFE ECU 749 853 284 309 0.806 0.062 
ZC URD BB 0.007 0.042 0.029 0.027 0.383 0.788 
ZC URD TB -0.003 -1.149 0.813 0.757 0.312 1.063 
ZC URD TB2 -0.014 0.87 0.694 0.646 0.36 0.869 
ZC URD PT -0.002 0.02 0.014 0.013 0.256 1.348 
ZC URD FCU N/A N/A N/A N/A N/A N/A 
ZC URD ECU -0.005 0.172 0.14 0.13 0.364 0.853 
ZC HOC BB 146 242 43.64 42 0.129 2.479 
ZC HOC TB 140 350 119 114 0.216 1.616 
ZC HOC TB2 325 526 104 100 0.179 1.921 
ZC HOC PT 455 422 70 67 0.74 0.113 
ZC HOC FCU 461 655 180 174 0.446 0.601 
ZC HOC ECU 613 513 1856 178 0.7 0.153 
ZC Ball BB 364 300 38 36.9 0.235 1.473 
  
 
176 
176 
ZC Ball TB 277 569 159 153 0.198 1.745 
ZC Ball TB2 356 469 59 57 0.178 1.915 
ZC Ball PT 445 366 73 71 0.443 0.607 
ZC Ball FCU 845 600 235 227 0.459 0.563 
ZC Ball ECU 409 468 83.9 81 0.622 0.249 
Table C.3 MSA statistical analysis between patients and healthy individuals in 6 
motions 
Metric 
Motio
n 
Muscl
e 
Mean 
Healthy 
Mean 
Patients 
SE 
Health
y 
SE 
Patient
s 
p 
Valu
e 
F 
statisti
c 
MSA EFE BB 0.918 0.527 0.249 0.24 0.269 1.28 
MSA EFE TB 0.429 0.626 0.167 0.161 0.404 0.72 
MSA EFE TB2 0.122 0.392 0.089 0.093 0.046 4.397 
MSA EFE PT 0.269 0.218 0.092 0.078 0.676 0.179 
MSA EFE FCU 0.558 0.433 0.164 0.171 0.6 0.283 
MSA EFE ECU 0.105 0.448 0.108 0.126 0.054 4.289 
MSA PS BB 0.495 0.241 0.119 0.127 0.155 2.132 
MSA PS TB 0.154 0.416 0.083 0.086 0.037 4.838 
MSA PS TB2 0.089 0.083 0.015 0.018 0.815 0.056 
MSA PS PT 0.165 0.326 0.088 0.085 0.2 1.729 
MSA PS FCU 0.172 0.211 0.057 0.06 0.644 0.219 
MSA PS ECU 0.175 0.36 0.083 0.086 0.133 2.411 
MSA WFE BB 0.332 0.251 0.058 0.063 0.356 0.888 
MSA WFE TB 0.218 0.407 0.102 0.112 0.226 1.56 
MSA WFE TB2 0.095 0.138 0.036 0.039 0.432 0.653 
MSA WFE PT 0.158 0.247 0.053 0.056 0.263 1.332 
MSA WFE FCU 0.319 0.51 0.128 0.141 0.328 1.005 
MSA WFE ECU 0.245 0.398 0.123 0.128 0.397 1.243 
MSA URD BB 0.373 0.242 0.055 0.051 0.092 3.058 
MSA URD TB 0.185 0.433 0.12 0.106 0.135 2.402 
MSA URD TB2 0.071 0.644 0.471 0.376 0.355 0.907 
MSA URD PT 0.144 0.18 0.054 0.054 0.65 0.212 
MSA URD FCU 0.178 0.203 0.055 0.05 0.746 0.108 
MSA URD ECU 0.263 0.318 0.114 0.124 0.748 0.106 
MSA HOC BB 0.333 0.222 0.063 0.058 0.211 1.663 
MSA HOC TB 0.204 0.33 0.114 0.108 0.431 0.649 
MSA HOC TB2 0.064 0.663 0.486 0.406 0.359 0.895 
MSA HOC PT 0.131 0.219 0.059 0.064 0.326 1.015 
MSA HOC FCU 0.265 0.308 0.079 0.076 0.703 0.15 
MSA HOC ECU 0.115 0.429 0.121 0.116 0.074 3.528 
MSA Ball BB 0.314 0.199 0.029 0.028 0.008 8.102 
  
 
177 
177 
MSA Ball TB 0.796 0.63 0.103 0.099 0.254 1.36 
MSA Ball TB2 0.478 0.715 0.309 0.324 0.603 0.279 
MSA Ball PT 0.382 0.25 0.124 0.114 0.444 0.606 
MSA Ball FCU 0.394 0.302 0.087 0.087 0.46 0.564 
MSA Ball ECU 0.187 0.662 0.269 0.31 0.26 1.346 
Table C.4 MNF statistical analysis between patients and healthy individuals in 6 
motions 
Metric Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic 
MNF EFE BB 120 94 9.697 8 0.05 4.34 
MNF EFE TB 148 212 105 87 0.641 0.224 
MNF EFE TB2 289 200 64 53 0.294 1.161 
MNF EFE PT 113 257 69 57.8 0.127 2.541 
MNF EFE FCU 313 284 93 77.9 0.81 0.059 
MNF EFE ECU 303 484 115 95.7 0.242 1.455 
MNF PS BB 99 168 30 30 0.118 2.726 
MNF PS TB 219 277 111 111 0.713 0.141 
MNF PS TB2 655 597 152 152 0.787 0.075 
MNF PS PT 272 257 50 50 0.836 0.044 
MNF PS FCU 677 367 133 133 0.122 2.668 
MNF PS ECU 412 474 102 102 0.675 0.183 
MNF WFE BB 99.7 94.2 11.8 11.77 0.756 0.099 
MNF WFE TB 143 122.3 18.75 19.7 0.447 0.602 
MNF WFE TB2 359 239.7 126 132 0.52 0.429 
MNF WFE PT 346 333.2 100 105 0.931 0.008 
MNF WFE FCU 372.8 429.7 92 96.5 0.674 0.182 
MNF WFE ECU 341 412.4 81.5 85.4 0.553 0.366 
MNF URD BB 273.7 146.4 109 257 0.657 0.208 
MNF URD TB 289.6 166.2 100 235 0.639 0.232 
MNF URD TB2 591.4 147.1 111 261 0.146 2.452 
MNF URD PT 353.6 243.6 119 278.7 0.723 0.132 
MNF URD FCU 773.3 654.7 139 326.1 0.744 0.112 
MNF URD ECU 458.2 223.3 101 237 0.382 0.829 
MNF HOC BB 90.5 122.7 9.62 13 0.065 3.952 
MNF HOC TB 197.7 285.5 102 138 0.616 0.262 
MNF HOC TB2 373.9 670.6 103.6 140.1 0.109 2.899 
MNF HOC PT 327.2 244 65.3 88.3 0.46 0.576 
MNF HOC FCU 420.8 483 101 136.8 0.719 0.135 
MNF HOC ECU N/A N/A N/A N/A N/A N/A 
MNF Ball BB 118.2 121 15.8 17.5 0.897 0.017 
  
 
178 
178 
MNF Ball TB 143.9 219 66.7 73.7 0.459 0.574 
MNF Ball TB2 238.9 179 50.7 56.1 0.439 0.625 
MNF Ball PT 318 213.2 76.5 85 0.37 0.844 
MNF Ball FCU 504 435.5 102 112.7 0.658 0.203 
MNF Ball ECU 423 370.4 108 119.8 0.747 0.108 
 
Table C.5 MDF statistical analysis between patients and healthy individuals in 6 
motions 
Metric Motion Muscle 
Mean 
Healthy 
Mean 
Patients 
SE 
Healthy 
SE 
Patients 
p 
Value 
F 
statistic 
MDF EFE BB 1097 1197 35.851 45 0.095 3.027 
MDF EFE TB 1178 1216 44.5 56 0.598 0.286 
MDF EFE TB2 1187 1089 72.7 92 0.414 0.692 
MDF EFE PT 1086 1131 41.1 52 0.507 0.453 
MDF EFE FCU 1108 1274 63.1 79.8 0.116 2.661 
MDF EFE ECU 1144 1114 47.8 60.4 0.699 0.154 
MDF PS BB 1090 1180 64.8 64.8 0.34 0.966 
MDF PS TB 1191 1206 78.5 78.6 0.893 0.019 
MDF PS TB2 1007 1114 54 54 0.179 1.974 
MDF PS PT 1145 1232 50.8 50.8 0.243 1.467 
MDF PS FCU 1231 1199 84.2 84 0.79 0.073 
MDF PS ECU N/A N/A N/A N/A N/A N/A 
MDF WFE BB 1054 1184 60 67.1 0.169 2.08 
MDF WFE TB 1029 1055 81.7 91.3 0.837 0.044 
MDF WFE TB2 1080 1085 68 76 0.969 0.002 
MDF WFE PT 1187 1088 50.7 56.7 0.213 1.685 
MDF WFE FCU 1221 1326 70.7 79.1 0.335 0.987 
MDF WFE ECU 1171 1250 63.4 71 0.417 0.693 
MDF URD BB 1233 1020 61.5 123 0.16 2.399 
MDF URD TB 1145 1365 44.4 88.9 0.057 4.913 
MDF URD TB2 909 1450 107.1 214.3 0.054 5.091 
MDF URD PT 1109 1061 70.9 142 0.768 0.093 
MDF URD FCU 970 923 128.7 257.5 0.876 0.026 
MDF URD ECU 1019 1019 87.2 174.6 0.999 0 
MDF HOC BB 1122 1089 49.4 60.5 0.673 0.187 
MDF HOC TB 1243 1153 65.7 80.5 0.403 0.747 
MDF HOC TB2 1043 1294 85.7 105 0.086 3.443 
MDF HOC PT 1186 1203 60.8 74.4 0.855 0.035 
MDF HOC FCU 1149 1147 82 100 0.986 0 
  
 
179 
179 
MDF HOC ECU 995 1055 107 131 0.732 0.123 
MDF Ball BB 1117 1183 54.3 63.7 0.439 0.629 
MDF Ball TB 1137 1129 67.8 79.4 0.936 0.007 
MDF Ball TB2 1107 1090 57.1 67 0.848 0.038 
MDF Ball PT 1209 1303 63.7 74.6 0.353 0.911 
MDF Ball FCU 1139 1031 61.4 72 0.269 1.303 
MDF Ball ECU 1223 1129 57.9 67.9 0.305 1.12 
The following section shows comparisons of the patient population at 0–1 month post 
injury versus 4+ months post injury. 
Table C.6 RMS statistical analysis between early rehab patient group and late 
stage rehab group individuals in 6 motions 
Metric Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month  
SE 4+ 
Months Sig 
RMS EFE BB 0.221 0.139 0.165 0.062 0.703 
RMS EFE TB 1.35 0.413 0.283 0.185 0.01 
RMS EFE TB2 5.29 0.339 1.464 0.958 0.009 
RMS EFE PT 0.139 0.094 0.044 0.029 0.408 
RMS EFE FCU 0.062 0.133 0.07 0.047 0.418 
RMS EFE ECU 0.110 0.09 0.07 0.04 0.827 
RMS WFE BB 0.131 0.086 0.049 0.026 0.429 
RMS WFE TB 0.9 0.105 0.192 0.1022 0.002 
RMS WFE TB2 0.0826 0.222 0.156 0.08 0.438 
RMS WFE PT 0.0727 0.0596 0.043 0.023 0.791 
RMS WFE FCU 0.0209 0.178 0.104 0.055 0.2 
RMS WFE ECU 0.184 0.127 0.072 0.039 0.489 
RMS PS BB 0.104 0.083 0.079 0.044 0.809 
RMS PS TB 0.861 0.133 0.24 0.13 0.014 
RMS PS TB2 0.0717 0.158 0.071 0.041 0.3 
RMS PS PT 0.05 0.201 0.06 0.035 0.04 
RMS PS FCU 0.015 0.0844 0.048 0.028 0.226 
RMS PS ECU 0.05 0.108 0.055 0.032 0.395 
RMS URD BB 0.214 0.083 0.05 0.046 0.071 
RMS URD TB 5.377 0.123 1.592 1.43 0.022 
RMS URD TB2 4.27 0.088 1.498 1.34 0.049 
RMS URD PT 4.2683 0.088 0.0346 0.0309 0.817 
RMS URD FCU 0.0912 0.0567 0.035 0.0317 0.475 
RMS URD ECU 0.7954 0.167 0.241 0.2163 0.065 
RMS HOC BB 0.2533 0.0893 0.061 0.04 0.035 
RMS HOC TB 04.202 0.1133 0.999 0.654 0.003 
RMS HOC TB2 4.263 0.076 1.311 0.858 0.015 
RMS HOC PT 0.111 0.08 0.041 0.027 0.553 
  
 
180 
180 
RMS HOC FCU 0.157 0.216 0.111 0.072 0.659 
RMS HOC ECU 0.156 0.195 0.068 0.045 0.638 
RMS Ball BB 0.159 0.069 0.031 0.031 0.051 
RMS Ball TB 4.415 0.431 0.193 0.193 0.883 
RMS Ball TB2 4.416 0.3878 1.244 1.244 0.031 
RMS Ball PT 0.077 0.155 0.049 0.0485 0.268 
RMS Ball FCU 0.335 0.0634 0.04 0.037 0.000026 
RMS Ball ECU 0.023 0.435 0.128 0.1285 0.032 
Table C.7 ARV statistical analysis between early rehab patient group and late 
stage rehab group individuals in 6 motions 
Metric Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month 
SE 4+ 
Months Sig. 
ARV EFE BB 0.078 -0.0789 0.142 0.100927 0.379 
ARV EFE TB 0.722 -0.0175 0.152 0.106913 0.001 
ARV EFE TB2 -3.421 -0.2554 0.999 0.706369 0.016 
ARV EFE PT 0.0251 0.0221 0.049 0.033161 0.96 
ARV EFE FCU -0.011 -0.008 0.039 0.027701 0.957 
ARV EFE ECU -0.03 -0.004 0.009 0.006035 0.017 
ARV PS BB -0.027 0.0072 0.062 0.043549 0.657 
ARV PS TB 0.387 -0.0014 0.137 0.096527 0.029 
ARV PS TB2 0.018 0.1019 0.045 0.031690 0.14 
ARV PS PT 0.027 0.0833 0.037 0.026062 0.225 
ARV PS FCU -0.003 0.0142 0.021 0.015090 0.523 
ARV PS ECU -0.033 -0.047 0.014 0.009819 0.431 
ARV WFE BB 0.082 -0.134 0.093 0.066210 0.07 
ARV WFE TB 0.709 -0.0225 0.16 0.112527 0.001 
ARV WFE TB2 -3.459 -0.0662 1.026 0.725293 0.012 
ARV WFE PT 0.03 0.0121 0.032 0.022694 0.657 
ARV WFE FCU -0.01 0.0036 0.052 0.036749 0.836 
ARV WFE ECU -0.029 -0.0027 0.028 0.020422 0.456 
ARV URD BB 0.095 0.01433 0.054 0.048776 0.279 
ARV URD TB -4.255 -0.0303 1.363 1.218694 0.03 
ARV URD TB2 3.229 0.042 1.199 1.072292 0.06 
ARV URD PT 0.038 0.04 0.026 0.022880 0.952 
ARV URD FCU -0.025 -0.014 0.015 0.013104 0.567 
ARV URD ECU 0.68 -0.0233 0.237 0.212126 0.036 
ARV HOC BB -0.13 -0.012 0.065 0.042554 0.142 
ARV HOC TB 2.31 -0.024 0.493 0.322551 0.001 
ARV HOC TB2 -2.8 0.0162 0.892 0.584003 0.014 
ARV HOC PT -0.05 0.024 0.03 0.019640 0.059 
ARV HOC FCU -0.04 -0.0179 0.0553 0.036223 0.792 
  
 
181 
181 
ARV HOC ECU -0.012 -0.055 0.0433 0.028350 0.423 
ARV BALL BB -0.017 -0.0122 0.0265 0.017362 0.093 
ARV BALL TB 0.097 0.0567 0.0387 0.059006 0.311 
ARV BALL TB2 1.535 0.0139 0.768 1.172901 0.001 
ARV BALL PT -0.009 0.0594 0.0123 0.018650 0.005 
ARV BALL FCU -0.09 0.00167 0.0324 0.049571 0.002 
ARV BALL ECU -0.008 -0.1422 0.0401 0.061185 0.22 
 
Table C.8 ZC statistical analysis between early rehab patient group and late stage 
rehab group individuals in 6 motions 
Metric Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0-1 
Month 
SE 4+ 
Months Sig. 
ZC EFE BB 788.73 547.5 94 94.05 0.082 
ZC EFE TB 440.27 592.9 434.8 367.45 0.791 
ZC EFE TB2 1079.25 565.6 290.3 237.04 0.183 
ZC EFE PT 876.77 414.4 295.2 249.49 0.242 
ZC EFE FCU 144.83 577.8 421 243.03 0.382 
ZC EFE ECU 1074.33 998 277.2 209.51 0.828 
ZC PS BB 274.67 430 139 74.3 0.333 
ZC PS TB 332.25 462.1 159.6 85.28 0.479 
ZC PS TB2 864 230 220 117.6 0.018 
ZC PS PT 1000.25 503 196.2 104.89 0.035 
ZC PS FCU 1000.25 2037 1019.8 545.09 0.091 
ZC PS ECU 415.17 583.3 192 102.9 0.448 
ZC WFE BB 0.12 0.086 0.07 0.03 0.429 
ZC WFE TB 0.9 0.1056 0.192 0.102 0.002 
ZC WFE TB2 0.083 0.222 0.155 0.083 0.438 
ZC WFE PT 0.07 0.056 0.04 0.023 0.791 
ZC WFE FCU 0.021 0.178 0.1 0.056 0.2 
ZC WFE ECU 0.18 0.127 0.072 0.038 0.489 
ZC URD BB 396.33 277.2 83.7 54.82 0.312 
ZC URD TB 239.28 272. 265.8 174 0.918 
ZC URD TB2 N/A N/A N/A N/A N/A 
ZC URD PT 1487.5 374.2 414.5 271 0.035 
ZC URD FCU 1487.5 374.2 386.8 253.2 0.07 
ZC URD ECU 1789.06 777.6 631.6 413.4 0.193 
ZC HOC BB 261.67 257 91.8 60.1 0.966 
ZC HOC TB 56.78 270.7 196.29 128.5 0.373 
ZC HOC TB2 174.4 703.3 199.31 130.48 0.038 
  
 
182 
182 
ZC HOC PT 698.06 282.1 123.47 80.83 0.011 
ZC HOC FCU 1436.89 474.6 329.12 215.46 0.024 
ZC HOC ECU 692.72 478 390.65 255.74 0.651 
 
Table C.9 MSA statistical analysis between early rehab patient group and late 
stage rehab group individuals in 6 motions 
Metric Motion Muscle 
Mean 0–1 
Month 
Mean 4+ 
Months 
SE 0–1 
Month 
SE 4+ 
Months Sig. 
MSA EFE BB 0.0967 -0.132 0.104 0.08 0.07 
MSA EFE TB 0.6 -0.04 0.177 0.137 0.001 
MSA EFE TB2 -3.427 -0.06 0.159 0.112 0.012 
MSA EFE PT 0.0433 0.013 0.032 0.022 0.621 
MSA EFE FCU -0.01 0.0067 0.052 0.037 0.843 
MSA EFE ECU -0.0333 0.003 0.029 0.021 0.447 
MSA PS BB 0.243 0.167 0.29 0.205 0.82 
MSA PS TB 0.657 0.26 0.174 0.135 0.111 
MSA PS TB2 0.0833 0.055 0.03 0.027 0.352 
MSA PS PT 0.1 0.693 0.163 0.115 0.035 
MSA PS FCU 0.26 0.263 0.217 0.088 0.785 
MSA PS ECU 0.39 0.467 0.185 0.131 0.785 
MSA WFE BB 0.180 0.277 0.126 0.082 0.673 
MSA WFE TB 0.66 0.223 0.196 0.139 0.103 
MSA WFE TB2 0.087 0.164 0.0627 0.049 0.325 
MSA WFE PT 0.194 0.298 0.104 0.074 0.336 
MSA WFE FCU 0.351 1.23 0.306 0.163 0.2 
MSA WFE ECU 0.199 0.439 0.249 0.163 0.375 
MSA URD BB 0.265 0.22 0.104 0.085 0.837 
MSA URD TB 0.75 0.283 0.223 0.158 0.004 
MSA URD TB2 1.473 0.19 0.604 0.54 0.215 
MSA URD PT 0.14 0.285 0.098 0.098 0.711 
MSA URD FCU 0.27 0.258 0.105 0.091 0.939 
MSA URD ECU 0.257 0.55 0.245 0.212 0.53 
MSA HOC BB 0.183 0.21 0.1293 0.085 0.933 
MSA HOC TB NA NA NA NA NA 
MSA HOC TB2 1.85 0.156 0.692 0.536 0.081 
MSA HOC PT 0.147 0.33 0.117 0.091 0.272 
MSA HOC FCU 0.217 0.642 0.154 0.109 0.301 
MSA HOC ECU 0.207 0.61 0.222 0.145 0.11 
MSA Ball BB 0.197 0.18 0.184 0.066 0.828 
MSA BALL TB 1.13 0.697 0.232 0.232 0.96 
  
 
183 
183 
MSA BALL TB2 2.66 0.467 0.602 0.492 0.019 
MSA BALL PT 0.163 0.613 0.24 0.24 0.213 
MSA BALL FCU 0.525 0.47 0.23 0.19 0.673 
MSA BALL ECU 0.117 1.677 0.497 0.497 0.076 
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